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ABSTRACT 
 
Synthesis and Characterization of Aqueous Quantum Dots for Biomedical Applications 
Hui Li 
Advisors: Dr. Wei-Heng Shih, Dr. Wan Y. Shih 
 
 
 
Quantum Dots (QDs) are semiconductor nanocrystals (1~20 nm) exhibiting 
distinctive photoluminescence (PL) properties due to the quantum confinement effect.  
Having many advantages over organic dyes, such as broad excitation and resistance to 
photobleaching, QDs are widely used in bioapplications as one of most exciting 
nanobiotechnologies.  
To date, most commercial QDs are synthesized through the traditional 
organometallic method and contain toxic elements, such as cadmium, lead, mercury, 
arsenic, etc. The overall goal of this thesis study is to develop an aqueous synthesis 
method to produce nontoxic quantum dots with strong emission and good stability, 
suitable for biomedical imaging applications. 
Firstly, an aqueous, simple, environmentally friendly synthesis method was 
developed. With cadmium sulfide (CdS) QDs as an example system, various processing 
parameters and capping molecules were examined to improve the synthesis and optimize 
the PL properties. The obtained water soluble QDs exhibited ultra small size (~5 nm), 
strong PL and good stability. Thereafter, using the aqueous method, the zinc sulfide (ZnS) 
QDs were synthesized with different capping molecules, i.e., 3-mercaptopropionic acid 
(MPA) and 3-(mercaptopropyl)trimethoxysilane (MPS). Especially, via a newly 
developed capping molecule replacement method, the present ZnS QDs exhibited bright 
blue emission with a quantum yield of 75% and more than 60 days lifetime in the 
xiii 
 
ambient conditions. Two cytotoxicity tests with human endothelial cells verified the 
nontoxicity of the ZnS QDs by cell counting with Trypan blue staining and fluorescence 
assay with Alamar Blue. Taking advantage of the versatile surface chemistry, several 
strategies were explored to conjugate the water soluble QDs with biomolecules, i.e., 
antibody and streptavidin. Accordingly, the imaging of Salmonella t. cells and 
biotinylated microbeads has been successfully demonstrated. In addition, 
polyethylenimine (PEI)-QDs complex was formed and delivered into PC12 neuronal cells 
for intracellular imaging with uniform distribution. The water soluble QDs were also 
embedded in electrospun polymer fibers as fluorescent nanocomposite. In summary, the 
ease of aqueous processing and the excellent PL properties of the nontoxic water soluble 
ZnS QDs provide great potential for various in vivo applications. 
 

1 
 
CHAPTER 1: MOTIVATION AND GOAL  
 
 Nanotechnology is a field of applied science and technology whose theme is the 
control of matter and the fabrication of devices or materials on the atomic and molecular 
scale, generally between 1 and 100 nanometers (nm). This is a highly multidisciplinary 
field, benefiting from the efforts and developments in many fields, including applied 
physics, materials science, interface and colloid science, supramolecular chemistry, 
chemical engineering, mechanical engineering, biological engineering, and electrical 
engineering, etc. Since the birth of cluster science and the invention of the scanning 
tunneling microscope (STM) in 1980’s, nanotechnology has been prosperously developed 
with the ability to measure and visualize the novel phenomena, and to manipulate and 
manufacture the materials and devices with nanostructures of 100 nanometers or smaller.  
In a subfield of nanotechnology, researchers study and develop nanomaterials 
which are reduced to the nanoscale dimension showing very different properties 
compared to what they exhibit on a macroscale. For example, as the size of the system 
decreases, the ‘quantum size effect’ becomes pronounced where the electronic properties 
of solids are altered. Meanwhile, the increase of surface area to volume ratio changes the 
mechanical, thermal and catalytic properties of materials significantly. The distinct 
properties enable unique applications of nanomaterials. So far, carbon nanotubes and 
fullerenes, nanoparticles made of silver, gold, silica, zinc (including zinc oxide) and 
titanium (including titanium dioxide) have been widely used in various commercially 
available products. As of April 2008, there are already over 609 nanotech products 
existing in the world, with new ones hitting the market at a pace of 3-4 per week.1 
2 
 
Especially, the semiconductor nanocrystals, so called quantum dots (QDs), are a 
newly emerging nanomaterial, which have attracted many interests. Having excitons 
confined in all three spatial dimensions, quantum dots have properties that are between 
those of bulk semiconductors and those of discrete molecules. When excited by photons 
or electric field with energy higher than the band gap, quantum dots can emit photons 
releasing the absorbed energy. Moreover, the emission energy is adjustable by controlling 
the composition and the particle size of quantum dots due to the quantum confinement 
effect.2 Due to the distinguished photoluminescence and electroluminescence properties, 
quantum dots have been explored extensively for various applications, including imaging, 
detection, therapy, display and energy harvesting, etc.  
The integration of nanotechnology with biotechnology is an attractive trend as 
nanotechnology provides the analytical tools and platforms for the investigation of 
biological systems. As a powerful fluorescent probe, quantum dots have been used for 
imaging of biological targets, disease diagnoses and prognoses, tracking cell/protein 
interactions and cell vitality, etc. Traditional organic dyes are limited by their narrow 
excitation range, low fluorescence intensity and short lifetime. On the contrary, QDs have 
broad excitation but narrow, strong and tunable emission spectra,3 which allow the 
simultaneous observation of multiple probes with different fluorescent colors using a 
single light source.4 With bright emission and extraordinary photostability,5 QDs make 
the long-term real-time monitoring and tracking of molecules and cells more feasible. For 
example, researchers were able to observe QDs in lymph nodes of mice for more than 4 
months.6 The improved photostability of quantum dots also allows the acquisition of 
many consecutive focal-plane images that can be reconstructed into a high-resolution 
3 
 
three-dimensional image. Furthermore, QDs have the fluorescence lifetime significantly 
longer7 than that of organic dyes or auto-fluorescent flavin proteins. Therefore, combined 
with pulsed laser and time-gated detection, the use of QDs label can produce images with 
greatly reduced background noise.8  
Traditionally, most colloidal quantum dots are synthesized through an 
organometallic method, which involves hazardous precursors, high temperature reaction, 
and organic solvents. Although there are some efforts to make the QDs water-soluble, 
many complicated post-synthesis steps have to be taken to exchange the solvent and to 
achieve the strong emission. There is a considerable need for a simple, economic and 
environment-friendly aqueous route to produce biocompatible QDs with strong emission 
and good stability. 
Another remaining issue with quantum dot probes is their in vivo toxicity. So far 
most QDs contain toxic elements, such as cadmium (Cd), lead (Pb), mercury (Hg) and 
arsenic (As), etc. It was reported that9 the Cd-core QDs were cytotoxic, especially when 
surface oxidation through exposure to air or UV irradiation led to the formation of 
reduced Cd on particle surface and the release of free Cd2+ ions. A variety of synthesis, 
storage, and coating strategies have been proposed. But the toxicity of QDs can only be 
reduced to some extent, rather than being eliminated completely. The need for 
understanding the potentially harmful side effects of QDs becomes clear and must be 
carefully examined. More important, the nontoxic QDs are extremely desirable and the 
biocompatibility of QDs is crucial before the quantum dot applications can be approved 
for human clinical use.  
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Along with the booming nanotechnology, quantum dots are a novel and 
outstanding nanomaterial with various promising applications and advantages over other 
materials. However, there is still a lack of an environmentally friendly synthesis of water 
soluble QDs that are nontoxic and can be directly conjugated for bioapplications. The 
overall goal of this research work is to develop such an aqueous synthesis method to 
produce the nontoxic quantum dots with strong emission and good stability, suitable for 
biomedical imaging applications. 
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CHAPTER 2: INTRODUCTION AND BACKGROUND 
 
2.1. Quantum dots and photoluminescence 
 Quantum dots are semiconductor nanocrystals with a typical size of 1-20 nm, 
containing as few as 100 to 100,000 atoms in each particle. As a new nanomaterial with 
confinement in all three spatial dimensions, quantum dots exhibit properties that are 
between those of bulk semiconductors and those of discrete molecules. 
The most common QDs are the binary semiconductor compounds consisting of II-
VI elements, i.e., cadmium sulfide (CdS), cadmium selenide (CdSe), cadmium telluride 
(CdTe), zinc selenide (ZnSe), lead sulfide (PbS), and mercury sulfide (HgS), etc. There 
are also some QDs comprising III-V elements, i.e., indium phosphide (InP), gallium 
nitride (GaN), indium arsenide (InAs), etc. Moreover, some QDs composed of single 
element (such as silicon), or of ternary elements with two of them in either cation or 
anion site (such as CdZnS, CdSSe, InNP, etc.) have also been reported. All these QDs 
compositions are semiconductors with the bulk band gap energy of less than 4 eV usually. 
As nanocrystals, QDs have the atoms aligned periodically with certain crystal lattice 
structure. For instance, the CdS and ZnS QDs usually have the cubic zinc blende or 
hexagonal wurtzite structure.  
Attributed to the energy band structure of semiconductor and the nanosize, 
quantum dots exhibit distinguished photoluminescence (PL) properties, which can be 
illustrated with the schematic in Fig. 2.1. As can be seen, QDs have discrete energy levels 
in both the valence band (VB) and the conduction band (CB), since there are atoms with 
limited number in each particle. When being excited by an energy (Eex) higher than the 
band gap energy (Eg), electrons (represented by the solid circle) in the valence band 
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atic of excitation and emission of quantum dots with the typical energy 
2.2. Quantum confinement effect 
 As semiconductor nanocrystals with the particle size smaller than the Bohr’s 
radius, quantum dots have the dominant quantum confinement effect, with which the size 
dependent standing wave diffraction of electrons occurs as an electron moves through the 
interior and senses the periodical lattice potential and the crystallite boundaries.  
absorb the energy and ‘jump’ to the conduction band, forming short-lived electron-hole 
pairs (the so-called excitons). Then the electrons and holes (represented by the open 
circle) recombine quickly, and photons are emitted with a specific energy corresponding 
to the band gap, which is the band edge emission. As part of the energy may be released 
in a non-radiative way due to the Stokes shift (ΔE), the emission energy (Eem0) is usually 
lower than the excitation energy. When there are some trap states existing in the band gap, 
more possible emissions can happen with various energies (i.e., Eem1, Eem2, Eem3, Eem4), 
which are usually lower than the band gap emission energy (Eem0).   
 
CB 
VB 
ΔE 
Fig. 2.1. Schem
band structure of semiconductor. 
 
Eg Eem1 
Eem2 
Eem3 
Eex 
Eem0 Eem4 
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According to Brus’ study,2 the electronic properties of sufficiently small 
semiconductor crystallites differ from those of bulk materials. The excited states and 
ionization potentials are a strong function of size. Bulk properties will not be reached 
even though the crystallite contains thousands of individual ‘molecular’ units. 
Nevertheless, the bulk band structure, through the effective masses, is of critical 
importance in determining the deviation from bulk properties. With the effective mass 
approximation, an approximate formula was given for the lowest excited electronic state 
energy of semiconductor nanocrystal: 
                                                            (2.1) RemmREE heb επ /8.1)/1/1)(2/( 2222 −++= h
where Eb is the band gap energy of corresponding bulk material, ħ is Plank constant, me 
and mh are the effective mass of electron and hole respectively, e is the charge of electron, 
R and ε are the radius and dielectric constant of the semiconductor nanocrystal 
respectively.  
According to Eq. 2.1, the excited state energy (E) of semiconductor nanocrystals 
is a strong function not only of the material (Eb, ε) but also of the particle size (R). As a 
result, QDs with ultra small size will have higher excited state energy and thereof the 
blue-shifted excitation and emission, compared with those of the corresponding bulk 
material. Meanwhile, the band gap of QDs can be adjusted by changing the composition 
or by controlling the nanoparticle size. Especially, with the same material, the excitation 
and emission of QDs are size-dependent, which is one of QDs’ unique characteristics.  
The calculation of the band gap of small crystallites was also performed based on 
the tight-binding approximation.10 Although there was some discrepancy between the 
semi-quantitative results from the two different calculations, they both predicted the 
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strong size effect on the electronic properties of small semiconductor crystals. Base on 
the photoluminescence mechanism and the quantum confinement effect, the QDs excited 
by a ultra-violet (UV) light can usually emit visible light and exhibit different colors with 
different particle sizes. 
2.3. Synthesis of QDs 
 Quantum dots can be produced through the vapor-phase deposition, evaporation, 
sputtering and epitaxial growth on certain substrates,11-14 which is the so-called Stranski-
Krastanov growth. The lattice-mismatch strain-driven, spontaneously formed, coherent 
island based quantum dots are widely studied and utilized in devices such as transistors, 
light emitters, and detectors. The main limitations of this method are the cost of 
fabrication and the lack of control over positioning of individual dots. 
In this work, we mainly focus on the quantum dots synthesized via solution 
chemistry routes, which have become most popular given their usefulness for biological 
and biomedical applications in vivo and in vitro. Besides the preparation of QDs with 
reverse micelle,15-18 there are several synthetic methods used to form colloidal 
nanocrystals.  
Traditionally, many quantum dots of II-VI and III-V compounds are formed in a 
hot mixture of the tri-n-octylphosphine (TOP) and tri-n-octylphosphine oxide (TOPO) 
with the experimental setup as shown in Fig. 2.2.19 The mixture functions as both a 
solvent and as the stabilizing ligand. Take the synthesis of CdSe QDs as an example.20 
First, certain amount of TOPO is purged with nitrogen or argon gas flow and heated in a 
reaction flask to 200oC ~ 300oC. Stock solutions of dimethylcadmium (Me2Cd) and tri-n-
octylphosphine selenide (TOPSe) are then added to the flask and mixed with vigorous 
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stirring, where the CdSe nanocrystals nucleate quickly and grow with time. Aliquots of 
the reaction solution are removed from the flask at regular time intervals to obtain the 
nanocrystals with different sizes. Isolation and purification of the nanocrystals are 
required to remove the byproducts of the reaction and the excess solvent. To narrow the 
size distribution, the large crystallites are precipitated by adding methanol and then re-
dispersed in 1-butanol. After this size-selective precipitation is repeated for a few times, 
the final product is dispersed in organic solvent, having good size distribution with the 
standard deviation less than 5%. However, this procedure is detrimental to the 
environment and human health, because the raw materials, especially the organometallic 
precursors, are extremely toxic, expensive, unstable, explosive, and/or pyrophoric. 
Although a relatively ‘greener’ approach was developed later using CdO as the 
precursor,21 it has some inevitable disadvantages. The hydrophobic surface of organic 
ligand coated QDs are not suitable for biological applications. High temperature reaction 
is still required. The complexity of the organic synthesis causes the price of the 
commercial QDs prohibitively high. 
                                     
Fig. 2.2. Representation of the synthetic apparatus employed in the preparation of 
quantum dots by the organometallic method.19 
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To make QDs water-soluble and biocompatible, the QDs surface was modified 
with silica coating.22 The 3-(mercaptopropyl) trimethoxysilane (MPS) was adsorbed on 
the surface of nanocrystals and displaced the TOPO molecule, making the QDs stable in 
water and ready for bioconjugation. But this process is tedious, involving multiple steps 
to change the solvent from organic to aqueous. On the other hand, the synthesis of QDs 
directly in water was reported with various systems. The CdTe nanoparticles were 
formed via the reaction between Cd2+ and NaHTe, and started to crystallize and show 
visible photoluminescence after reflux at 96oC for hours.23 The QDs capped with 2-
mercaptoethanol yielded the undesirable broadband emission at large wavelengths. The 
CdSe nanocrystals were also synthesized in water phase.24 The chemical etching in a 
solution of 3-amino-1-proponal/H2O at 80oC was required to achieve the band-edge 
photoluminescence. Moreover, the CdS-mercaptoacetic (CdS/M) clusters were prepared 
using mercaptoacetic acid as the stabilizing agent in the aqueous solution.25 The CdS/M 
cluster was found to be constructed of small nanocrystals, but it was difficult to obtain 
individually dispersed QD. 
2.4. Surface modification 
 Having high surface energy due to the large surface-to-volume ratio, QDs tend to 
aggregate especially in the presence of heat, UV light, and ions. In addition, their 
fluorescence is susceptible to quenching in the biological environment. Proper surface 
modification, therefore, is critical to keep QDs colloidal and photostable under 
intracellular or intercellular conditions. Besides, flexible QD surface chemistry and 
functionality will enable these fluorescent inorganic probes to efficiently couple with the 
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organic reagents and to be capable of targeting and/or sensing ongoing biological 
processes. 
Various surface modifications of QDs have been explored, among which the 
inorganic coating is one of the most popular strategies to provide dense surface protection. 
Passivation of the nanocrystals surface by a thin semiconductor shell didn’t significantly 
modify the absorption and emission wavelengths, but increased the quantum yield up to 
50-70%, e.g., CdSe/ZnS,26 CdSe/CdS27 and ZnSe/ZnS28 core/shell structure. With higher 
band gap energy than that of the core, the ZnS or CdS shell didn’t absorb the emission 
from the core and helped eliminate the broadband emission of the QDs.29 The core-shell-
shell nanocrystals were also developed, i.e., CdSe/CdS/ZnS, CdSe/ZnSe/ZnS,30 and 
CdSe/ZnTe/ZnS31 QDs. The middle shell allows considerable strain relaxation between 
the inner core and the outer shell, and helps to further improve the photoluminescence 
efficiency and photostability exceeding those of CdSe/ZnS nanocrystals.  
Depending on the relative position of band gaps of the core and shell materials, 
there are two types of core/shell QDs, as illustrated by the schematics in Fig. 2.3.  When 
the valence band (VB) edge of core is higher than that of shell and the conduction band 
(CB) edge of core is lower than that of shell, the electron (solid circle) and hole (open 
circle) are localized in the same region and can recombine very quickly. This is the so-
called type I core/shell structure, as shown in Fig. 2.3 (A). On the contrary, if both the 
valence and conduction band edges of core are higher or lower than those of shell, the 
electron and hole are prone to being spatially separated between the core and shell for 
lower energy states, resulting in longer lifetime of excitons before recombination. This is 
the type II core/shell structure, as shown in Fig. 2.3 (B) and (C). Based on the relative 
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band edge position of the semiconductor compounds,32 the CdS/ZnS core/shell QDs are 
type I, while the CdSe/CdS, CdTe/CdSe,33, 34 CdSe/ZnTe31 QDs are type II. Interestingly, 
the core/shell QDs can be tuned between type I and type II by continuously changing the 
shell thickness.35 
 
Core/Shell Core/Shell Core/Shell 
CB 
E  b
VB 
        A B C 
Fig. 2.3. Schematics of the energy band alignment of type I (A) and type II (B and C) 
core/shell QDs. 
 
Besides the semiconductor coating, many other methods for surface modification 
of QDs were proposed and studied. For example, the silica coated CdSe QDs were 
obtained by using 3-mercaptopropyl trimethoxysilane in a weak alkaline solution, to 
achieve the enhanced PL intensity and stability.36 The hydroxide shell can be generated 
under basic condition too, to cover the nanoparticles and enhance their emission intensity 
by passivation of surface state.37 The biocompatible modification and functionalization of 
QDs was realized via the direct reaction of organic silanes in toluene.38 Multidentate 
organic ligands consisting of various lengths of polyethylene glycol (PEG) and thioctic 
acid provided a method to achieve the aqueous solubility of QDs over a broad pH range 
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based on the dihydrolipoic acid (DHLA) ligand motif.39 The homogeneous CdS and 
CdSe/polymer nanocomposites were prepared via in situ radical polymerization in 
miniemulsion, which maintained the optical properties of encapsulated QDs.40 It was also 
reported that the water-soluble QD micelles were synthesized through encapsulation of 
hydrophobic QDs into surfactant/lipid micelles, showing good monodisperse and 
biocompatibility.17 Conjugates of bovine serum albumin and L-cysteine capped CdTe 
nanoparticles were produced with a significant increase of the emission.41  
Sometimes the QDs surface is modified with multiple layers in the sequence of 
inorganic coating, functional biomolecule or amphiphilic polymer, and linker molecule or 
receptor protein. As an example, Fig. 2.4 shows the QD core covered by a ZnS shell and 
DHLA capping molecules, and then conjugated with avidin which can specifically link 
with any biotinylated targets.42 The MBP-zb was used to regulate the number of avidin 
molecules present on each QD. In this case, the enhanced emission, improved stability 
and bioconjugation flexibility of QDs are all achieved. However, the ultra small size of 
QDs may be sacrificed as the complex become considerably big. 
 
 
Fig. 2.4. The mixed surface approach for conjugating biotinylated biomolecules to 
DHLA-capped QDs using avidin as the linker molecule.42  
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2.5. Applications of QDs 
 Quantum dots have been used and displayed great potentials in numerous 
applications. 
 
 
Fig. 2.5. Simultaneous in vivo imaging of multicolor QD-encoded microbeads in a live 
animal (left) and the QD-encoded microbeads emitting green, yellow or red light (right). 
The scale bar is 1 µm.4 
 
In the biomedical field, the QD-based fluorescent imaging approach was used as a 
sensitive and convenient tool for quantitative assessment of cancer cell behavior43 and for 
sentinel lymph node mapping.44 Labeled by QDs with different emission colors, the 
microbeads injected in a mouse body were imaged and differentiated under a single UV 
light source, as shown in Fig. 2.5.4 The decoration of virus with luminescent QDs has 
also been demonstrated.45 The QDs fluorescence characteristic offers the opportunity to 
label the myosin46 or any protein undergoing conformational changes in multiple 
locations, so that a three-dimensional picture of the structure dynamics can be obtained at 
the molecular level in real time. Moreover, QDs conjugated with a paramagnetic lipidic 
coating enable the use both for optical imaging and magnetic resonance imaging (MRI).47 
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The QD-tagged microbeads are emerging as a new class of fluorescent labels with 
enhanced photostability and brightness, which are expected to open new opportunities in 
nanotechnology and biology.48 
 
 
Fig. 2.6. Schematic of the TNT titration assay using the QD-TNB2-45 nanosensor 
assembly.49 
 
QDs can also be used as valuable analytical tools for various detection 
applications. With surface modification by different ligands, QDs as a chemical sensor 
have the luminescence responding selectively to many physiologically important metal 
cations, e.g., Zn2+, Cu2+,50, 51 Ca2+, Mg2+, Mn2+, Ni2+, Co2+,52 and Ag+,53 etc. The QDs 
conjugated with a certain receptor also exhibited the fluorescence tunability with the 
presence of some anions, such as F-, Cl-, Br-, HS-, and CH3COO-, etc.54 Based on the 
proximity-induced fluorescence resonance energy transfer (FRET), the luminescent QDs 
conjugated to antibody fragments and emission receptors were developed as solution-
phase nano-scale sensing assemblies. As a specific example, the explosive 2,4,6-
trinitrotoluene (TNT) in aqueous environments were detected by monitoring the increase 
of QD emission, as indicated in Fig. 2.6.49 When TNB-BHQ-10 is bound to the QD-
TNB2-45 conjugate, the QD fluorescence is quenched (left). As TNT is added to the 
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assay, it competes for binding to the antibody fragment and the QD fluorescence 
increases following TNB-BHQ-10 release from the conjugate (right). The photo-induced 
electron transfer between quenchers and QDs has also been utilized to probe protein-
ligand interactions with luminescence measurements.55  
Furthermore, the QDs linked to a photosensitizer were used for photodynamic 
cancer therapy.56 And studies for drug delivery have benefited from the use of QDs due 
to their ability to accumulate in tumors by enhanced permeability and retention at tumor 
sites or by antibody binding to cancer-specific cell surface biomarkers.57 It was indicated 
that QDs can bind with bacteria and impair the functions of a cell’s antioxidative system, 
which have the potential to be a novel antimicrobial material with excellent optical 
properties.58 
Besides photoluminescence, QDs can also be excited by an electric field and emit 
photons, or absorb photons and generate electric potential difference. Significant amount 
of research has been carrying out to utilize QDs in displaying and solar cells based on 
their electroluminescence59-63 and photovoltaic64-67 properties. The integration of organic 
and inorganic materials at the nanometer scale into hybrid optoelectronic structures 
enables active devices that combine the diversity of organic materials with the high-
performance electronic and optical properties of QDs.68 A light-emitting device (LED) 
with QDs as the luminescent source usually consists of a QDs layer sandwiched between 
organic thin films and electrodes on indium tin oxide (ITO) coated glass substrate.59 
Compared with other light source, QDs can generate purer color because they emit light 
in a very specific wavelength, and require less power input since they are not color 
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filtered. The multilayer structure can also be used in optoelectronic applications with 
QDs as the light absorber and electric carrier source.  
Many other interesting phenomena have been explored and investigated to 
understand the behavior and properties of QDs for their wide spreading applications. It 
was reported that QDs could initiate current bursts in lipid bi-layer membranes upon 
application of a bias voltage, as a large permanent dipole moment of the QDs resulted in 
insertion into the lipid bi-layer in the presence of an electric field.69, 70 Due to the large 
surface-to-volume ratio, nanometer-sized QDs colloids can be used to degrade water 
pollutants as efficient photocatalyst in environmental remediation technologies.71 
2.6. Toxicity of QDs 
 Although QDs offer potentially invaluable societal benefits such as in vivo 
biomedical imaging and detection, they may also pose risks to human health and the 
environment under certain conditions.72 Generally, there are at least three different 
pathways by which QDs can interfere with organism function and lead to metabolic 
disability or death.73 First and most important is the composition of QDs. Upon corrosion 
inside the organism, toxic ions could be released from QDs and poison the cells. 
Compared with the bulk material, nanoparticles are more likely to have partial 
decomposition and release of ions due to their high surface-to-volume ratio. Another 
possible negative effect of QDs results from their small size, regardless of the 
composition of material. Particles can stick onto the surface of cell membranes, or can be 
ingested and retained inside cells, causing the impairing effects. The shape of particles 
may cause some adverse problems as well. It was reported, for example, that carbon 
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nanotubes can impale cells like needles. In this work, more attention will be paid to the 
toxicity of QDs composition, which is universally momentous. 
To date, most commercial QDs contain toxic elements, such as Cd, Pb, Hg and As 
etc. It was reported that9 the Cd-core QDs were indeed cytotoxic, especially when surface 
oxidation through exposure to air or UV irradiation led to the formation of reduced Cd on 
particle surface and the release of free Cd2+ ions. As demonstrated in Fig. 2.7, the cells 
cultured with CdSe QDs for 7 days were damaged with poorly defined cell boundaries 
and diffused nuclei. It was also shown that74 CdTe QDs exerted deleterious effects on 
cellular processes, and the smaller ones with green emission were more harmful than the 
larger red-emitting ones.  
 
 
Fig. 2.7. Phase contrast micrographs (left column) and corresponding fluorescence 
images (right column) of hepatocyte colonies cultured with CdSe QDs on day 1 (A and B) 
and after 7 days (C and D). Scale bar is 100 µm.9 
  
Meanwhile, studies suggest that the QD toxicity depends on multiple factors 
derived from both inherent physicochemical properties and environmental conditions. 
The QD size, charge, concentration, outer coating bioactivity (capping material and 
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functional groups), and oxidative, photolytic, and mechanical stability have each been 
implicated as determining factors in QD toxicity.75-78 
To alleviate the toxicity of QDs, a variety of synthesis, storage, and coating 
strategies have been proposed. Surface coatings such as ZnS, bovine serum albumin 
(BSA) and Vitamin E79 were shown to reduce, but not eliminate the cytotoxicity. With 
different surface modifications including mercaptopropionic acid, silanization, and 
polymer coating, there were always quantitative concentration limits of QDs for the onset 
of cytotoxic effects to occur.80, 81 Therefore, QDs with toxic elements will eventually 
induce cell death due to their inherent chemical composition. They can never be 
considered as 100% biocompatible or safe, but depending on the experimental conditions 
under which the toxicity can be tolerated. 
2.7. Summary and objectives 
In summary, quantum dots are semiconductor nanocrystals, exhibiting many 
distinctive properties different from those of the corresponding bulk materials, which 
make QDs more attractive with more potential applications. Although the research on 
quantum dots has been developed for over one decade, there are still many challenges 
which need to be addressed before QDs can be widely used, especially for the clinical 
applications in humans.  
The overall goal of this research work can be described with the specific 
objectives as listed below: 
1. Develop an aqueous, simple, economic and environment-friendly method to 
synthesize the water soluble QDs by a one-step reaction of inorganic chemicals. The 
aqueous QDs are expected to be dispersed well in water with ultra small size. Various 
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processing parameters are to be investigated to improve the synthesis procedure and to 
optimize the properties of the aqueous QDs.  
2. Produce the non-heavy-metal ZnS QDs to avoid the toxic elements in QDs. 
These intrinsically nontoxic QDs are to be synthesized using the developed aqueous 
method. Different capping molecules and optimized processing parameters are employed 
to produce the water soluble ZnS QDs with strong photoluminescence as well as good 
colloidal and photo stability. 
3. Perform cytotoxicity tests to verify the nontoxicity of the obtained ZnS QDs 
and to compare with the results of CdS QDs. The live/dead cells and metabolism 
activities of cells are monitored to examine the effects of QDs with different 
concentrations and surface conditions. 
4. Explore conjugations of the water soluble QDs for various bioapplications. 
With different surface modifications and functional groups, the aqueous QDs are to be 
attached to biomolecules and polymers via covalent bonding and/or electrostatic 
interaction for conjugation and imaging applications.  
Based on the specific objectives discussed above, the rest of the thesis will be 
organized as follows. Chapter 3 describes the development of aqueous synthesis method 
with CdS QDs as the example system. The effects of many processing parameters are 
studied. Chapter 4 describes the synthesis and characterization of non-heavy-metal ZnS 
QDs with different capping molecules which offer the opportunities to enhance PL 
intensity and stability. Chapter 5 describes the cytotoxicity tests of the aqueous ZnS QDs 
and compares with the results of the CdS QDs. Chapter 6 describes several conjugation 
strategies and examples of the bioimaging applications of the aqueous QDs. We have 
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collaborated with several researchers in the applications of our QDs. The collaborated 
work is described in Chapter 7. Finally, conclusions will be discussed in Chapter 8 and 
future work in Chapter 9. 
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CHAPTER 3: SYNTHESIS AND CHARACTERIZATION OF AQUEOUS 
CARBOXYL-CAPPED CdS QUANTUM DOTS 
 
Introduced in the early 90’s, most quantum dots were traditionally synthesized 
using the organometallic method which involved the pyrolysis of organometallic 
precursors in the coordinating solvents TOP and TOPO.20 Specifically, the dimethyl 
cadmium (Cd(CH3)2) was used as the cadmium precursor, which was toxic, expensive 
and unstable. Meanwhile, the size selective precipitation has to be repeated to obtain the 
nanocrystals with narrow size distribution.  
More recently, the synthesis of CdS,82 CdSe83 and CdTe84 QDs using cadmium 
oxide (CdO) and hexylphosphonic acid (HPA) or tetradecylphosphonic acid (TDPA) was 
developed by Peng et al.21 Although this is a relatively ‘greener’ chemical approach, the 
reaction still had to occur at high temperature around 300oC and in organic solvent. 
For biomedical applications, the hydrophobic QDs were coated with a silica shell 
to become water-soluble.22 The 3-(mercaptopropyl) trimethoxysilane (MPS) and/or 
tetraethyl orthosilicate (TEOS) was added, which replaced the TOPO molecules on the 
QD surface, forming a polymerized layer by hydrolysis and silanization. This process 
involved multiple steps to bring the QDs from organic to aqueous solvent. Furthermore, 
additional functionalization with different biomolecules was required to make the surface 
of QDs suitable for subsequent bioconjugation and applications.   
To produce quantum dots in water directly, Vossmeyer et al.85 examined the 
aqueous synthesis of CdS nanoclusters using Cd(C1O4)·6H2O, H2S and 1-thioglycerol as 
the precursors. The as-synthesized nanoclusters showed the size-dependent UV-Vis 
absorption, but no photoluminescence was observed. The CdS-mercaptoacetic (CdS/M) 
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clusters were also prepared using mercaptoacetic acid as the stabilizing agent in the 
aqueous solution.25 The CdS/M cluster was found to be comprised of small nanocrystals, 
but it was difficult to obtain individually dispersed QD. Besides, the CdSe nanocrystals 
were synthesized in water phase,24 while the chemical etching in a solution of 3-amino-1-
proponal/H2O at 80oC was required to achieve the band-edge photoluminescence. 
Meanwhile, Rogach et al.23 and Gao et al.86 described the synthesis of CdTe nanocrystals 
in an aqueous solution via the reaction between Cd2+ and NaHTe. This method required 
the complex preparation of the Te precursor NaHTe, where H2Te was first generated via 
the reaction between Al2Te3 and H2SO4, followed by titration into NaOH solution under 
N2 atmosphere to obtain NaHTe. In addition, the reflux at 96oC for several hours was 
needed to obtain the photoluminescence emission of the CdTe QDs. The QDs capped 
with 2-mercaptoethanol exhibited the broadband emission at large wavelengths. In 
addition, the aqueous synthesis of CdTe QDs was reported through the assistance of 
microwave irradiation.87 
Apparently, there remains a need to investigate a direct aqueous synthesis route 
that is benign to the environment, friendly to human health, simple and cost-effective, can 
produce highly luminescent water-soluble QDs that are well dispersed and ready for 
bioapplications.  
In this research work, we first developed a new aqueous synthesis method, which 
can be used to produce high quality QDs with various compositions.88 Using CdS QDs as 
a model system and with 3-mercaptopropionic acid (MPA) as the capping molecule, the 
aqueous method is described. The effects of several processing parameters on the 
photoluminescence properties of the CdS QDs are examined and discussed, including the 
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sonication time, the refrigeration condition, the synthesis atmosphere, the pH, the 
suspension temperature, the precursor concentration, and the MPA/Cd molar ratio. MPA 
molecule was chosen to serve both as a stabilizer to disperse QDs and as a cross linker 
for subsequent conjugation of QDs with other biomolecules.89  
3.1. Aqueous synthesis 
            All chemicals were used as purchased without further purification. A typical 
synthesis procedure is described as follows. The cadmium nitrate [Cd(NO3)2] (Alfa Aesar, 
Ward Hill, MA) solution (0.04 M) and the sodium sulfide [Na2S] (Sigma-Aldrich, St 
Louis, MO) solution (0.02 M) were first prepared in deionized (DI) water, respectively. 
The Cd(NO3)2 solution developed white precipitates over a long period of time. For the 
synthesis, the prepared solutions were used fresh while they were completely dissolved. 
For the sample with a ratio of MPA:Cd:S = 2:2:1, 0.16 mmol MPA (Sigma-Aldrich, St 
Louis, MO) was added in 40 ml of DI water and stirred for 5 min. 2 ml of the 0.04 M 
Cd(NO3)2 solution was dropped slowly into the MPA solution with constant stirring for 
10 min. Subsequently, the mixture was titrated with tetrapropylammonium hydroxide 
[(CH3CH2CH2)4NOH] (Sigma-Aldrich, St Louis, MO) to pH 9 and stirred for 10 min, 
followed by rapid addition of 4 ml of the 0.02 M Na2S solution. We then waited for 5 min 
before adding another 2 ml of the 0.04 M Cd(NO3)2 solution. The pH of the suspension 
was maintained at 9 by adding (CH3CH2CH2)4NOH with constant stirring for 5 more 
minutes. The obtained CdS QDs suspension was clear with a light yellow tint. The final 
volume of the sample was about 50 ml and the nominal CdS concentration was 1.6 mM 
based on the concentration of S. The aqueous CdS QDs suspension was quenched to 0°C 
in a freezer and stored in a refrigerator at 4°C.  
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For comparison purpose, another capping molecule, 2-mercaptoethanol (ME) 
(Pierce Biotechnology, Rockford, IL), was also used for the synthesis of aqueous CdS 
QDs via the same procedure. If not mentioned otherwise, all the QDs samples have the 
same CdS concentration of 1.6 mM.   
The whole synthesis process occurred at room temperature, and the CdS QDs 
were produced in water directly. The simple inorganic chemical precursors were used, 
which reacted in one-step to form the nanoparticles capped by MPA. Compared with the 
other synthesis methods discussed earlier, this newly developed approach avoided the 
detrimental organometallic precursors and the organic solvents, the heating and other 
complicated post-treating processes. The obtained MPA-capped QDs were dispersed well 
in water and their properties were characterized as below. 
3.2. Size and structure 
 
 
  10 nm 
Fig. 3.1. TEM micrograph of the MPA-capped CdS QDs exhibiting individually 
dispersed particles with a size of 4-5 nm. 
 
To image the as-synthesized MPA-capped CdS QDs and characterize the particle 
size, transmission electron microscopy (TEM) was carried out with a 2000FX electron 
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microscope (Japan Electron Optics Ltd., Tokyo, Japan) operated at 200 kV. Samples 
were prepared by dropping the CdS QDs suspension on the surface of carbon-coated 
copper grid and drying it in air. Figure 3.1 is a typical TEM micrograph of the MPA-
capped CdS QDs, which showed the individual particles with a size of 4-5 nm. This is 
consistent with the filtering results which indicated that most of the CdS QDs can pass 
through 50 kD filter with the pore size of around 5 nm.  
The MPA-capped CdS QDs suspension was also dropped on a clean silicon 
substrate and characterized with an atomic force microscope (AFM). As shown in Fig. 
3.2, a slow scan with high resolution indicated that the relatively smaller particle had a 
height of about 2 nm.  
 
 
Fig. 3.2. (a) AFM micrograph of the MPA-capped CdS QDs and (b) the corresponding 
scanning spectrum along the red line in (a) exhibiting the height of the smaller particle of 
2 nm. 
(b) 
(a) 
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For X-ray diffraction (XRD) study, the MPA-capped CdS QDs were precipitated 
from the suspension by adding ethanol. The powder sample was centrifuged and 
separated from the solution, collected and dried in air at 50oC overnight. The powder 
XRD pattern was measured by a Siemens D 500 X-Ray Diffractometer operated in the 
Bragg configuration using Cu Kα radiation with the wavelength of 1.54 Å. The 
accelerating voltage was set at 40 kV and the current flux was 30 mA. The X-ray 
scanning step was 0.05o and the speed was 0.05o per second.  
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Fig. 3.3. XRD pattern of the MPA-capped CdS QDs. The vertical lines indicate the 
pattern with relative intensities of bulk CdS with cubic zinc blende structure. 
 
The obtained XRD pattern of the MPA-capped CdS QDs is shown in Fig. 3.3, 
along with the pattern and relative intensities of CdS bulk material with cubic zinc blende 
structure. It is indicated that the present CdS QDs have a cubic zinc blend crystalline 
structure with the three peaks indexed as (111), (220), (311), respectively. Note that the 
peaks in the pattern of the CdS QDs exhibited significant line broadening, due to the ultra 
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small size of the nanocrystals. The crystallite size can be estimated according to the 
Scherrer’s equation:90 
                                               
BB
Kd θ
λ
cos∗
∗=                                                      (3.1) 
where d is the average diameter of crystallites, K is a constant of 0.89 usually, λ is the X-
ray wavelength, B is the full width at half maximum (FWHM) of the peak in the pattern, 
and θ is the corresponding Bragg angle. Based on the data from Fig. 3.2, the crystalline 
size of the CdS QDs was estimated to be about 2 nm. This is smaller than the particle size 
indicated by the TEM result, due to the fact that one particle may contain several 
nanocrystallites. 
3.3. PL and absorption 
Photoluminescence spectra of the QDs suspension were measured using a QM-
4/2005 spectrofluorometer (Photon Technology International, Birmingham, NJ). For all 
PL measurements, the spectrofluorometer was maintained in the same configuration, i.e., 
the power for the xenon lamp was 75 W, both the excitation and emission slit width 2 nm, 
the voltage for the photomultiplier tube (PMT) detector 1050 V, the integration time 0.25 
s and the step size 1 nm. To ensure that we had the constant instrumental conditions for 
all the PL measurements, the Raman peak of DI water was monitored as a standard for 
calibration. With a 350 nm incident light beam and under the above specified 
measurement conditions, DI water would exhibit a Raman peak at 399 nm with an 
intensity of 3500 ± 2% counts per second (cps). After each measurement, we routinely 
scanned DI water again. The Raman peak still had the intensity of 3500 ± 2% cps, which 
ensured that the spectrofluorometer worked under the same conditions for all 
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measurements. Background correction was carried out to remove the wavelength 
dependence of the detector. For an excitation spectrum, the detection wavelength was 
fixed, while the excitation wavelength was scanned. For an emission spectrum, the 
excitation wavelength was fixed, while the detection wavelength was scanned. For a 
given sample, the excitation wavelength resulting in the optimal emission intensity was 
identified first from the excitation spectrum, and then the emission spectrum was 
obtained using the optimal excitation wavelength.  
UV-Vis absorption spectra were measured with a Lambda-40 UV-Vis 
spectrometer (PerkinElmer Life And Analytical Sciences Inc., Boston, MA), which was 
configured with the slit width of 2 nm, the scanning speed of 4 nm per second and the 
data interval of 1 nm.  
During all the PL and absorption measurements, the QDs suspension was loaded 
in a 4.5 ml disposable plastic cuvette and scanned.  
Figure 3.4 shows the typical PL emission (solid line) and absorption (dashed line) 
spectra of the MPA-capped CdS QDs. Because the UV-Vis absorption increases 
dramatically below the wavelength corresponding to the band edge, empirically, the 
absorption edge is determined as the wavelength with the greatest change in slope, i.e., 
the wavelength where the absorption curve bends the most and starts to deviate from the 
longer wavelength background absorption. As can be seen, the present MPA-capped CdS 
QDs had the emission peak at around 560 nm, while the absorption edge was at 460 nm. 
Note that the emission peak wavelength was about 100 nm larger than the corresponding 
absorption edge wavelength. This indicates the emission of the present CdS QDs was due 
to the trap-state emission, rather than the band-edge emission. The trap-state emission is 
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associated with electron transitions between the trap states and the conduction band (or 
valence band). Because of the smaller energy difference between the trap states and the 
edge of the conduction band (or that of the valence band) than that of the band gap, trap-
state emissions occur at larger wavelengths than that of the band-edge emission. There 
are many possible trap-state emissions each with different emission wavelength. All these 
emissions could contribute to the photoluminescence of the QDs, resulting in the 
relatively wide emission peak. As shown in Fig. 3.4, the PL spectrum of the present 
aqueous CdS QDs had the FWHM of about 150 nm. 
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Fig. 3.4. PL emission (solid line) and absorption (dashed line) spectra of the MPA-capped 
CdS QDs. 
 
3.4. Quantum yield 
The fluorescence quantum yield (QY) is the ratio of photons absorbed to photons 
emitted through fluorescence. In other words, the quantum yield gives the probability of 
the excited state being deactivated by fluorescence rather than by another non-radiative 
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mechanism. The most reliable method for measuring QY is the comparative method 
developed by Williams et al.,91 which involves the use of well characterized standard 
samples with known QY values. Essentially, solutions of the standard and test samples 
with identical absorbance at the same excitation wavelength can be assumed to absorb the 
same number of photons. Hence, a simple ratio of the integrated fluorescence intensities 
of the two solutions (recorded under identical conditions) will yield the ratio of the 
quantum yield values. Since QY for the standard sample is known, it is easy to calculate 
the QY for the test sample. To have the quantum yield measurement more reliable, it is 
required that the standard and the test samples have similar optimal excitation and 
emission wavelengths.  
To obtain the quantum yield of the aqueous CdS QDs with the ratio MPA:Cd:S of 
2:1:1, Rhodamine 101 (Fisher Scientific, Fairlawn, NJ) (with the optimal excitation of 
367 nm and the emission of 589 nm) was used as a standard. The commercial EviTags 
CdSe/ZnS core/shell QDs (Evident Technologies Inc., Troy, New York) were also 
included for comparison. The absorbance and the PL emission spectrum of each system 
were measured with a fixed excitation wavelength of 365 nm at several dilute 
concentrations. The wavelength of 365 nm was chosen because it was the proper 
excitation wavelength for all the samples. To minimize the potential re-absorption,92 the 
absorbance was kept below 0.15 to avoid any effect due to concentration. The integrated 
fluorescence intensity was obtained by integrating the emission intensity over the entire 
area under the emission peak in the PL spectrum. 
In Fig. 3.5, we plot the integrated fluorescence intensity versus absorbance of the 
aqueous MPA-capped CdS QDs (solid triangles with solid line), along with those of 
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Rhodamine 101 (open squares with dashed line) and EviTags CdSe/ZnS core/shell QDs 
(open circles with dotted line). The quantum yield, φX, can be expressed as93  
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where φX (φST), GradX (GradST), and ηX (ηST) denote respectively the quantum yield, the 
slope of the integrated fluorescence intensity versus absorbance, and the solvent 
refractive index of the test sample (the standard). In this experiment, Rhodamine 101 was 
dissolved in ethanol (ηethanol = 1.36) as the standard with the known quantum yield of 
100%.94 The aqueous CdS QDs and the EviTags CdSe/ZnS QDs were dispersed in DI 
water (ηwater = 1.33). Using Eq. (3.2), we deduced the quantum yield of the aqueous CdS 
QDs to be 6.0%, and that of the EviTags CdSe/ZnS QDs 8.9%.  
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Fig. 3.5. Integrated fluorescence intensity versus absorbance of the aqueous MPA-capped 
CdS QDs (solid triangles with solid line), along with those of Rhodamine 101 (open 
squares with dashed line) and EviTags CdSe/ZnS core/shell QDs (open circles with 
dotted line) for comparison. 
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It was encouraging that with the present aqueous synthesis route, we have 
produced CdS QDs exhibiting quantum yield comparable to that of the commercial core-
shell QDs. It is most likely that the quantum yield of the aqueous QDs can be further 
improved by adding a shell, since it is well known that the core-shell structure enhances 
the quantum yield of QDs.26, 27 
3.5. Capping molecules 
In the synthesis of the aqueous CdS QDs, MPA (HSCH2CH2COOH) was used as 
the capping molecule to disperse the nanoparticles in the suspension and to control the 
particle size. The thiol group (HS-) of the MPA attached to the Cd cations on the particle 
surface and the carboxyl group (COO-) on the other end of the MPA was fully charged at 
high pH, as illustrated in Fig. 3.6 (a). As a result, the QDs were stabilized and dispersed 
from each other due to the electrostatic repulsion, as shown in Fig. 3.6 (b). 
 
                              
                                      (a)                                                           (b) 
Fig. 3.6. (a) Schematic of a CdS particle bound with the MPA through the thiol group; (b) 
schematic of CdS particles stabilized by the MPA on the surface with negatively charged 
carboxyl groups at high pH. 
 
To further investigate the effect of capping molecules, we synthesized the MPA-
capped CdS QDs with a MPA:Cd:S ratio of 2:2:1. For comparison, we also synthesized 
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the CdS QDs with 2-mercaptoethnol (ME) as the capping molecule and with the ratio 
ME:Cd:S of 2:2:1. The PL emission and absorption spectra of the MPA-capped CdS QDs 
(solid lines) are shown in Fig. 3.7, together with those of the ME-capped CdS QDs 
(dashed lines). As can be seen, the MPA-capped QDs exhibited a much higher PL 
intensity than the ME-capped QDs. Meanwhile, the absorption edge of the MPA-capped 
QDs was larger than that of the ME-capped QDs. Because the absorption edge 
wavelength corresponds to the band edge energy, and according to the relationship 
between the band edge energy and the particle size,2 we estimated the particle size of the 
MPA-capped QDs to be 3.2 nm, larger than that of the ME-capped QDs, 2.9 nm.  
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Fig. 3.7. PL emission and absorption spectra of the MPA-capped CdS QDs (solid lines), 
along with those of the ME-capped CdS QDs (dashed lines).  
 
The emission peak of the CdS QDs was much larger than the absorption edge, 
indicating that the present QDs had the trap-state emissions, rather than the band-edge 
emissions. If the trap-state emissions were surface-trap-state emissions, the emission 
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intensity would have increased with a decreased QD particle size, as both the surface area 
and the particle number would increase, given the same CdS concentration. However, to 
the contrary, the present QDs exhibited the opposite trend: the MPA-capped QDs, though 
larger, had higher emission intensity than the ME-capped QDs. Note that both samples 
had the same CdS concentration of 1.6 mM. It would be more reasonable that the trap-
state emissions were related to bulk defects, as the MPA-capped QDs with larger size had 
more molecules inside the particles contributing to the stronger emission. Earlier, the 
emission of CdS colloidal particles synthesized in water was found 0.9 eV lower than the 
band-edge emission and was attributed to bulk-trap-state emissions involving the 
recombination of electrons with holes at sulfur vacancies.95 Given the Cd-rich synthesis 
environment of the present aqueous QDs, it is likely that sulfur vacancies also existed in 
the present QDs and the observed emissions could be sulfur-vacancy related bulk-trap-
state emissions.   
As can be seen in Fig. 3.7, the emission peak wavelength of the MPA-capped CdS 
QDs was larger than that of the ME-capped QDs. This indicated that the trap-state 
emissions of the present QDs were also size dependent, similar to the band edge emission. 
This result was consistent with a recent study which showed that along with band edges, 
the energies of trap states could also change with the particle size to result in particle-size 
dependent trap-state emissions.96 
The size distribution of the CdS QDs in aqueous suspension was measured via 
dynamic light scattering (DLS) with a Zetasizer Nano ZS (Malvern Instruments Ltd., 
Worcestershire, United Kingdom). During the measurement, because the solvent was DI 
water, the reflective index and viscosity were set as 1.330 and 0.8872, respectively. 
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00
Because the solute was CdS, the reflective index and absorption were set as 2.50 and 0.10, 
respectively. A laser with wavelength of 633 nm was used as the incident light source.  
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Fig. 3.8. Size distribution of the MPA-capped CdS QDs (solid squares with solid line) 
and of the ME-capped CdS QDs (open circles with dashed line) 
. 
As shown in Fig. 3.8, the MPA-capped CdS QDs (solid squares with solid line) 
had the average size of about 6 nm, while the ME-capped CdS QDs (open circles with 
dashed line) had the average size of 31 nm. These were consistent with the result shown 
in Fig. 3.7, where the MPA-capped QDs had much smaller measured absorbance 
compared with the ME-capped QDs, because the small particles scatter much less light 
than the large ones. Apparently, the average sizes of both samples were larger than their 
particle sizes as deduced from the absorption edge. Since the DLS measured the cluster 
size of the QDs rather than the primary nanocrystal size, these results indicated that both 
the MPA-capped and ME-capped QDs aggregated to some degree in the suspensions. 
The cluster size of the ME-capped QDs was much larger than that of the MPA-capped 
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QDs, indicating that the ME-capped QDs were more prone to aggregation. This 
difference may be attributed to the fact that MPA was more highly charged than ME at 
the same pH, as the carboxyl group of MPA can be dehydrogenized more easily than the 
hydroxyl group of ME. As a result, the MPA can maintain the colloidal stability of the 
QDs better than ME. Meanwhile, the lower PL intensity of the ME-capped QDs may be 
partially due to their higher-degree of clustering. Because of the proximity in the cluster, 
the emission of QDs could be dissipated in a non-radiative way through the interfacial 
states which resulted in the decreased PL intensity.19  
3.6. Effect of processing parameters 
We examined the effects of several processing variables, including the sonication 
time, the refrigeration conditions, the synthesis atmosphere, and the pH, on the PL 
properties of the obtained aqueous CdS QDs.  
Sonication was carried out after synthesis when desired using the Ultrasonic 
Homogenizer 4710 series (Cole-Parmer Instrument Co., Chicago, IL). The sonication tip 
was immersed in the QDs suspension, and the output control was set at 4. As shown in 
Fig. 3.9 (a), compared with the sample sonicated for 5 min, the sample sonicated for 10 
min exhibited about 80 nm red-shift of the emission spectrum. This can be explained by 
the increased suspension temperature which promoted further particle growth during the 
sonication process. Although conventional sonication may break up agglomerates and 
result in smaller particles, it usually applies to systems where particle nucleation and 
growth occur at high temperature. However, the present aqueous CdS QDs nucleated and 
grew at room temperature. A slight increase in temperature could have a significant 
impact on the particle size, which can then affect the emission peak wavelength. In 
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contrast to sonication, refrigeration had the opposite effect on the PL properties of QDs. 
As shown in Fig. 3.9 (b), the sample refrigerated at 4ºC for 28 days exhibited an emission 
peak wavelength 20 nm smaller than that of the sample stored at room temperature. The 
lower temperature in a refrigerator apparently slowed the growth of QDs.  
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Fig. 3.9. PL emission spectra of the MPA-capped CdS QDs (a) sonicated after synthesis 
for 5 min (solid line) and 10 min (dashed line); (b) stored for 28 days at 4oC (solid line) 
and at room temperature (dashed line). 
 
The synthesis atmosphere played an important role in the formation and stability 
of the aqueous CdS QDs. Following the same procedure described in the section 3.1, 
synthesis in N2 atmosphere was performed in a sealed glove bag (Fisher Scientific, 
Fairlawn, NJ) flown with nitrogen. As shown in Fig. 3.10, the QDs synthesized in N2 
(dashed lines) had both the absorption edge and emission peak blue-shifted relative to 
those of the QDs synthesized in air (solid lines). According to Peng’s study,97 in the 
presence of both light and oxygen, the thiol groups of two adjacent MPA molecules can 
react to form a disulfide bond and dissociate from the QD surface. More recently, the 
process and mechanism of photochemical instability of MPA-capped CdTe QDs in 
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aqueous solution were also experimentally confirmed by the Raman and DLS 
measurements.98 Having less surface covering by the capping molecules, the QDs 
synthesized in air would grow to a larger size, therefore exhibiting a red-shifted 
absorption edge and the emission wavelength. Meanwhile, the less surface protection 
may cause more surface defects and increase the possibility of energy dissipation in a 
non-radiative way, which resulted in the relatively lower emission intensity of the QDs 
synthesized in air. 
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Fig. 3.10. PL emission and absorption spectra of the CdS QDs synthesized in air (solid 
lines) and those of the CdS QDs synthesized in N2 atmosphere (dashed lines). 
 
Figure 3.11 shows that increasing the solution pH during synthesis enhanced the 
emission intensity of the obtained CdS QDs. This can be understood with the properties 
of MPA and CdS. The negative logarithm of the acid dissociation constant (pKa) of the 
thiol group is about 8.3.99 At higher pH, more thiol groups became dehydrogenated, 
which was expected to strengthen the covalent bonding between MPA and Cd2+ on the 
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surface of QDs. Meanwhile, the higher pH also promoted the negative charge of carboxyl 
groups of MPA and helped disperse the nanoparticles better. Both these effects would 
provide better surface protection for the aqueous CdS QDs and make them emit photons 
more efficiently with less non-radiative loss. Furthermore, the solubility of CdS decreases 
with increasing pH,100 which benefited the nucleation and growth of QDs and therefore 
generated more nanoparticles. As a result, higher pH during the synthesis could help 
improve the PL intensity of the aqueous CdS QDs. 
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Fig. 3.11. PL emission spectra of the CdS QDs synthesized at different pH, i.e., pH = 
10.5 (solid line), 10.0 (dashed line), 9.0 (dotted line) and 7.4 (dash-dotted line). 
 
3.7. Effect of temperature  
It was found that the photoluminescence behavior of the aqueous CdS QDs were 
dependent on the temperature during measurement. In Fig. 3.12 (a) we plot the PL 
emission spectra of the CdS QDs obtained at 8ºC (solid line), 22ºC (dashed line), 40ºC 
(dotted line) and 65ºC (dash-dotted line), respectively. It is shown that with increasing 
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temperature, the emission peak shifted to larger wavelength with decreased emission 
intensity and reduced FWHM. The sample was cooled down and stored at 4ºC overnight, 
and then was applied with another cycle of temperature change. Interestingly, the above 
PL’s dependence on temperature was reversible and repeatable for successive cycles. As 
shown in Fig. 3.12 (b), the emission intensity followed the same temperature-dependent 
trend for all four cycles.  
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Fig. 3.12. (a) PL emission spectra of the CdS QDs measured at different temperatures in 
the first cycle, i.e., at 8oC (solid line), 22oC (dashed line), 40oC (dotted line) and 65oC 
(dash-dotted line); (b) PL emission intensity of the CdS QDs versus varying temperature 
for four cycles, i.e., for cycle 1 (solid squares with solid line), cycle 2 (open circles with 
dashed line), cycle 3 (open up-triangles with dotted line) and cycle 4 (open down-
triangles with dash-dotted line). 
 
Similar emission intensity decrease with increasing temperature was recently 
reported in other QDs systems also.101-103 The phenomenon was attributed to the 
enhanced exciton-phonon interaction at higher temperature. Therefore the energy was 
more dissipated in a non-radiative mode rather than contributing to PL emission via the 
electron-hole recombination. Meanwhile, Vossmeyer et al. reported the absorption edge 
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of CdS nanoclusters shifted to larger wavelength when the temperature increased in the 
range of 4-295 K.85 Similarly, our emission peak shifted to larger wavelength with 
increasing temperature. This was probably due to the particle growth of QDs at higher 
temperature. On the other hand, the FWHM was reduced with increasing temperature. It 
was suggested that at higher temperature, the smaller particles diminished while the 
larger ones grew due to the Oswald ripening. Therefore the size distribution became more 
uniform and the emission spectrum was narrower.104 The temperature-dependent PL and 
the reversible change of the QDs can be used for some detection applications. 
3.8. Effect of concentration  
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Fig. 3.13. Normalized PL emission spectra of the CdS QDs at various concentrations, i.e., 
0.1 mM (solid line), 0.4 mM (dashed line), 1.6 mM (dotted line), and 6.4 mM (dash-
dotted line). The normalized PL spectra represent the ratio of PL intensity over CdS 
concentration versus wavelength.  
 
Following the procedure described in the section 3.1, four batches of the CdS 
QDs were prepared with different CdS concentration, i.e., 0.1 mM, 0.4 mM, 1.6 mM, and 
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6.4 mM. Surprisingly, it was noticed that their emission intensity did not increase in 
proportion to the concentration. In particular, the sample of 1.6 mM exhibited the 
emission intensity even higher than that of the sample of 6.4 mM. This is contrary to 
one’s intuition that the sample with the highest concentration should exhibit the highest 
emission intensity. To better illustrate the concentration effect, we plot the concentration-
normalized PL spectra measured at 8ºC in Fig. 3.13, where the normalized PL refers to 
the PL intensity divided by the molar concentration of CdS. As can be seen, the 
normalized emission intensity decreased with increasing CdS concentration. Note that the 
same phenomenon was observed when diluting a sample with higher concentration to 
lower concentrations.  
When the emission spectrum of a donor overlaps with the excitation spectrum of 
an acceptor, the energy can be delivered from the donor to the acceptor through the so-
called fluorescence resonant energy transfer (FRET).105 During this process, the emission 
of the donor will be quenched, while the emission of the acceptor will be enhanced. 
Intuitively, it seems that the observed concentration effect of the QDs was related to 
FRET. But in fact this is not the case, and can be shown in several aspects. First, the 
FRET only happens when the donor and accepter are close enough, usually less than 10 
nm as reported in films or packed solid.106 However, based on the average particle size of 
5 nm, the QDs in the prepared suspension with the concentration of 1.6 mM can be 
estimated to be dispersed from each other with the average distance of around 100 nm, 
which is too far for the FRET to occur. Secondly, for a fluorescent system with FRET, 
the measured lifetime should have a linear relationship with the quantum yield as below 
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where ф is the quantum yield, τrad and τexp are the lifetime of the radiative process 
(constant value) and that of the measured experimental value, respectively.107 In a 
separate experiment, the QDs with the concentrations of 1.6 mM exhibited about one 
third of quantum yield of the QDs of 0.16 mM. However, the measured lifetimes of the 
samples of 1.6 mM and 0.16 mM were 1.2 ns and 1.3 ns respectively, which were not 
very different. Therefore, the FRET cannot be the main reason of the observed 
fluorescence quenching or quantum yield reduction at high concentration. Thirdly, even 
if there were FRET, the energy transferred from the donor to the absorber would 
eventually be released as photons by the absorber, provided there was no extra non-
radiative energy loss. Thus the measured overall emission intensity should not decrease 
due to FRET.  
Based on all the considerations above, it is implied that some non-radiative 
interaction rather than the FRET eliminated the photoluminescence of QDs at high 
concentrations. There are several possible reasons which may contribute to this 
interesting concentration effect. We found that after the excess MPA and other ions in the 
suspension were removed by dialysis, the PL intensity of the QDs increased by more than 
30% even though the QDs concentration remained the same. It suggested that, for the as-
synthesized QDs with higher concentration, the emission intensity was reduced in part 
due to higher concentration of excess MPA and other ions in the suspension. On the other 
hand, higher concentration might promote the formation of QDs clusters. The poor 
dispersion would introduce more non-radiative energy dissipation and reduce the PL 
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intensity as well, which was consistent with the discussion in the comparison of MPA-
capped and ME-capped QDs. More studies are needed to further elucidate the 
mechanisms involved in the effect of concentration. 
3.9. Effect of MPA/Cd molar ratio  
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Fig. 3.14. (a) PL emission spectra of the CdS QDs synthesized with different MPA:Cd 
ratios: 1:1 (dashed line), 2:1 (solid line), 4:1 (dotted line), and 8:1 (dash-dotted line); (b) 
PL intensity versus time under UV irradiation of the CdS QDs with different MPA:Cd 
ratios: 1:1 (open circles with dashed line), 2:1 (solid squares with solid line), 4:1 (open 
up-triangles with dotted line), and 8:1 (open down-triangles with dash-dotted line). 
 
As the capping molecule, MPA stabilized the QDs in the aqueous suspension. 
With the same CdS concentration of 1.6 mM, several batches of samples were 
synthesized with different MPA:Cd molar ratios, while the Cd:S ratio was maintained as 
1:1. As shown in Fig. 3.14 (a), the ratio of MPA:Cd = 2:1 was optimal which produced 
the highest emission intensity. At MPA:Cd = 1:1, the PL intensity was lower than that at 
MPA:Cd = 2:1, probably because the CdS QDs were not covered by MPA sufficiently. 
As a result, more clusters of QDs were generated due to the poor dispersion, and the 
emission intensity was reduced by non-radiative energy transfer. On the other hand, at 
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MPA:Cd = 4:1 and 8:1, too many MPA molecules in the suspension resulted in lower PL 
intensity as well, which is consistent with the observation in the concentration effect. 
However, the excess MPA could help improve the photostability of QDs 
significantly. As shown in Fig. 3.14 (b), under continuous UV irradiation of 365 nm, the 
sample with higher MPA:Cd ratio retained the photoluminescence for longer time. With 
MPA:Cd = 8:1, the CdS QDs were stable for more than 12 hr, while the sample with 
MPA:Cd = 1:1 could only withstand for less than 1 hr. The PL intensity eventually 
vanished, because the coexistence of UV light and oxygen led to the gradual 
photooxidation of MPA and the generation of disulfides,97 resulting in agglomeration, 
settling and eventual degradation of QDs.98 However, it is worth noting that in the 
absence of light, the aqueous CdS QDs remained stable for more than 12 months at 4oC.  
3.10. Colloidal and photo stability in PBS and cytosol  
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Fig. 3.15. PL intensity of the CdS QDs mixed with DI water (solid squares with solid 
line), PBS (open circles with dashed line) and the cytosol (open triangles with dotted line) 
versus time.  
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For bioapplications, the colloidal and photo stability of QDs in the physiological 
environment is also critical. To examine the stability of the present CdS QDs, we mixed 
the suspension at the volume ratio of 1:3 with DI water, phosphorus buffered saline (PBS, 
1x) solution, and the cytosol (cell line U937, 106 cells/ml), respectively. The cytosol was 
prepared by heating and cooling the cells repeatedly, breaking the cell membrane and 
extracting the cytoplasm from supernatant after centrifugation. The three mixture samples 
were stored at 4oC in darkness and the changes of their PL intensities were monitored for 
up to 26 days, as shown in Fig. 3.15. Clearly, all three samples remained stable over time, 
with no observable degradation of the photoluminescence. Therefore, the present aqueous 
CdS QDs were demonstrated to have excellent stability in DI water, saline solution, and 
the cytosol, showing their potential applications in real biological systems for long term 
imaging and tracking. 
3.11. Summary 
A direct one-step and environmentally friendly synthesis method was developed 
to produce the aqueous CdS QDs at room temperature. The TEM micrograph exhibited 
the small size of 5 nm, and the XRD result indicated the cubic zinc blende structure of the 
nanocrystals. Despite of the trap-state emissions, the QDs had the size-dependent 
emission wavelength and the quantum yield comparable to that of the commercial 
CdSe/ZnS core/shell QDs. MPA served as the capping molecule better than ME, and 
helped disperse the QDs in the aqueous suspension. The PL properties of the CdS QDs 
can be optimized by adjusting various processing parameters. It was shown that, the 
synthesis of the CdS QDs in N2 atmosphere, with higher pH and with the MPA:Cd ratio 
of 2:1 can enhance the obtained PL intensity significantly. The temperature- and 
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concentration-dependent PL properties of QDs probably resulted from the intrinsic 
interactions between nanoparticles and the non-radiative energy dissipation, though the 
mechanism was not completely clear yet and needs further investigation. The aqueous 
CdS QDs displayed excellent stability under UV irradiation for 12 hr, and in DI water, 
PBS, and the cytosol for more than 26 days. Potentially they can be used as fluorescent 
labels for long-term imaging and tracking applications in biological systems, i.e., kinetic 
study of molecular/cellular interactions.  
The ease of processing and good PL properties of the aqueous CdS QDs provided 
a practical and economical approach for synthesis of aqueous QDs. The obtained QDs are 
suitable and ready for bioapplications. Especially, the carboxyl group of MPA can be 
used as a functional linker to conjugate the aqueous QDs with specific target via selective 
bonding, which will be demonstrated later. 
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CHAPTER 4: NON-HEAVY-METAL AQUEOUS ZnS QUANTUM DOTS WITH 
BRIGHT BLUE PHOTOLUMINESCENCE AND AMBIENT STABILITY 
 
 Since the first demonstration of quantum dots for biological imaging applications 
in 1998,108, 109 numerous breakthroughs in QDs technology have led to the recent success 
of targeted imaging using QDs both in vitro and in vivo.110, 111 For example, various 
cellular components and proteins (in live or fixed cells) have been labeled and visualized 
with functionalized QDs, such as the nuclei,112 mitochondria,113 microtubules,114 actin 
filaments,115 cytokeratin, endocytic compartments,116 mortalin,117 and chaperonin 
proteins.118-120 The biocompatible QDs have also been used in living mouse, chick and 
pig models for the mapping of tumors,4, 121, 122 lymph nodes,44, 123-129 vasculature,130-133 
and neural system,134 etc.  
However, no QDs have been used in human bodies yet. There have been many 
serious questions and concerns raised regarding the cytotoxicity of the QDs containing 
Cd, Se, Te, Hg, and Pb.75, 135-137 These chemicals, especially the heavy-metal elements, 
can be potent toxins, neurotoxins, and/or teratogens depending on the dosage, 
complexation, and accumulation in the liver and the nervous system. Cadmium has a half 
life of about 20 years in humans and it is a suspected carcinogen that can accumulate in 
the liver, kidney, and many other tissues since there is no known active mechanism to 
excrete cadmium from the human body.138 Although many studies have found no adverse 
effects of QDs on cell viability, morphology, function, or development over the duration 
of experiments (hours to days) at concentrations optimized for labeling efficiency,139-142 
the cellular toxicity of QDs under extreme conditions such as photo-oxidation and strong 
UV excitation has been demonstrated,9, 80 In general, the less protected the QD core or 
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core/shell is, the sooner the appearance of signs of interference with cell viability or 
function as a result of Cd2+ release. Clearly, the elemental toxicity is a most critical 
problem that must be addressed before the QDs can be applied for real clinical 
applications. Extensive scrutiny and research into the toxicity profiles will be needed 
before QDs can be employed in any medical procedures. In addition, further studies are 
needed to investigate the clearance mechanism of QDs from living systems.143 
Zinc has been considered as a good candidate to replace the heavy metals 
contained in QDs. Since an average adult ingests 10-15 mg of zinc daily as a nutrient and 
absorbs about 5 mg,144 trace amount of zinc is not hazardous to human body. Mn or Cu 
doped ZnSe QDs have been reported and can cover a similar emission range as that of 
CdSe QDs.145, 146 Such QDs are less sensitive to environmental changes such as thermal, 
chemical, and photochemical disturbances. The Cd-free ZnSe1-xTex QDs were also 
reported with necessary post-preparative UV irradiation at high temperature to show 
luminescence in the blue region.147 Evident Technology Inc. developed a type of non-
heavy-metal QDs, the T2-MP EviTags,148 which consist of an InGaP core with ZnS shell, 
and have a size of about 25 nm with red emissions at 650-680 nm. Similar InGaP/ZnS 
core/shell QDs bound to chitosan were demonstrated for deep tissue imaging with the 
diameter of about 29 nm.149 Furthermore, pure ZnS can be another good candidate as 
non-heavy-metal QDs. Many of the ZnS systems were made using the complicated 
method with organic solvents,150-152 or deposited in a silica matrix,153 which were not 
suitable for bioimaging applications. Denzler et al.154 precipitated ZnS colloidal particles 
in aqueous solution without using capping molecules. As a result, the ZnS particles had 
large size and settled quickly. Becker et al.155 showed that with the use of a capping 
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molecule, colloidally stable ZnS nanocrystals could be produced in an aqueous process at 
pH 8, but no bright emission was obtained from the as-synthesized sample.  Kho et al.156 
reported a colloidal synthesis route of ZnS nanocrystals powder using cysteine as the 
capping molecule and in N2 saturated environment, but didn’t show the PL properties. In 
another study, the ZnS QDs were produced in water and ethanol solutions with different 
coatings, showing near-UV emission.37, 157 More recently, the synthesis of ZnS QDs was 
reported via a two-step reaction at 60oC also in water and ethanol mixture.158 
For human health and environmental considerations, it is important to have bright 
stable QDs that are free of heavy metals and are produced through a simple aqueous 
synthesis route. The purpose of this study is to investigate the aqueous synthesis of non-
heavy-metal ZnS QDs with strong visible emissions and excellent stability. In this 
chapter, the aqueous syntheses of MPA-capped ZnS QDs, MPS-capped ZnS QDs and 
MPS-replaced ZnS QDs are described. The obtained ZnS QDs were characterized for 
their morphology and structure. In addition, the photoluminescence properties and 
stability under various conditions were examined and compared for the QDs prepared 
with different capping molecules and methods. 
4.1. MPA-capped ZnS QDs 
 As discussed in chapter 3, a new aqueous synthesis procedure was developed to 
successfully produce the CdS QDs with small size (around 5 nm) and good 
photoluminescence properties. This method avoids the detrimental organometallic 
precursors and high temperature reaction, and is friendly to the environment and energy 
efficient. The QDs were synthesized via simple one-step reaction and in water directly, 
showing strong emission without any post-treatment. With MPA as the capping molecule, 
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the QDs are dispersed well with functionalized surface, which can be conjugated with 
biomolecules for subsequent applications.  
Using the very similar synthesis method, the aqueous MPA-capped ZnS QDs 
were produced with all the above advantages. The MPA was used as the capping 
molecule, which bonded to the surface of ZnS QDs via the thiol group, and stabilized the 
QDs in basic solution with the negatively charged carboxyl group by electrostatic 
repulsion. Various processing parameters were adjusted and studied to optimize the 
properties of the obtained ZnS QDs. 
4.1.1. One-step aqueous synthesis  
 All chemicals were used as purchased without further purification. The aqueous 
MPA-capped ZnS QDs were synthesized as follows. First, The zinc nitrate [Zn(NO3)2] 
(Fisher Scientific, Fairlawn, NJ) solution (0.04 M) and the sodium sulfide [Na2S] (Sigma-
Aldrich, St Louis, MO) solution (0.02 M) were prepared in DI water, respectively. For a 
sample with a MPA:Zn:S composition ratio of 8:4:1, 0.64 mmol (56 µl) MPA (Sigma-
Aldrich, St Louis, MO) was added in 36 ml of DI water and stirred for 5 min. 2 ml of the 
0.04 M Zn(NO3)2 solution was dropped slowly into the MPA solution with constant 
stirring for 10 min. Subsequently, the mixture was titrated with tetrapropylammonium 
hydroxide [(CH3CH2CH2)4NOH] (Sigma-Aldrich, St Louis, MO) to pH 12 and stirred for 
10 min, followed by rapid addition of 4 ml of the 0.02 M Na2S solution. We then waited 
for 5 min before adding another 6 ml of the 0.04 M Zn(NO3)2 solution. The pH of the 
suspension was maintained at 12 by adding (CH3CH2CH2)4NOH with constant stirring 
for 5 more minutes. The obtained ZnS QDs suspension was clear and colorless. The final 
volume of the sample was about 50 ml and the nominal ZnS concentration was 1.6 mM 
53 
 
based on the concentration of S. The aqueous ZnS QDs suspension was quenched to 0°C 
in a freezer and stored in a refrigerator at 4°C.  
For comparison, the ZnS QDs with different MPA:Zn:S ratios and synthesized at 
different pH were also prepared in the same way, except for changing the amount of 
precursors accordingly. Unless mentioned otherwise, all ZnS QDs suspensions described 
below had a 1.6 mM nominal concentration. All the syntheses were performed at room 
temperature and in air. 
4.1.2. Morphology and structure  
 For transmission electron microscopy, the excess capping molecules and ions in 
the MPA-capped ZnS QDs suspension were removed by microcentrifugation (MiniSpin 
plus, Eppendorf North America Co., Westbury, NY) with 10 kD filter (Millipore Co., 
Billerica, MA) and rinsing with DI water for a few times. The obtained QDs suspension 
was then dropped on a copper grid with an ultra thin carbon film, dried in air, and 
examined with a JEM-2010F FasTEM high resolution analytical transmission electron 
microscope (Japan Electron Optics Ltd., Tokyo, Japan).  
 
                                     
5 nm
Fig. 4.1. TEM micrograph of the MPA-capped ZnS QDs with a MPA:Zn:S ratio of 8:4:1.  
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A typical TEM micrograph of the MPA-capped ZnS QDs with a MPA:Zn:S ratio 
of 8:4:1 is shown in Fig. 4.1. As can be seen, the nanoparticles were 4-5 nm in size, well-
separated, more or less spherical in shape, and with clear lattice fringes. The contrast of 
the image was not very high due to the inevitable background of the carbon film which is 
in an amorphous phase. 
Because of the ultra small particle size, it is very difficult to differentiate the 
crystal structure of QDs between the hexagonal wurtzite and the cubic zinc blende using 
electron diffraction with TEM. Therefore, the XRD pattern of the ZnS QDs powder was 
collected using the Siemens D 500 X-Ray Diffractometer. The powder sample was 
prepared by adding ethanol to precipitate the QDs from the suspension, followed by 
centrifugation and air-drying at 50oC overnight.  
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Fig. 4.2. XRD pattern of the MPA-capped ZnS QDs with a ratio of MPA:Zn:S = 4:2:1. 
The vertical lines indicate the pattern and relative intensities of bulk ZnS with cubic zinc 
blende structure. 
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Figure 4.2 shows the XRD pattern of the MPA-capped ZnS QDs with a 
MPA:Zn:S ratio of 4:2:1 as an example. By comparing with the pattern of the bulk ZnS 
material, it was indicated that the MPA-capped QDs had a cubic zinc blende crystal 
structure. Due to the small crystalline size, the peaks in the pattern of QDs were broad 
and overlapped at the higher diffraction angle.  
4.1.3. Bright blue emission 
 The photoluminescence spectra of the ZnS QDs suspension were measured using 
the QM-4/2005 spectrofluorometer (Photon Technology International, Birmingham, NJ). 
The UV-Vis absorption spectra were also collected using the Lambda-40 UV-Vis 
spectrometer (PerkinElmer Life And Analytical Sciences Inc., Boston, MA). All the 
measurements were carried out under the same instrument calibration and configuration 
conditions as described in section 3.3.  
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Fig. 4.3. PL emission (solid line) and absorption (dashed line) spectra of the MPA-capped 
ZnS QDs with the ratio of MPA:Zn:S = 8:4:1, with the inset showing a photograph of the 
ZnS QDs suspension placed on a UV lamp (302 nm). 
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Figure 4.3 shows the PL emission (solid line) and absorption (dashed line) spectra 
of the MPA-capped ZnS QDs with a ratio MPA:Zn:S of 8:4:1. As can be seen, the QDs 
had an absorption edge near 315 nm and an emission peak at around 415 nm. The inset 
photograph displays the bright blue emission of the ZnS QDs suspension, which was 
placed on a UV lamp (UVM-14, Ultra Violet Product Inc., Upland, CA) with the 
excitation wavelength of 302 nm.  
Note that the bulk ZnS has a band gap of 3.6 eV.159 According to the quantum 
confinement effect and the relationship between band gap and particle size of 
semiconductor nanocrystals,2 the ZnS QDs were expected to have a band gap larger than 
3.6 eV and emit light in the UV range. However, as shown in Fig. 4.3, our aqueous ZnS 
QDs exhibited visible blue photoluminescence with the wavelength around 415 nm, 
which was about 100 nm larger than the absorption edge. This broad Stokes shift 
indicated that the present ZnS QDs had the trap-state emissions, rather than the band-
edge emissions. As discussed by Denzler et al,154 the bulk defects such as vacancies 
(Schottky defects) and interstitials (Frenkel defects) were the main source of trap states in 
the aqueous ZnS QDs. With cubic zinc blende structure, ZnS usually has Schottky 
defects predominant over Frenkel defects.160 Therefore, the observed photoluminescence 
of the aqueous MPA-capped ZnS QDs could be ascribed to a recombination of electrons 
at the sulfur vacancy donor level or in the conduction band with holes trapped at the zinc 
vacancy acceptor level or in the valence band.161 There are many possible recombination 
paths and thereby many trap-state emissions, each with different emission energy, 
causing the relatively wide emission peak. The PL spectrum of our aqueous ZnS QDs had 
the full width at half maximum of about 100 nm.  
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 Fig. 4.4. Integrated fluorescence intensity versus absorbance of the MPA-capped ZnS 
QDs with the ratio MPA:Zn:S = 8:4:1 (full triangles with solid line), along with that of 
Rhodamine 101 (open squares with dashed line) and that of the commercial EviTags 
CdSe/ZnS QDs (open circles with dotted line). 
 
To quantify the efficiency of the present ZnS QDs in converting the excitation 
into fluorescent emission, the quantum yield was measured using the same method as 
described in section 3.4.  In the experiment, Rhodamine 101 (Fisher Scientific, Fairlawn, 
NJ) was used as the standard, and the commercial EviTags CdSe/ZnS QDs (Evident 
Technologies, Troy, NY) were also included for comparison. The absorption and PL 
emission spectra were measured with a fixed excitation wavelength of 312 nm for all 
three samples at several concentrations, while the absorbance was kept below 0.15 to 
avoid the re-absorption effect. In Fig. 4.4, we plotted the integrated fluorescence intensity 
versus absorbance for the present aqueous ZnS QDs (full triangles with solid line), 
Rhodamine 101 (open squares with dashed line), and the EviTags CdSe/ZnS QDs (open 
circles with dotted line). With the quantum yield of Rhodamine 101 taken as 100%,94 we 
compared the slops and deduced the quantum yield of the ZnS QDs as 31%, which was 
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much higher than that of the commercial QDs, 11%. Therefore, although the aqueous 
ZnS QDs exhibited the trap-state emissions with broad PL spectrum, they emitted 
strongly and potentially can be used for imaging single targets. 
4.1.4. pH and hydrothermal effects 
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Fig. 4.5. PL spectra of the MPA-capped ZnS QDs with the same ratio of MPA:Zn:S = 
8:4:1, but synthesized at different pH, 12 (solid line) and 8 (dashed line). 
 
It is worth noting that usually the aqueous ZnS QDs were synthesized at pH 12, 
while the CdS QDs can be produced at pH 9 with good photoluminescence properties. 
The emission intensity of the ZnS QDs could be strongly affected by the pH at which 
they were synthesized. To examine the pH effect, two samples were prepared with the 
same composition ratio of MPA:Zn:S = 8:4:1, but at two different pH values, 12 and 8. 
The PL emission spectra of these two ZnS QDs suspensions were shown in Fig. 4.5. 
Clearly the QDs synthesized at pH 12 had a strong emission peak around 415 nm, while 
the QDs at pH 8 did not exhibit appreciable photoluminescence. As a result, compared 
with the aqueous CdS QDs, the bright blue emission of ZnS QDs can only be obtained 
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from the sample synthesized at very high pH. This can be attributed to the higher 
solubility of ZnS than that of CdS at the same pH.100 Only at much higher pH, the 
solubility of ZnS decreases, which allows the ZnS QDs to precipitate and crystallize 
better and hence possess better PL properties. 
On the other hand, although the ZnS QDs synthesized at pH 8 didn’t show 
appreciable photoluminescence, they can be improved by hydrothermal treatment after 
synthesis. We heated the sample to 100oC in a hydrothermal bomb (Parr Instrument Co., 
Moline, IL) for various period of time and monitored the emission spectrum at each step. 
Note that the sample was sealed in the bomb during the heat treatment. Therefore the 
concentration of the QDs didn’t change over time.  
 
300 400 500 600 700 800
0
1
2
3
4
40 hrs
28 hrs
10 hrs
18 hrs
2 hrs
P
L 
in
te
ns
ity
 (1
05
 c
ps
)
Wavelength (nm)
0 hr
 
Fig. 4.6. PL spectra of the MPA-capped ZnS QDs with MPA:Zn:S = 8:4:1 and 
synthesized at pH 8, after hydrothermal treatment at 100oC for various period of time, i.e., 
0 hr (no heat treatment), 2 hrs, 10 hrs, 18 hrs, 28 hrs, and 40 hrs. 
 
As shown in Fig. 4.6, the PL intensity of the ZnS QDs initially increased with 
time and reached the maximum value after being heated for 18 hrs, beyond which the 
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intensity started to decrease. The emission peak position shifted to larger wavelength 
slowly and continuously. After 40 hrs, not only the PL intensity reduced but the 
suspension was observed cloudy, indicating that aggregation occurred. It is speculated 
that the increase of emission intensity resulted from the rearrangement and crystallization 
of the ZnS QDs at the elevated temperature, which improved the quality of the 
nanocrystals and minimized the surface defects, like other post-treatments such as UV 
irradiation162 and reflux.163 Meanwhile, the QDs would grow to larger size during heating, 
causing the red-shift of the emission spectrum. Since we did not control the atmosphere 
during the heat treatment, at the presence of oxygen and thermal energy, it was likely that 
the disulfide bond formed between adjacent MPA, and the capping molecules detached 
from the QD surface,97 leading to the aggregation and degradation of the QDs gradually. 
It should be noted that even though the ZnS QDs synthesized at pH 8 had the enhanced 
PL intensity after 18 hrs hydrothermal treatment, it was still not as bright as the sample 
synthesized at pH 12. In other words, as long as the aqueous ZnS QDs were synthesized 
at high enough pH, no post-treatment is necessary to obtain the strong photoluminescence. 
4.1.5. Effect of MPA:Zn:S ratio  
 Besides the synthesis pH, the composition ratio of MPA:Zn:S played an important 
role in the photoluminescence of the aqueous ZnS QDs as well. For comparison, several 
samples were produced at pH 12, with the different ratios of MPA:Zn:S = 2:1:1, 4:2:1 
and 8:4:1. As shown in Fig. 4.7, the sample with more excess Zn exhibited higher 
emission intensity. Because the excess Zn was added after the nucleation of ZnS, it was 
most likely that Zn precipitated on the surface of ZnS QDs. Under the basic condition, a 
Zn(OH)2 shell was expected to form and cover the ZnS core.37 The core-shell structure 
61 
 
has been studied in many QD systems and well-known to be able to increase the 
photoluminescence significantly.31, 164, 165 Meanwhile, the excess Zn plugged the 
otherwise negatively charged S2- sites on the QD surface, thus enabled more MPA 
binding to the QDs, which also helped to passivate the surface and eliminate the non-
radiative energy loss by surface defects. It was found that the ratio of MPA:Zn:S = 8:4:1 
was the optimal composition; the obtained MPA-capped ZnS QDs showed the strongest 
emission and the highest quantum yield.  
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Fig. 4.7. PL spectra of the MPA-capped ZnS QDs synthesized at pH 12, with different 
MPA:Zn:S ratios, i.e., 8:4:1 (solid line), 4:2:1 (dashed line) and 2:1:1 (dotted line). 
 
In addition, it may be noticed that the ZnS QDs with more MPA exhibited smaller 
emission peak wavelength. For more systematic study, we prepared the samples with 
different amount of MPA but with the same ratio of Zn:S = 1:1. The absorption spectra 
were measured as shown in Fig. 4.8. One can see that, the absorption edge shifted to 
smaller wavelength with more MPA, showing the same trend as that of the emission peak 
position in Fig. 4.7. 
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Fig. 4.8. Absorption spectra of the MPA-capped ZnS QDs synthesized at pH 12 with 
different MPA:Zn:S ratios, 8:1:1 (solid line), 4:1:1 (dashed line) and 2:1:1 (dotted line).  
 
            The particle sizes of the QDs were calculated according to the relationship 
between the band gap energy and the radius, as given in Eq. 2.1:2  
RemmREE heb επ /8.1)/1/1)(2/( 2222 −++= h  
The band gap energy of QDs, E, can be deduced by E = hc/λ, where λ is the absorption 
edge shown in Fig. 4.8. h and c are the Planck’s constant and light speed, respectively. 
For ZnS, the bulk band gap energy Eb is 3.6 eV, the dielectric constant ε is 8.76, the 
effective mass of electron and hole, me and mh, are 0.34 and 0.23, respectively. Taking all 
these values along with the constants into the equation above, we calculated the particle 
size of the ZnS QDs. As listed in Table 4.1, the sample with more MPA had smaller 
particle size with more blue-shifted absorption edge. Specifically, the ZnS QDs with 
MPA:Zn:S = 8:1:1 were 4.7 nm in size.  
We then filtered the three ZnS QDs samples through 50 kD filter (Millipore Co., 
Billerica, MA) which has the pore size of about 5 nm. After centrifugation (MiniSpin 
plus, Eppendorf North America Co., Westbury, NY) at 12000 rpm for 2 min, the smaller  
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Fig. 4.9. PL spectra of the original (solid line), retentate (dashed line) and filtrate (dash-
dotted line) of the MPA-capped ZnS QDs synthesized at pH 12 with different MPA:Zn:S 
ratios, (a) 8:1:1; (b) 4:1:1; and (c) 2:1:1. The vertical dotted line is a guide for eyes to 
compare the peak position of the spectra. 
 
particles in the original suspension passed through the filter into the filtrate, while the 
larger particles remained in the retentate. In Fig. 4.9, we showed the PL spectra of the 
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original suspension (solid line), of the retentate (dashed line), and of the filtrate (dash-
dotted line) for the three samples with different MPA:Zn:S ratios.  As can be seen, with 
MPA:Zn:S = 8:1:1, the filtrate showed the PL intensity as high as the original suspension 
(the two PL spectra overlapped), but the retentate had very low intensity; with MPA:Zn:S 
= 4:1:1, decent emission was observed in both the retentate and filtrate; with MPA:Zn:S 
= 2:1:1, the retentate retained most of the PL intensity while the filtrate showed 
negligible luminescence. These results suggested that the QDs with higher MPA:Zn:S 
ratio had smaller particle size, consistent with the calculation from the absorption edge. 
Meanwhile, the QDs with higher MPA:Zn:S ratio also exhibited smaller emission peak 
wavelength, as indicated by the vertical dotted line. For the QDs with a particular 
MPA:Zn:S ratio, the filtrate (retentate) usually had a smaller (larger) emission peak 
wavelength than that of the original QDs suspension, as summarized in the Table 4.1. 
 
Table 4.1. Absorption edge and particle size (calculated) of the MPA-capped ZnS QDs 
synthesized at pH 12 with different MPA:Zn:S ratios, and the emission peak wavelength 
of the original, filtrate and retentate of the three samples. 
 
 
MPA:Zn:S 
8:1:1 4:1:1 2:1:1 
absorption edge (nm) 313 317 321 
particle size (nm) 4.7 5.0 5.4 
emission peak 
wavelength 
(nm) 
original 418 426 442 
filtrate 418 420 426 
retentate 420 429 446 
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All the results above suggested that the particle size of the aqueous ZnS QDs can 
be adjusted by the amount of MPA during synthesis. The particle growth is controlled by 
the competition between the S2- ions and the thiol group HS- of MPA for linking to the 
cations on the growing particle surface.166 Apparently, with more MPA in the solution, 
more particle surface was covered by MPA, thus the particle growth was slowed down. In 
the present study, we have achieved the ZnS QDs smaller than 5 nm (or the pores of 50 
kD filter) with MPA:Zn:S = 8:1:1, which is much smaller than the ZnS QDs prepared by 
other methods with a size of about 100 nm.167 In comparison, the commercial QDs 
typically have a size of 25-40 nm due to the multilayer core-shell structure.  
4.1.6. Summary 
 Non-heavy-metal ZnS QDs with bright blue photoluminescence have been 
synthesized via an aqueous one-step process at room temperature with MPA as the 
capping molecule. They present a step forward in reducing the potential hazards to the 
environment and to human health, as the conventional QDs usually contain toxic heavy 
metal elements and are synthesized through an organic route.  
The TEM and XRD results indicated that the MPA-capped ZnS QDs were 4-5 nm 
in size with a cubic zinc blend structure. The very high synthesis pH and optimal 
composition ratio are important to achieve the strong PL intensity. The present aqueous 
ZnS QDs synthesized at pH 12 with the ratio of MPA:Zn:S = 8:4:1 exhibited strong 
emission with the quantum yield of 31%, higher than that of the commercial CdSe/ZnS 
core-shell QDs. With MPA:ZnS = 8:1:1, we have obtained the ZnS QDs as small as 4.7 
nm that passed through 50 kD filter. Although the present ZnS QDs had the trap-state 
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emissions, they were bright, small, and contained no heavy metal elements, thus offering 
great potential for in vivo bioimaging of single targets. 
4.2. MPS-capped ZnS QDs 
 As discussed in section 4.1, the MPA-capped ZnS QDs are very attractive as they 
are not only made in water and free of heavy metals, but also exhibit bright blue 
photoluminescence. However, it was found that the MPA-capped ZnS QDs were not as 
stable as the MPA-capped CdS QDs, probably due to the higher solubility of ZnS in 
water as compared with CdS. Because ZnS has the solubility product constant (Ksp) 2-4 
magnitudes higher than that of CdS,168 the ZnS QDs would like to dissolve 10-100 times 
more than the CdS QDs, given the same surface condition and particle size. It has been 
noticed that the MPA-capped ZnS QDs can only retain the photoluminescence well when 
stored in a refrigerator (at 4oC and with no light). If left at room temperature and under 
the normal laboratory lighting condition (ambient conditions), they will gradually lose the 
emission over time. Therefore, it is necessary to improve the stability of the aqueous ZnS 
QDs, since most applications are performed under ambient conditions.  
In this part of work, the (3-mercaptopropyl) trimethoxysilane (MPS) was studied 
as the capping molecule for the aqueous ZnS QDs. The obtained MPS-capped ZnS QDs 
maintained the small size and strong photoluminescence, with significantly improved 
photostability in various circumstances. The present work differs from the earlier silica 
coating on ZnS where sodium silicate or tetraethyl orthosilicate (TEOS) was added after 
ZnS was precipitated, yielding large (> 100 nm) particles with multiple ZnS QDs 
embedded in the silica shell.169, 170 Although Chung et al. also made ZnS QDs with MPS 
as the capping molecule,171 the solvent they used was ethanol that resulted in large 
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agglomerates of ZnS with weak photoluminescence. In contrast to the earlier work, we 
will show that well dispersed ZnS QDs, 5 nm in size, that are bright and stable, can be 
synthesized in water directly with MPS as the capping molecule.  
4.2.1. One-step aqueous synthesis 
 The MPS-capped ZnS QDs were synthesized directly in an all-aqueous procedure 
as described below. All the chemicals were used as received without further purification. 
First, 0.04 M zinc nitrate (Zn(NO3)2) and 0.02 M sodium sulfide (Na2S) solutions were 
prepared in DI water, respectively. For a sample with the MPS:Zn:S ratio of 1/2:2:1, 0.04 
mmol of MPS was dissolved in 41 ml of DI water and stirred for 5 min. 2 ml of the 0.04 
M Zn(NO3)2 solution was added in a drop-wise fashion with constant stirring for 10 min. 
The mixture was then titrated with tetrapropylammonium hydroxide 
((CH3CH2CH2)4NOH) to pH 12 and stirred for 10 min, followed by the rapid addition of 
4 ml of the 0.02 M Na2S solution with vigorous stirring. We waited for 5 min for the ZnS 
nanoparticles to form before adding another 2 ml of the 0.04 M Zn(NO3)2 solution with 
constant stirring for 5 more minutes. More (CH3CH2CH2)4NOH was added when needed 
to maintain the pH at 12. The final suspension was clear and colorless with a volume of 
about 50 ml. The nominal ZnS concentration was1.6 mM based on the concentration of S. 
The obtained QDs suspension was quenched at 0oC and then stored at 4oC in a 
refrigerator. 
Samples with different MPS:Zn:S ratios were synthesized in the same manner, but 
with a varying amount of MPS added at the beginning of the procedure. For stability 
comparison, the MPA-capped ZnS QDs were also prepared following the procedures 
described in the section 4.1.1. 
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4.2.2. Morphology and structure 
 For transmission electron microscopy, the MPS-capped ZnS QDs suspension was 
dropped onto a copper grid coated with a carbon film, dried in air and examined with the 
JEM-2010F FasTEM high resolution analytical transmission electron microscope (Japan 
Electron Optics Ltd., Tokyo). The powder sample for XRD was prepared by adding 
acetone to the suspension to precipitate the QDs, followed by centrifugation and air-
drying at 70oC for a few hours. The powder X-ray diffraction pattern of the MPS-capped 
ZnS QDs was obtained using the Siemens D 500 X-Ray Diffractometer.  
 
 
50 nm 
5 nm 
Fig. 4.10. TEM micrograph of the MPS-capped ZnS QDs with a MPS:Zn:S ratio of 
1/2:2:1, with the inset of an image at higher magnification. 
 
Figure 4.10 shows the TEM micrograph of the MPS-capped ZnS QDs with a 
MPS:Zn:S ratio of 1/2:2:1. The dispersed QDs (individual black dots) can be clearly seen. 
The higher magnification image in the inset shows that the nanoparticles are about 5 nm 
in size, with well-defined lattice fringes which indicate that the QDs are crystalline. The 
XRD pattern of the QD powder sample is shown in Fig. 4.11, which indicates that the 
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MPS-capped ZnS QDs have a cubic zinc blende crystal structure, same as the MPA-
capped ZnS QDs. The broad peaks and overlapping at high angles in the XRD pattern 
resulted from the ultra small size of the nanocrystallines. 
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Fig. 4.11. XRD pattern of the MPS-capped ZnS QDs with a MPS:Zn:S ratio of 1/2:2:1. 
The vertical lines indicate the pattern and relative intensities of bulk ZnS with a cubic 
zinc blende structure. 
           
4.2.3. Effect of MPS:Zn:S ratio  
 It was noticed that the photoluminescence properties of the MPS-capped ZnS 
QDs were highly dependent on the ratio of MPS:Zn:S. A few batches of samples with the 
same nominal ZnS concentration of 1.6 mM, but with different MPS:Zn:S ratios were 
prepared and compared. The PL emission spectra of the QDs suspensions were measured 
using the QM-4/2005 spectrofluorometer (Photon Technology International, Birmingham, 
NJ). The absorption spectra were measured using the Lambda-40 UV-Vis spectrometer 
(PerkinElmer Life and Analytical Sciences Inc., Boston, MA). All the measurements 
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300 325 350 375
were carried out with the same instrument calibration and configuration conditions as 
described in section 3.3. 
 
 
Fig. 4.12. (a) Normalized absorption spectra and (b) PL emission spectra of the MPS-
capped ZnS QDs with various MPS:Zn:S ratios as indicated in the figure. 
 
The normalized UV-Vis absorption spectra of the MPS-capped ZnS QDs with 
various MPS:Zn:S ratios are shown in Fig. 4.12 (a), and the corresponding PL emission 
spectra are shown in Fig. 4.12 (b). Note that the absorption spectra are staggered for 
better illustration of the absorption edge. As can be seen, for each sample, the emission 
peak wavelength was about 100 nm larger than the absorption edge. This indicates the 
emissions of the present MPS-capped ZnS QDs were trap-state emissions associated with 
electron transitions between the trap states and the conduction band (or valence band), 
similar to the MPA-capped ZnS QDs. On the other hand, both the absorption edge and 
the emission peak position shifted to smaller wavelength with an increasing MPS molar 
ratio. Conceivably, with more MPS molecules binding to the QD surface, the growth of 
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the QDs would be impeded, resulting in a smaller QD size and thereby a larger band gap 
and blue-shifted absorption edge. The diameters of the present ZnS QDs with various 
MPS:Zn:S ratios were estimated from the absorption edge as listed in Table 4.2, along 
with the emission peak wavelengths and the absorption edges. As can be seen, for all six 
samples, the QDs were around 5-6 nm, consistent with the QD size indicated by the TEM 
images shown in Fig. 4.10. 
           
Table 4.2. Emission peak wavelengths, absorption edges, and particle sizes (calculated) 
of the MPS-capped ZnS QDs with various MPS:Zn:S ratios. 
 
MPS:Zn:S ratio 
emission peak 
wavelength (nm) 
absorption edge 
(nm) 
particle size (nm) 
1:2:1 401 316 4.9 
1/2:2:1 407 319 5.2 
1/4:2:1 413 321 5.4 
1/8:2:1 420 323 5.6 
1/12:2:1 421 325 5.8 
0:2:1 427 328 6.2 
 
Not only the absorption edge, emission wavelength and particle size, but also the 
emission intensity of the MPS-capped ZnS QDs were affected by the MPS:Zn:S ratio 
significantly. During the synthesis, we added the excess Zn after the ZnS nanoparticles 
were formed. The excess Zn can result in higher emission intensity than those without the 
excess Zn, as discussed in section 4.1.5.  
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Moreover, the amount of MPS is another important factor to optimize the PL 
properties of the MPS-capped ZnS QDs. As shown in Fig. 4.12 (b), the sample with the 
MPS:Zn:S ratios of 1/4:2:1 and 1/2:2:1 exhibited higher emission intensity than the 
others. This may be understood as follows. We consider each QD as a 5 nm cube for ease 
of calculation. With a cubic zinc blende crystalline structure, each unit cell of ZnS have 
four Zn atoms and four S atoms with a lattice parameter of about 0.5 nm.172 Therefore, 
each QD would contain 1000 unit cells consisting of 4000 ZnS molecules. On the other 
hand, the surface area of each QD would be 150 nm2. As the length of a Si-O bond is 
about 0.2 nm,173 the smallest distance between two MPS molecules adsorbed on the QD 
surface would be 0.4 nm, leading to an area of 0.16 nm2 for each adsorbed MPS molecule. 
Dividing the surface area of each QD by the area occupied by a single adsorbed MPS 
molecule, we estimated that every QD would need about 1000 MPS molecules to cover 
the surface completely. Since each QD consists of 4000 ZnS molecules, it is indicated 
that QDs with a MPS:Zn:S ratio of 1/4:2:1 would have about one layer of MPS on the 
surface. (Note that the excess Zn is not considered as the core of QDs.) When the MPS 
molar ratio was less than 1/4, the MPS coverage was insufficient to protect the QDs, 
resulting in surface defects and aggregation that impaired the PL emission.16, 174 When 
the MPS:Zn:S ratio was 1/2:2:1, the adsorbed MPS would double the thickness by cross 
linking of the hydrolyzed silane groups between the first MPS layer and the MPS 
adsorbed on top of it, making the QDs even better protected with high emission intensity. 
However, when the MPS molar ratio was increased to 1, too many capping molecules 
impeded the particle growth, causing smaller QDs which had the reduced percentage of 
bulk materials and less contribution to the PL emission. Furthermore, the excess capping 
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.3
molecules in the suspension could also lead to clustering and decrease the PL intensity, 
similar to what we have observed in the system of CdS QDs and discussed in section 3.8. 
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Fig. 4.13. Integrated fluorescence intensity versus absorbance of the MPS-capped ZnS 
QDs with the MPS:Zn:S ratios of 1/2:2:1 (full circles with solid line) and 1/4:2:1 (full 
triangles with solid line), compared with that of Rhodamine 101 (open squares with 
dashed line) as the standard. 
 
The quantum yields of the MPS-capped ZnS QDs with the MPS:Zn:S ratios of 
1/2:2:1 and 1/4:2:1 were measured with Rhodamine 101 as the standard. As shown in Fig. 
4.13, by comparing the slope of the integrated fluorescence intensity versus absorbance, 
we deduced the quantum yield of the sample with MPS:Zn:S = 1/2:2:1 was 42%, and that 
of the sample with MPS:Zn:S = 1/4:2:1 was 25%. These quantum yields are comparable 
with that of the MPA-capped ZnS QDs, which was 31%.  
4.2.4. Stability 
 The main advantage of the MPS-capped ZnS QDs over the MPA-capped ZnS 
QDs was the much better stability, which we examined in various circumstances. For 
74 
 
comparison, all ZnS QDs suspensions had a nominal concentration of 1.6 mM, based on 
the concentration of S. During the experiments, all the samples were placed in a cuvette 
covered with parafilm. Therefore, the concentration of QDs would not change over time. 
All the measurements were performed at room temperature. 
 First, we left both the MPS-capped and the MPA-capped ZnS QDs at room 
temperature and under the normal laboratory lighting conditions (we call this ambient 
condition). The PL intensities of the samples were monitored constantly for up to 54 days. 
The results were plotted in Fig. 4.14 for the MPS-capped ZnS QDs with MPS:Zn:S ratios 
of 1/2:2:1, 1/4:2:1, and 1/8:2:1. Also shown is the result for the MPA-capped ZnS QDs 
with a MPA:Zn:S ratio of 8:4:1, which was the optimized composition that exhibited the 
highest emission intensity among all the MPA-capped ZnS QDs. As can be seen, even 
though the PL intensity of the MPA-capped ZnS QDs was initially higher than those of 
the MPS-capped ZnS QDs, it decreased quickly and diminished greatly after 5 days. The 
flocculation of the QDs was observed accompanying the emission degradation. Over time, 
the initially clear suspension became increasingly cloudy and the aggregates eventually 
settled out. In comparison, the PL intensity of the MPS-capped QDs with MPS:Zn:S = 
1/8:2:1 also decayed rapidly, probably due to the insufficient MPS coverage on the QD 
surface. As a sharp contrast, the QDs with MPS:Zn:S = 1/4:2:1 and 1/2:2:1 had the 
emission intensity increase more than 40% over time. Especially, the sample with 
MPS:Zn:S = 1/4:2:1 remained stable for more than 50 days under the ambient conditions. 
Note that we stopped monitoring the QDs with MPS:Zn:S = 1/2:2:1 after 20 days, due to 
too small a sample volume available for the measurement rather than any observable 
degradation.  
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Fig. 4.14. PL intensity versus time of the MPS-capped ZnS QDs with various MPS:Zn:S 
ratios, 1/2:2:1 (full circles with solid line), 1/4:2:1 (full up-triangles with solid line) and 
1/8:2:1 (full down-triangles with solid line), along with that of the MPA-capped ZnS QDs 
with MPA:Zn:S ratio of 8:4:1 (open squares with dashed line) at room temperature and 
under normal laboratory lighting conditions. 
 
            It was evident that when there was sufficient MPS coverage on the surface, the 
MPS-capped ZnS QDs were much more stable than the MPA-capped ZnS QDs. To 
understand this, we measured the zeta potential of all the samples mentioned above, using 
the Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, United Kingdom). At 
the suspension pH of 12, the QDs with MPS:Zn:S ratios of 1/2:2:1, 1/4:2:1, and 1/8:2:1 
exhibited a zeta potential of -34±1 mV, while the MPA-capped QDs exhibited a zeta 
potential of -30±1 mV. These results indicated that the MPS-capped QDs had more 
negative charges on the surface, which helped disperse the QDs better. On the other hand, 
according to the study of Aldana et al.,97 in the presence of both light and oxygen, two 
adjacent thiol groups can react to form a disulfide bond and then the capping molecules 
would dissociate from the QD surface, leading to the aggregation of QDs and the 
degradation of the PL intensity. Although this disulfide reaction may happen to both the 
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MPA and the MPS, the cross linking of the hydrolyzed silane groups of the MPS could 
form a network wrapping the QDs, minimizing the dissociation effect of the disulfide 
formation. Meanwhile, the silica network could also serve as a diffusion barrier to keep 
oxygen from reaching the QD surface and consequently suppress the disulfide reaction.36 
The PL intensity increase over time of the MPS-capped ZnS QDs may be attributed to the 
gradual cross linking of MPS which provided better surface protection for the QDs. Note 
that the present MPS-capped ZnS QDs required a much lower molar ratio for the capping 
molecule as compared to the MPA-capped ZnS QDs, clearly indicating MPS is a better, 
more efficient capping molecule for the QDs.  
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Fig. 4.15. PL intensity versus time of the MPS-capped ZnS QDs with a MPS:Zn:S ratio 
of 1/2:2:1 in the original solution (full circles with solid line), in DI water (open squares 
with dashed line) and in PBS (open triangles with dotted line).  
 
To examine the photostability of the MPS-capped ZnS QDs in DI water and in 
PBS, the sample with MPS:Zn:S = 1/2:2:1 was first micro-centrifuged (MiniSpin plus, 
Eppendorf, Westbury, NY) with a 10 kD filter (Millipore Co., Billerica, MA) to remove 
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the unreacted species, and then re-suspended in DI water and in PBS, respectively. The 
pH of the QDs suspension decreased from 12 to around 7 after the centrifugation and re-
suspension. The samples with QDs in the original synthesis solution, in DI water, and in 
PBS were stored in ambient conditions, and their PL intensities were monitored over time. 
As shown in Fig. 4.15, the QDs remained stable both in DI water and in the synthesis 
solution with no degradation of the PL intensity. In PBS, the QDs retained 70% of the 
initial emission intensity and remained clear after 10 days. These results indicated that the 
MPS-capped ZnS QDs were stable not only in the synthesis solution at high pH, but also 
in physiological environment, which is preferable for bioapplications. 
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Fig. 4.16. PL intensity versus heat treatment time at 50oC of the MPS-capped ZnS QDs 
with various MPS:Zn:S ratios, i.e., 1/2:2:1 (circles), 1/4:2:1 (up-triangles) and 1/8:2:1 
(down-triangles). 
 
The effect of temperature on the stability of the MPS-capped ZnS QDs was also 
examined. The QDs with MPS:Zn:S ratios of 1/2:2:1, 1/4:2:1 and 1/8:2:1 were heat 
treated in three hydrothermal bombs (Parr Instrument Co., Moline, IL) at 50oC. After 
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every 1-2 hrs, the samples were removed from the bombs, cooled to room temperature, to 
have their PL spectra measured. In Fig. 4.16 we plot the PL intensity of the QDs with 
various MPS:Zn:S ratios versus heat treatment time. For all three samples, the emission 
intensity initially increased slightly for 4 hrs of heat treatment and then followed by a 
slow decrease over time. After treated at 50oC, the QDs with MPS:Zn:S = 1/2:2:1, 1/4:2:1 
and 1/8:2:1 retained the initial PL intensity for up to 20 hrs, 9 hrs and 6 hrs, respectively. 
The sample with a higher MPS:Zn:S ratio retained the PL intensity longer, probably due 
to the better surface protection by a thicker MPS layer. This is consistent with the result 
reported by Kubo et al.,175 where the coating of MPS on ZnS:Mn2+  nanoparticles was 
effective to suppress the decrease of the PL intensity due to heating by suppressing the 
oxidation of nanoparticles. 
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Fig. 4.17. PL intensity versus time under continuous UV exposure of the MPS-capped 
ZnS QDs with various MPS:Zn:S ratios, i.e., 1/2:2:1 (circles), 1/4:2:1 (up-triangles) and 
1/8:2:1 (down-triangles). 
 
In addition, we examined the stability of the MPS-capped ZnS QDs under 
continuous UV exposure. The QDs with MPS:Zn:S ratios of 1/2:2:1, 1/4:2:1, and 1/8:2:1 
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were placed on a 4W UV lamp with an illumination wavelength of 302 nm (UVP LLC., 
Upland, CA). Note that the samples could be warmed up to 30~40oC after several hours 
of UV exposure. However, the samples were cooled to room temperature before each PL 
measurement. As shown in Fig. 4.17, the QDs with MPS:Zn:S = 1/2:2:1 retained better 
than 80% of the initial PL intensity after 3 hrs of continuous UV exposure. Even the QDs 
with MPS:Zn:S = 1/4:2:1 and 1/8:2:1 retained about 50% of their initial intensity after 1 
hr of continuous UV exposure. Apparently, more MPS can improve the photostability of 
the QDs under UV, like other inorganic shell.176, 177 The MPS-capped ZnS QDs were 
good for applications requiring long-term imaging with continuous excitation. 
            According to all the stability studies above, the MPS-capped ZnS QDs, especially 
the ones with a MPS:Zn:S ratio of 1/2:2:1, exhibited stable PL intensity in physiological 
solutions, at the elevated temperature and under the continuous UV exposure. The 
excellent photostability of the QDs under various conditions indicates the potential of 
using these QDs in physiological environments for long-term imaging applications and 
kinetic investigations. Although the fluorescence occurs in the short wavelength of blue 
and green, with a limited penetration depth in living tissues and organs, it should not 
prevent the general use of the ZnS QDs in biological systems. For example, Gao et al.3 
have demonstrated in vivo cancer targeting and imaging using QDs with multiple 
emission colors, including green, yellow and red. It is expected that the ZnS QDs with 
blue emission can also be used for applications not requiring deep penetration, such as 
imaging of tissues underneath the skin (in vivo) and cells in culture (in vitro).  
 
 
80 
 
4.2.5. Summary 
 We have examined the synthesis of ZnS QDs using an all-aqueous route at pH 12 
with MPS as the capping molecule. The obtained MPS-capped ZnS QDs were well 
dispersed with a particle size around 5 nm and a cubic zinc blende crystalline structure. 
The QDs exhibited high quantum yields, 25-42%, and reached the optimal PL emission 
when the MPS:Zn:S ratio was between 1/4:2:1 and 1/2:2:1, providing one to two 
molecular layers of MPS coating on the QD surface. Compared with the earlier MPA-
capped ZnS QDs, the MPS-capped ZnS QDs were more negatively charged and much 
more stable under ambient conditions. As the capping molecule, MPS can eliminate the 
dissociation effect of disulfide reaction, and protect the QD surface better by the cross 
linking of the hydrolyzed silane groups to form a network surrounding the QDs. 
Therefore the MPS-capped ZnS QDs exhibited significantly improved colloidal, thermal 
and photostability under various conditions. Even though the aqueous ZnS QDs had trap-
state emissions with blue color, with the high quantum yield and the excellent stability, 
the MPS-capped ZnS QDs could be good imaging tools for many biological applications. 
The thiol group of MPS can functionalize the QD surface for conjugation with other 
biomolecules. Also the silanol network is benign to human body, which would enable the 
MPS-capped ZnS QDs for in vivo applications. 
4.3. MPS-replaced ZnS QDs 
 Aqueous non-heavy-metal ZnS QDs have been successfully synthesized through 
our environmentally-friendly method using MPA as the capping molecule.178 The MPA-
capped ZnS QDs exhibited strong photoluminescence with 31% quantum yield, but 
limited photostability. When left at room temperature under normal laboratory lighting 
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condition (ambient condition), the emission of the MPA-capped ZnS QDs degraded 
quickly and diminished completely after a few days.  
As shown in section 4.2, to improve the stability, we used MPS as the capping 
molecule for the synthesis of the aqueous ZnS QDs.179 The MPS-capped ZnS QDs can be 
left on the shelf in ambient conditions for more than 50 days without degradation. They 
also showed excellent photostability in the physiological environment, at the elevated 
temperature and under continuous UV exposure. However, the initial PL intensity of the 
MPS-capped ZnS QDs was not as high as that of the MPA-capped ZnS QDs, as shown in 
Fig. 4.14, although they had comparable quantum yields. 
It is very desirable to have a non-heavy-metal ZnS QDs system that combines the 
brightness of the MPA-capped ZnS QDs and the stability of the MPS-capped ZnS QDs 
via an aqueous process. Since both MPA and MPS have the thiol group which can bind 
with the Zn cations on QD surface, the manipulation and combination of these two kinds 
of capping molecules can be utilized to achieve the optimal properties of QDs. Here we 
explored a modified aqueous method to produce both highly photoluminescent and very 
stable ZnS QDs. The QDs were synthesized with MPA first and then part of MPA were 
replaced by MPS, therefore benefiting from both the capping molecules’ merits but 
avoiding their shortcomings. The replacement of MPA-capped Mn-doped ZnS QDs with 
MPS was reported recently.180 In that method, after the addition of MPS and complicated 
multiple steps of further silica deposition, the nanoparticles showed no enhancement of 
the emission intensity compared with the original MPA-capped QDs. Meanwhile, the 
particle size was built up to about 30 nm, with multiple cores contained in each silica 
shell. As comparison, via our simple replacement, the obtained MPS-replaced ZnS QDs 
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exhibited significantly improved photoluminescence and maintained the small particle 
size as well. 
4.3.1. Aqueous synthesis with capping molecules replacement 
 The synthesis of the desired MPS-replaced ZnS QDs included two steps: 
precipitation with MPA and then replacement with MPS. Firstly, the MPA-capped QDs 
with the ratio of MPA:Zn:S = 8:4:1 and the concentration of 1.6 mM were produced in 
water directly, as described in section 4.1.1. In brief, the zinc nitrate (Zn(NO3)2) solution 
and MPA were mixed and then the pH of the mixture was adjusted to 12 by adding the 
tetrapropylammonium hydroxide ((CH3CH2CH2)4NOH). Then the sodium sulfide (Na2S) 
solution was added in quickly to precipitate ZnS nanoparticles and followed by the 
excess Zn(NO3)2 solution to achieve the enhanced emission. The obtained MPA-capped 
ZnS QDs suspension was quenched to 0oC and stored in a refrigerator at 4oC. After one 
day, the sample reached equilibrium and the second step of MPS replacement can be 
carried out. The MPA-capped QDs were first micro-centrifuged (MiniSpin plus, 
Eppendorf North America Co., Westbury, NY) with a 10 kD filter (Millipore Co., 
Billerica, MA). The filtrate containing the free MPA and other ions separated from the 
suspension was discarded. Meanwhile, an aqueous MPS solution with appropriate 
concentration was prepared with its pH adjusted to 12 by (CH3CH2CH2)4NOH. Then the 
MPS solution was added in the retentate of the MPA-capped QDs suspension and mixed 
thoroughly, resulting in a nominal ratio of MPS:Zn:S = 1/2:4:1. The obtained ZnS QDs 
suspension was still clear and colorless, and stored in a refrigerator at 4oC for one day 
before any characterization was performed. As the final volume of the sample was 
recovered to the initial value before centrifugation and the 10 kD filter (with the pore size 
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JEM-2010F FasTEM high resolution analytical transmission electron microscope (Japan 
about 1 nm) could keep most of the QDs from passing through, the concentration of the 
MPS-replaced ZnS QDs was approximately maintained at 1.6 mM.  
During the procedure, different amounts of MPS can be used to produce the MPS-
replaced QDs with different MPS:Zn:S ratios. For comparison, the MPA-capped ZnS 
QDs with the ratio of MPA:Zn:S = 8:4:1 and the MPS-capped ZnS QDs with the ratio of 
MPS:Zn:S = 1/2:2:1 were also prepared according to the procedures described in earlier 
studies. Unless mentioned otherwise, all the ZnS QDs suspensions below had a 1.6 mM 
nominal concentration based on the concentration of S. 
4.3.2. Size and structure 
 
 
5 nm 
Fig. 4.18. TEM micrograph of the MPS-replaced ZnS QDs with a MPS:Zn:S ratio of 
1/2:4:1. The dashed lines indicate the outline of the nanoparticles. 
 
For transmission electron microscopy, the excess capping molecules and ions in 
the MPS-replaced ZnS QDs suspension were removed by centrifugation with a 10 kD 
filter and rinsing with DI water. The obtained QD suspension was then dropped onto a 
copper grid coated with an ultrathin carbon film, dried in air, and examined with the 
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e the QDs from 
the sus
Electron Optics Ltd., Tokyo). The TEM micrograph shown in Fig. 4.18 indicated that the 
MPS-replaced ZnS QDs had the size of about 5 nm with clearly defined lattice fringes, 
similar to the MPA-capped and MPS-capped ZnS QDs. According to the dynamic light 
scattering (DLS) measurement, the average particle size was also no more than 6-7 nm. 
Apparently, the obtained MPS-replaced ZnS QDs maintained the ultra small size after 
replacement, and were well dispersed with no observable agglomeration. 
The powder sample was prepared by adding acetone to precipitat
pension, followed by centrifugation and air-drying at 50oC overnight. The powder 
X-ray diffraction pattern of the resultant ZnS QDs was collected using the Siemens D 500 
X-Ray Diffractometer, as shown in Fig. 4.19. It was indicated that the MPS-replaced ZnS 
QDs had the cubic zinc blend crystalline structure, same as that of the MPA-capped and 
MPS-capped ZnS QDs. Therefore, it suffices to say the replacement of capping 
molecules did not change the crystal structure of the nanoparticles.  
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Fig. 4.19. XRD pattern of the MPS-replaced ZnS QDs with a MPS:Zn:S ratio of 1/2:4:1. 
The vertical lines indicate the pattern and relative intensities of bulk ZnS with a cubic 
zinc blende structure. 
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d compare the surface condition of the ZnS QDs before and after 
the capping molecules replacement, the Fourier Transform Infrared (FTIR) spectroscopy 
results were collected using an Excalibur Series FTS 3000MX spectrometer (Digilab Inc., 
Canton, MA) for three samples: the MPS-replaced ZnS QDs with MPS:Zn:S = 1/2:4:1, 
the MPA-capped ZnS QDs with MPA:Zn:S = 8:4:1 and the MPS-capped ZnS QDs with 
MPS:Zn:S = 1/2:2:1. For each sample, 10 mg QDs powder was mixed with 290 mg KBr 
powder, ground and pressed into a pellet with a diameter of 13 mm. A pellet made of 300 
mg pure KBr was also prepared and its spectrum was measured as the background. 
During the experiment, the pyroelectric detector deuterated triglycine sulfate (DTGS) 
was used, and the sensitivity and resolution were set as 2 and 4 cm , respectively. The 
interferogram had the intensity less than 8. After the sample was loaded, we purged the 
chamber with dry air for at least 10 min to eliminate the water vapor. Every sample was 
scanned 32 times to obtain the spectrum with the averaged data.  
The resultant FTIR spectrum of the MPS-replaced ZnS QDs (solid line) is shown 
in Fig. 4.20, along with that of the MPA-capped ZnS QDs (dash-dotted line) and that of 
the MPS-capped ZnS QDs (dotted line) for comparison. Since all the free capping 
molecules and ions were removed with the solvent and only the precipitated QDs were 
collected, the observed signature peaks of MPA and those of MPS in the FTIR spectra 
can only be attributed to the QD-bound MPA and MPS, respectively. As can be seen, the 
QDs directly synthesized with MPA exhibited strong absorbance peaks around 1570 cm  
and 1400 cm , which resulted from the stretching vibrations of C=O and C-OH bonds in 
the carboxyl group of MPA.  For the sample synthesized with MPA and then replaced 
4.3.3. Capping molecules on the surface  
To examine an
-1
-1
-1  
181
86 
 
with MPS, these two peaks also existed but with lowered intensity. Meanwhile, two new 
peaks around 980 cm-1 and 500 cm-1 appeared as the characteristic of Si-OH and Si-O-Si 
bonds.182 The QDs directly synthesized with MPS exhibited these two peaks 
corresponding to the sinanol group too and with higher intensity, consistent with the 
dominance of MPS as the capping molecule. A peak at 3000 cm-1 and a big hump around 
3400 cm-1 existed in the spectra of all three samples (not shown), as they resulted from 
the stretching of C-H and O-H183 bonds  which were contained in the structure of both 
MPA and MPS molecules.  
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Fig. 4.20. FTIR spectrum of the MPS-replaced ZnS QDs (solid line), along with that of 
the MPA-capped ZnS QDs (dash-dotted line) and that of the MPS-capped ZnS QDs 
It was shown that the FTIR spectrum of the MPS-replaced ZnS QDs had the 
signatu
(dotted line) for comparison. The vertical lines indicate the positions of the MPA and 
MPS signature peaks.  
 
re peaks of both MPA and MPS, indicating that some of MPA were substituted by 
MPS and both of them existed on the QD surface. Although exactly how many MPA 
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ence spectra of the ZnS QDs suspensions were obtained using the 
PL spectra of the three samples, the 
MPS-re
molecules were replaced by MPS is unknown, the replacement of MPA by MPS can be 
qualitatively understood as follows. First of all, after the centrifugation and filtering, the 
concentration of free MPA in the QDs suspension was minimized while the MPS solution 
was added. Due to the concentration difference, the MPA would more like to dissociate 
from the QD surface, whereas the MPS would tend to attach to the QDs and occupy the 
vacancy left by MPA. In addition, the MPA on the QD surface was not stable because of 
the possible disulfide reaction.97 In contrast, although the disulfide reaction happened to 
MPS too, the silane groups can form silanol bonding network by the hydroxylation and 
condensation reactions, which would wrap the QDs and would not let the MPS depart 
easily. Therefore, the MPS could stay much longer on the QD surface than the MPA did. 
The FTIR results confirmed that the obtained MPS-replaced ZnS QDs had both MPS and 
MPA on the surface. It suffices to say that the capping molecules replacement method is 
effective to modify the surface condition of the aqueous ZnS QDs. 
4.3.4. PL properties 
 Photoluminesc
QM-4/2005 spectrofluorometer (Photon Technology International, Birmingham, NJ). 
Absorption spectra were obtained with the Lambda-40 UV-Vis spectrometer 
(PerkinElmer Life and Analytical Sciences Inc., Boston, MA). All the measurements 
were carried out at room temperature with the same instrument calibration and 
configuration conditions as described in sections 3.3. 
Figure 4.21 shows the UV-Vis absorption and 
placed ZnS QDs with MPS:Zn:S = 1/2:4:1, the MPA-capped QDs with 
MPA:Zn:S = 8:4:1, and the MPS-capped QDs with MPS:Zn:S = 1/2:2:1. These ratios 
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were chosen because they were the optimal compositions which enabled the maximum 
emission intensity of the QDs synthesized in each method. As can be seen, all three 
samples exhibited the trap-state emissions, which had the peak wavelength about 100 nm 
larger than the absorption edge. The MPS-capped ZnS QDs had both the emission peak 
and absorption edge slightly blue-shifted, compared with those of the other two samples. 
More important, the MPS-replaced ZnS QDs had significantly higher PL intensity than 
both the MPA-capped and the MPS-capped ones.  
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Fig. 4.21. UV-Vis absorption (left) and PL (right) spectra of the MPS-replaced ZnS QDs 
with MPS:Zn:S = 1/2:4:1 (solid lines), along with those of the MPA-capped ZnS QDs 
Since the MPS would attach to the QD surface more stably, the MPS-capped QDs 
could n
with MPA:Zn:S = 8:4:1 (dashed lines), and those of the MPS-capped ZnS QDs with 
MPS:Zn:S = 1/2:2:1 (dotted lines).  
 
ot grow freely during synthesis, resulting in the relatively smaller particle size 
indicated by the blue-shifted absorption edge. As comparison, the bonding between MPA 
and the QD surface was more flexible and dynamic. Therefore the MPA-capped QDs 
were able to grow to a slightly larger particle size. It was indicated that the MPS 
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QDs with MPS:Zn:S = 1/2:4:1 (full circles), along with that of Rhodamine 101 (open 
The quantum yield of the MPS-replaced ZnS QDs with MPS:Zn:S = 1/2:4:1 was 
measur
replacement did not change the particle size of the original MPA-capped ZnS QDs, as the 
absorption edge of the MPS-replaced QDs did not change after replacement. On the other 
hand, compared with the MPS-capped QDs, the MPA-capped QDs had the lower surface-
to-volume ratio due to the larger particle size. Therefore, these QDs had less surface 
molecules but more interior molecules, which would partially contribute to the higher 
emission intensity. For the MPS-replaced QDs, the better surface coverage by MPS could 
eliminate the surface defects and further enhance the emission intensity. Clearly the 
replacement process improved the photoluminescence of the aqueous ZnS QDs as desired. 
 
 
Fig. 4.22. Integrated fluorescence intensity versus absorbance for the MPS-replaced ZnS 
0.00 0.05 0.10 0.15 0.20 0.2
squares) as the standard. Insert I and II respectively show a photograph of the QDs 
suspension in a glass vial and a pattern drawn with the QDs suspension on a glass slide, 
both of which were placed on a UV lamp with the excitation wavelength of 302 nm. 
 
ed and the result was shown in Fig. 4.22. Using the Rhodamine 101 with known 
100% QY as the standard and by comparing the slope of integrated fluorescence intensity 
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the PL properties, the stability of the MPS-replaced ZnS QDs was 
amin
ambien
versus absorbance, we deduced the quantum yield of the MPS-replaced ZnS QDs was 
75%. This was much higher than the QY of the MPA-capped ZnS QDs, 31%, and the QY 
of the MPS-capped QDs, 25% (with MPS:Zn:S = 1/4:2:1) or 42% (with MPS:Zn:S = 
1/2:2:1). Considering the relatively larger particle size due to the anterior precipitation 
with MPA and the better surface protection due to the posterior MPS replacement, the 
QDs could have good absorption of excitation and high emission-to-excitation ratio, 
which may result in the extraordinarily high quantum yield. It is worth noting that, due to 
the combination of higher extinction coefficient (~5*106 M-1cm-1) and higher quantum 
yield, the MPS-replaced ZnS QDs are much brighter than organic dyes, i.e., the green 
fluorescence protein (GFP).184 The inset I of Fig. 4.22 displayed the bright blue 
photoluminescence of the MPS-replaced ZnS QDs suspension, which was placed on a 
UV lamp with the excitation wavelength of 302 nm. A pattern of ‘QD’ written with the 
QDs suspension on a glass slide also fluoresced strongly when placed vertically above 
the UV lamp, as shown by the inset II. 
4.3.5. Stability 
 Besides 
ex ed as another important aspect. We prepared several samples by first synthesizing 
the ZnS QDs with MPA followed by replacement with different amounts of MPS to reach 
various ratios, i.e., MPS:Zn:S = 0:4:1, 1/4:4:1, 1/2:4:1, 1:4:1, 2:4:1, and 4:4:1. The MPA-
capped ZnS QDs with MPA:Zn:S = 8:4:1 were also prepared for comparison.  
Each sample was stored in a plastic cuvette sealed with parafilm under the 
t conditions, and the PL intensity was measured constantly over a long period of 
time. As shown in Fig. 4.23, the MPA-capped ZnS QDs (open squares) had the emission 
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degraded dramatically within 10 days, as well as the QDs with the ratio of MPS:Zn:S = 
0:4:1 (no MPS was added) (full circles). The MPS-replaced QDs with MPS:Zn:S = 
1/4:2:1 (full up-triangles) displayed slow decrease of the PL intensity over time. 
According to the estimation in section 4.2.3, the MPS molar ratio of 1/4 should result in 
one layer of MPS coverage on the QD surface. However, in the replacement process, not 
all the MPA was substituted by MPS, as indicated by the FTIR result. Therefore, the 
sample with MPS:Zn:S = 1/4:4:1 would not have complete MPS coverage to provide 
sufficient protection for the QDs. As comparison, the samples with the ratios of 
MPS:Zn:S = 1/2:4:1 or higher can maintain the PL intensity for more than 60 days 
without obvious degradation. These results are comparable with the photostability of the 
MPS-capped ZnS QDs as shown in Fig. 4.14. Apparently, more MPS in the suspension 
would favor the replacement reaction and it was more likely to form a complete network 
by the hydroxylation and condensation of silane groups. 
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Fig. 4.23. PL intensity over time of the MPS-replaced ZnS QDs with various MPS:Zn:S 
ratios (full symbols as indicated in the figure) and that of the MPA-capped ZnS QDs with 
MPA:Zn:S = 8:4:1 (open squares) in the ambient conditions.  
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sample with MPS:Zn:S = 
1/2:4:1. This probably resulted from the cross linking of MPS on the surface of multiple 
QDs, which may cause the clustering of QDs and more energy loss between the interface.  
 
It should be noted that the QDs after replacement with too much MPS had 
undesirably lower emission intensity, compared with the 
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Fig. 4.24. Size distribution change over time after synthesis of the MPS-replaced ZnS 
QDs with MPS:Zn:S = 1:4:1 (full diamonds) and the MPA-capped ZnS QDs with 
MPA:Zn:S = 8:4:1 (open squares) in the ambient conditions. 
e over time in the ambient 
conditions for the MPS-replaced ZnS QDs with MPS:Zn:S = 1:4:1 and the MPA-capped 
QDs with MPA:Zn:S = 8:4:1. The sizes were measured using the Zetasizer Nano ZS 
(Malvern Instruments Ltd., Worcestershire, United Kingdom) 2 days and 10 days after 
synthesis. As shown in Fig. 4.24, although these two samples had similar average QD 
size of 4-6 nm initially, they exhibited quite different behavior over time. After 10 days, 
 
Especially, we monitored the size distribution chang
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e the high PL intensity of the MPA-capped ZnS QDs and the excellent 
stabilit
the MPS-replaced QDs remained the small size of less than 10 nm, while the MPA-
capped QDs had the aggregation of nearly 100 nm and the suspension was observed to be 
a little cloudy. These results further confirmed that the QDs with MPS replacement were 
much more stable and dispersed better than the QDs directly synthesized with MPA. 
4.3.6. Summary 
To preserv
y of the MPS-capped ZnS QDs, we developed an aqueous two-step capping 
molecules replacement process. The ZnS QDs were first synthesized with MPA, and then 
followed by a second step to substitute some of MPA with MPS. The resultant MPS-
replaced ZnS QDs remained the small particle size of around 5 nm and the cubic zinc 
blende crystal structure, same as the MPA-capped and MPS-capped ZnS QDs. The FTIR 
results indicated that both MPA and MPS existed on the QD surface after replacement. 
With the ratio of MPS:Zn:S = 1/2:4:1, the MPS-replaced ZnS QDs were not only brighter 
than the original MPA-capped QDs, but also maintained the colloidal and photostability 
of the MPS-capped QDs. The extraordinary high quantum yield, 75%, and more than 60 
days lifetime in the ambient conditions enabled the new MPS-replaced ZnS QDs a very 
promising imaging tool for both basic science and clinical applications. It is also worth 
mentioning that, with both MPA and MPS on the surface, these ZnS QDs after 
replacement would have two different functional groups, carboxyl and thiol groups, 
available for bioconjugation. Therefore the MPS-replaced ZnS QDs are versatile for more 
possible applications. 
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CHAPTER 5: CYTOTOXICITY TEST OF AQUEOUS ZnS AND CdS QUANTUM 
DOTS 
 
5.1. Introduction 
 Applying quantum dots in biological imaging is one of the most exciting new 
nanobiotechnology developments of the past decade.185-191 QDs can be utilized as 
diagnostic and therapeutic tools to better detect, understand, and treat diseases for both 
scientific study and clinical applications. So far in situ imaging using QDs have been 
successfully demonstrated in living mouse,4, 124, 192-194 chick,133 dog123 and pig models.126-
129 However, using QDs in humans has not been realized yet, due to the concern of the 
potential toxicity.195 As a novel nanomaterial, QDs may interact with different organs and 
tissues such as lungs, brain, liver, kidneys, colon, bone, skin, blood, etc. and may cause 
various types of deformation, inhibit cell growth, and even cause diseases in humans and 
animals. The effect of nanoparticles on health is an important issue, which has become a 
newly emerging research topic and has not been fully understood up to now.  
Current commercially available QDs contain many elements known to be toxic at 
low concentrations, including cadmium, lead, mercury, and arsenic, etc.196, 197 If these 
QDs are exposed to conditions promoting degradation, such as an oxidative environment, 
toxicity related to the release of free ions is expected. The increase of reactive oxygen 
species (ROS) is closely related to the toxicity of QDs by inhibiting survival-related 
signaling events.198 The toxicity of QDs could be reduced by chemical approaches via 
surface treatment, functionalization, and composite formation. For example, an additional 
ZnS shell layer is often added to prevent core degradation, making the QDs more 
biocompatible and relatively nontoxic.9, 80, 198, 199 However, as several groups have 
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found,6, 200 the QDs are prone to being internalized and retained inside the cells and 
animals, and cannot be discharged after intravenous dosing. This suggests possible 
toxicity could result from the bioaccumulation and the release of toxic elements thereafter.  
To make in vivo applications of QDs possible in humans, it is necessary to have QDs 
containing nontoxic composition. Our recent studies have shown that water-soluble ZnS 
QDs could be synthesized with an environmentally friendly all-aqueous process. As 
discussed in chapter 4, the present ZnS QDs exhibited bright blue trap-state emissions at 
about 420 nm with the small size of 4-6 nm. With the MPA as the capping molecule, they 
exhibited a quantum yield of 31%178 which was further increased to 75% after the MPA 
was replaced by MPS.201 These highly luminescent ZnS QDs do not contain toxic 
element, thus, offering great potential for in vivo imaging in clinical use. 
Besides the toxicity due to composition, there are at least two other pathways by 
which QDs can interfere with organism function, i.e., size and shape of the 
nanoparticles.73 Due to the ultra small size, QDs may stick to the cell membrane or be 
ingested by cells, disturbing metabolism or causing death, even for absolutely inert 
compositions. Therefore, even though ZnS QDs do not contain toxic elements, they still 
need to be examined carefully before their clinical applications can occur, to understand 
their effect on human body and to ensure the safety. 
In this study, we carried out the cytotoxicity tests of the aqueous ZnS QDs with 
four different surface conditions, using human endothelial cells (EA hy926) as the target 
system. Since the potential toxicity of nanoparticles in human body is in question, human 
cells should be used for the study. The human endothelial cells were chosen in part 
because they are among the first normal cells that would come in contact with the QDs if 
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QDs were used in vivo. In addition to different capping conditions, we examined the 
cytotoxicity at different ZnS QD concentrations, i.e., 1 µM and 10 µM. These 
concentrations were chosen because they cover the range of concentrations which are 
appropriate for imaging applications.202 For comparison, we also carried out the same 
cytotoxicity tests for the CdS QDs prepared via the same all-aqueous method, with the 
same surface conditions and at the same concentrations. Because the size of ZnS and CdS 
QDs are similar, and both of them have roughly sphere shape, comparing the results of 
ZnS QDs with those of CdS QDs under the same conditions would allow us to better 
delineate the toxicity effect from the size and shape and that from the element. The 
cytotoxicity tests were conducted through both cell counting with Trypan blue staining 
and fluorescence assay with Alamar Blue (AB). Conducting multiple tests will help 
validate the results more conclusively. The cells were cultured with the QDs for up to 6 
days to monitor the potential long-term toxicity.  
5.2. Synthesis of QDs with various surface conditions 
 The syntheses of aqueous MPA-capped ZnS QDs and MPA-capped CdS QDs 
were carried out as described in chapter 4 and 3, respectively. Briefly, the Zn or Cd 
precursor and the MPA were dissolved and mixed in DI water, followed by adjusting the 
pH of the mixture to 9-12. The sulfur precursor was then added quickly followed by the 
addition of the excess Zn or Cd. More base was added in when needed to maintain the pH 
at 12. After synthesis, the samples were quenched to 0oC and stored in a refrigerator at 
4oC. The final QD suspensions had the same nominal elemental molar concentration of 
1.6 mM based on the sulfur concentration. The MPA-capped ZnS QDs had a MPA:Zn:S 
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ratio of 8:4:1 and the MPA-capped CdS QDs had a MPA:Cd:S ratio of 2:3:1. These ratios 
were chosen for their optimal photoluminescence performances. 
The synthesis procedure of the water soluble MPS-capped ZnS QDs was similar 
to that of the MPA-capped ZnS QDs except that in the initial mixture the Zn precursor 
was mixed with MPS instead of MPA. The MPS:Zn:S ratio of 1/2:2:1 was chosen  to 
achieve the optimal photoluminescence performance of the MPS-capped ZnS QDs.179 
Note that the CdS QDs cannot be synthesized and dispersed with MPS directly. Therefore, 
there was no MPS-capped CdS QDs available. 
To prepare the MPS-replaced ZnS and CdS QDs, the QDs were initially 
synthesized with MPA as described above, and followed by micro-centrifugation with a 
10 kD filter to remove free MPA in the suspension. An MPS solution at pH 12 was then 
added to the retentate of the QD suspension and the sample was stored in a refrigerator at 
4oC. By controlling the concentration and volume of the MPS solution added, we 
maintained the nominal ZnS or CdS elemental concentration of 1.6 mM. The resultant 
MPS-replaced ZnS QDs had a MPS:Zn:S ratio of 1/2:4:1 and the MPS-replaced CdS 
QDs had a MPS:Cd:S ratio of 1/2:3:1.  
To have an extra silica coating on the MPS-replaced ZnS and CdS QDs, 0.2 ml of 
Na2Si3O7 solution with Si concentration of 63 mM was added to 8 ml of QDs suspension 
(1.6 mM) without essentially changing the nominal ZnS or CdS QD concentration. The 
resultant MPS-replaced ZnS with silica coating had a Si:(MPS:Zn:S) ratio of 1:(1/2:4:1) 
and the MPS-replaced CdS with silica coating had a Si:(MPS:Cd:S) ratio of 1:(1/2:3:1). 
In total, there were seven different types of aqueous QDs used in the cytotoxicity 
tests, the MPA-capped ZnS, MPS-capped ZnS, MPS-replaced ZnS, and MPS-replaced 
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silica-coated ZnS, as well as the MPA-capped CdS, MPS-replaced CdS, and MPS-
replaced silica-coated CdS. Each sample was tested at two different concentrations, 1 µM 
and 10 µM. Before adding a QD suspension to a cell culture, it was micro-centrifuged 
with a 10 kD filter and rinsed with DI water for three times to remove the excess capping 
molecules and free ions in the suspension. 
5.3. Cell culture 
 The human endothelial cells (EA hy926) were kindly provided by Dr. Cora-Jean 
Edgell, University of North Carolina (Chapel Hill, NC). All cell culture media and 
supplements were purchased from Cellgro (Herndon, VA) and Hyclone (Logan, UT). 
Disposable cell culture supplies were purchased from VWR (West Chester, PA).  
The human endothelial cells (EA hy926) were previously frozen in the culture 
medium with 5-10% dimethyl sulfoxide (DMSO) in the vapor of liquid nitrogen at 77K. 
After being defrosted, the cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM) with 4.5 g/l glucose supplemented with 50 units/ml penicillin and 50 mg/ml 
streptomycin and 10% fetal bovine serum (complete DMEM, thereafter). The cells were 
cultured at 37°C in a humidified atmosphere with 5% CO2 and 95% air. Note that all 
cytotoxicity experiments were carried out to the cells immediately after they reached 
confluence.  
Cells cultured under the same conditions but without QDs were used as the 
controls. Each experiment was repeated for 3 times to eliminate operation errors. Where 
applicable, the data are expressed as mean ± standard deviation (SD). Two-tail t-test and 
single factor ANOVA were used for statistical data analysis with P<0.05 considered as 
being statistically significant. 
99 
 
5.4. Cell counting with Trypan blue staining 
In this test, the human endothelial cells (EA hy926) were seeded in T-25 cell 
culture flasks with a density of 150,000 cells/flask. We allowed 3 hrs for the cells to 
attach to the flask surface in the complete DMEM. After that, the complete DMEM was 
replaced with the culture medium containing one type of QDs at 1 µM or 10 µM, in 
which the cells were incubated for 3 days. Three days later, the cells floating in the 
medium were removed and stored in a tube. Then the cells adhering to the flask surface 
were detached by trypsinization with 0.5 ml of trypsin for 2-3 min and were also 
collected. Both the floating cells and attached cells were stained with Trypan blue and 
were counted using a hemacytometer (Hausser scientific, Horsham, PA) under a 
PhotoZoom inverted microscope (Leica Microsystems Gmbh, Wetzlar, Germany), 
separately. 
As a diazo dye, Trypan blue is only permeable to cells with compromised 
membranes. Because exposure to certain cytotoxic agents can break the cell membrane 
and allow cellular contents to leak out, Trypan Blue assay is usually applied to measure 
the plasma membrane integrity of target cells and the cytotoxicity of the introduced 
agents. After mixing with Trypan blue, dead cells are stained blue while live cells remain 
colorless. The amount of live or dead cell can be determined via light microscopy and 
cell counting.203 Because live cells would attach to the surface and dead cells would float 
in the supernatant, we used the number of attached cells as live cells number and the 
number of floating cells as dead cells number. Note that the detaching process may 
damage some cells even though they were not dead before the removal. After Trypan 
blue staining, the observation under a microscope confirmed that, more than 92% of the 
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attached cells appeared colorless, which were live cells. Meanwhile, all the floating cells 
appeared dark blue, which were dead cells. 
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Fig. 5.1. Total cell number after incubation for 3 days with (a) ZnS QDs and (b) CdS 
QDs with different concentrations and surface conditions. Results are presented as mean 
± standard deviation (n = 3). * indicates P<0.05 and ** indicates P<0.01, values are 
significantly different from the control. The dashed line indicates the initial cell number 
was 150,000 before incubation. 
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The total cell number is a sum of the live cell number and the dead cell number. 
Figure 5.1 shows the cell counting results of total cell number in three independent 
experiments with statistical analysis. As can be seen, after incubation for 3 days, the 
samples with all four types of ZnS QDs at both 1 μM and 10 μM indicated similar total 
cell numbers to that of the control, which were more than 4 times of the initial cell 
number. In comparison, the samples with three types of CdS QDs at 1 μM also showed 
the total cell number more than 3 times of the initial cell number, but the samples with 
CdS QDs at 10 μM showed significantly decreased total cell number, especially with the 
MPA-capped and the MPS-replaced ones. Apparently, the high concentration of CdS 
QDs impeded the increase of the total cell number during incubation, which may result 
from both the lower proliferation rate and the higher death rate. 
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Fig. 5.2. Live and dead cell number fractions for the cell samples incubated with ZnS 
QDs with four surface conditions at 1 µM or 10 µM for 3 days.  
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In Fig. 5.2, we plot the live and dead cell number fractions for the cell samples 
incubated with ZnS QDs with four surface conditions at 1 µM or 10 µM for three days. 
The live (dead) cell number fraction is the number of the live (dead) cells divided by the 
total cell number. As can be seen, the cell samples with all four types of ZnS QDs at both 
1 µM and 10 µM exhibited essentially the same live and dead cell number fractions as 
those of the control. It is indicated that the ZnS QDs would not cause any adverse effect 
to the human endothelial cells, and that the nontoxicity was independent of the surface 
conditions and the two concentrations used. 
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Fig. 5.3. Live and dead cell number fractions for the cell samples incubated with CdS 
QDs with three surface conditions at 1 µM or 10 µM for 3 days. * indicates P<0.05 and 
** indicates P<0.01, values are significantly different from the control.  
 
In Fig. 5.3, we plot the live and dead cell number fractions of the samples 
incubated with CdS QDs with three surface conditions at 1 µM or 10 µM for 3 days. As 
can be seen, at 1 µM, cells with all three types of CdS QDs exhibited no discernable 
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difference in their live and dead cell number fractions from those of the control, 
indicating that at this concentration, the CdS QDs could be considered nontoxic to the 
cells. However, at 10 µM, the live cell number fractions of cells incubated with the three 
types of CdS QDs became significantly smaller than that of the control, and the dead cell 
number fractions were much larger accordingly. It is indicated that the CdS QDs at this 
high concentration killed much more cells during incubation. Among the samples with 
three different surface conditions, the cells incubated with the MPS-replaced with silica 
coating CdS QDs showed the highest live cell number fraction, while the cells with the 
MPA-capped CdS QDs had the lowest live cell number fraction. It is suggested that the 
extra silica coating helped cover the CdS QDs better and reduced the leak of Cd from the 
core, therefore moderating the toxicity. The MPA capping was not as protective as MPS 
and silica, which can be attributed to that MPA would detach from the QD surface due to 
the disulfide bond formation,97 causing the toxic core material exposed and released.  
 It is worth noting that the cytotoxicity test was also performed with the 
commercial CdSe/ZnS core/shell QDs and with our ZnS and CdS QDs. In that 
experiment, human microvascular endothelial cells were used as the target system, and 
Trypan blue staining was applied for cell counting. Although the experiment was carried 
out under different conditions, the preliminary results indicated that our ZnS QDs had 
similar nontoxicity as the commercial QDs, while the CdS QDs exhibited more toxic than 
the other two. This is consistent with the results shown in Fig. 5.1 to Fig. 5.3. 
To further confirm the cell counting results, the morphology of cells after 
incubation with QDs was examined under a microscope. For this assessment, the EA 
hy926 cells were cultured in 6-well plates with each well containing one type of QDs at 
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one of the two QDs concentrations. After 3 days of incubation, the supernatant was 
discarded, and the cells were fixed with 10% buffered formalin for 15 min at room 
temperature. Following a gentle wash with PBS, the cells were incubated for 15 min in 
PBS containing 0.2% Triton-X 100 (Sigma-Aldrich, St. Louis, MO) for cell membrane 
penetration, 2 mg/ml Hoechst 33258 bis-benzimide (Sigma-Aldrich, St. Louis, MO) as a 
nuclear stain, and 1 mg/ml rhodamine-phalloidin (Phalloidin TRITC-labeled, Sigma-
Aldrich, St. Louis, MO) as a specific stain for microfilaments. Then the cells were 
washed and soaked in PBS for 15 min to eliminate non-specific staining and for deep 
cleaning. Finally, the cells were visualized under a Leica DMRX microscope (Leica 
Microsystems Gmbh, Wetzlar, Germany) equipped with the appropriate fluorescence 
filters. Digital images were acquired using a Leica 300F camera (Leica Camera AG, 
Solms, Germany). 
Under the fluorescence microscope, the nuclei of cells stained by bis-benzimide 
emitted in blue with UV excitation, so the DAPI filter (excitation 360 nm, emission 460 
nm) was used. Meanwhile, the microfilaments stained by rhodamine-phalloidin emitted 
in red, and the TRITC filter (excitation 555 nm, emission 635 nm) was used. Two 
pictures were taken for each sample with the same scope but different filters. Then the 
pictures were overlapped using PhotoShop to show the morphology of cells. Since the 
dead cells were not bound to the plate surface and were removed with the supernatant, the 
micrograph would only show the live cells left and fixed by Formalin. 
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(a) 
(b) (c) 
(d) 
 
(e) 
Fig. 5.4. Fluorescence micrographs of (a) the control cells sample, (b) cells with 1 µM of 
MPA-capped ZnS QDs, (c) cells with 10 µM of MPA-capped ZnS QDs, (d) cells with 1 
µM of MPA-capped CdS QDs, and (e) cells with 10 µM of MPA-capped CdS QDs, after 
incubated for 3 days. 
 
As examples, Figs. 5.4(a)-(e) show the images of the control cells sample, cells 
incubated with 1 µM of MPA-capped ZnS QDs, cells with 10 µM of MPA-capped ZnS 
QDs, cells with 1 µM of MPA-capped CdS QDs, and cells with 10 µM of MPA-capped 
CdS QDs, respectively. In the micrographs, the orange part indicated the cytoplasm, and 
the blue spots indicated the nuclei. The black background indicated the area that no cells 
covered. As can be seen, after 3 days of incubation, the cells with the MPA-capped ZnS 
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ting results shown in Fig. 5.2 and Fig. 5.3.  
ence 
assay w
QDs at both 1 µM and 10 µM proliferated well and reached confluence, similar to the 
control sample. The cells with 1 µM of MPA-capped CdS QDs also grew but with 
obviously reduced population indicated by the larger area of dark region. The sample 
with 10 µM of MPA-capped CdS QDs showed very few live cells remained, indicating 
the high cytotoxicity of CdS QDs at this concentration. The results from optical
microscope were consistent with the cell coun
5.5. Fluorescence assay with Alamar Blue 
 To assess cell growth and viability, the fluorescence assay with Alamar Blue (AB) 
(Biosource, Alameda, CA) was carried out. The human endothelial cells (EA hy926) 
were first seeded in a 24-well culture plate with a density of 10,000 cells in each well and 
allowed 3 hrs for the cells to attach to the surface. The density of cells was controlled by 
cell counting with a hemacytometer. Then each well was replenished with the culture 
medium containing one type of QDs of certain concentration, 1 µM or 10 µM. After 2 
days of incubation, the supernatant in each well was removed and 1 ml fresh complete 
DMEM containing 5% (v/v) AB was added. After 3 hrs of incubation, two 100 µl 
aliquots of AB-containing medium were collected from each well for fluorescence 
measurements, using the CytoFluor Multi-well Plate Reader (PerSeptive Biosystems Inc., 
Framingham, MA). Subsequently, the supernatant in the culture plate was replaced with 
the QD-containing fresh medium and the incubation continued. The AB fluoresc
as repeated every other day up till day 6 when the cells reached confluence.  
In this colorimetric assay, the non-fluorescent Alamar Blue dye can be reduced to 
a pink fluorescent dye by cell metabolic activity, mainly by acting as an electron acceptor 
for enzymes such as NADP and FADH during oxygen consumption.204 Since only the 
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vity can be quantified by measuring the fluorescence intensity of the 
reduced dye.  
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Fig. 5.5. Fluorescence intensity versus time of the AB-containing medium after reacting 
with cells, which were incubated with (a) ZnS QDs and (b) CdS QDs with various 
surface conditions and concentrations: control (full squares with solid line), 1 µM MPA-
capped (open circles with dashed line), 10 µM MPA-capped (full circles with solid line), 
1 µM MPS-capped (open up-triangles with dashed line), 10 µM MPS-capped (full up-
triangles with solid line), 1 µM MPS-replaced (open down-triangles with dashed line), 10 
µM MPS-replaced (full down-triangles with solid line), 1 µM MPS-replace
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d with silica 
(open diamonds with dashed line), and 10 µM MPS-replaced with silica (full diamonds 
with solid line). Results are presented as mean ± standard deviation (n = 3). 
 
After the AB-containing medium reacted with the cells, the measured 
fluorescence intensity of the reduced pink dye versus incubation time with various types 
of ZnS QDs is plotted in Fig. 5.5(a) and that with various CdS QDs is plotted in Fig. 
5.5(b). As can be seen, the samples with all types of ZnS QDs at both 1 µM and 10 µM 
showed similar fluorescence intensities as that of the control, indicating that the ZnS QDs 
were nontoxic no matter what the surface condition or QD concentration was. The 
fluorescence intensities of samples with all three types of CdS QDs at 1 µM were also 
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e 
intensities, indicating the reduced viability of cells with 10 µM of CdS QDs over time.  
 
comparable with that of the control. In comparison, with 10 µM of CdS QDs with all 
three surface conditions, the samples showed no significant difference from the control 
on day 2, which may result from the fact that the interaction between cells and QDs 
would take time. On day 4 and day 6, these samples started to show reduced fluorescenc
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Fig. 5.6. Cell number versus fluorescence intensity (solid squares) and the theoretically 
fitted polynomial calibration curve (dashed line). 
 
To convert the data of fluorescence intensities to viable cell numbers, we obtained 
a calibration curve by measuring the fluorescence intensity of AB-containing medium 
after reacting with live cells with known numbers. First, 0, 5000, 10000, 20000, 40000, 
70000, 100000, 150000, and 200000 cells were placed in 24-well plate, respectively. 
After 3 hrs of incubation, the complete medium was replaced with the medium containing 
5% (v/v) AB. After another 3 hrs of incubation, two 100 µl aliquots of the AB-containing 
medium were collected from each well for the fluorescence measurement. As shown in 
Fig. 5.6, the fluorescence intensity increased with increasing cell number, but the 
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ata, and was used to convert fluorescence intensity to number of live cells 
in the c
hat of samples incubated with all 
three types of CdS QDs at 1 µM or 10 µM in Fig. 5.8.  
 
relationship was not linear. In the limit of very large cell number, the measured 
fluorescence intensity would tend to saturate, though the nonlinearity was not very 
significant. The theoretically fitted polynomial calibration curve matched well with the 
experimental d
ulture. 
With the calibration curve, we converted the results in Fig. 5.5 (a) and (b) to live 
cell number versus time, and then further deduced the live cell number increase rate 
which was defined as the live cell number at day 6 divided by the live cell number at day 
0. We plot the deduced live cell number increase rate of samples incubated with all four 
types of ZnS QDs at 1 µM or 10 µM in Fig. 5.7 and t
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Fig. 5.7. Deduced live cell number increase rate of samples incubated with ZnS QDs at 1 
µM or 10 µM with four different surface conditions at day 6. 
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Fig. 5.8. Deduced live cell number increase rate of samples incubated with CdS QDs at 1 
µM or 10 µM with three different surface conditions at day 6. ** indicates P<0.01, values 
are significantly different from the control. # indicates P<0.05, value of the sample with 
10 µM MPS-replaced with silica CdS QDs is different from those of the samples with 10 
µM MPA-capped CdS QDs and with 10 µM MPS-replaced CdS QDs.  
 
Clearly, the samples with all types of ZnS QDs at both concentrations and the 
samples with 1 µM of all types of CdS QDs showed comparable live cell number 
increase rate with that of the control. In contrast, the samples with 10 µM of CdS QDs 
exhibited significantly reduced live cell number increase rates. It is worth noting that, 
among the three 10 µM CdS QDs samples, the sample with the MPS-replaced and silica 
capping showed relatively higher live cell number increase rate than the samples with the 
MPS-replaced capping and the MPA-capping. It was indicated that the CdS QDs with 
MPS-replaced and extra silica coating had lower toxicity than the other two, which can 
probably be attributed to the hydroxylization and condensation of silane groups on the 
QD surface.  
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The results in Fig. 5.7 and Fig. 5.8 were consistent with the results shown in Fig. 
5.1 to Fig. 5.3. Different from the Trypan blue staining method which measured only the 
numbers of live and dead cells, the fluorescence assay with Alamar Blue provided more 
detailed information about the metabolism condition of cells. In some cases, even though 
the toxicity of QDs may not be deadly and cells were still alive, their metabolic 
functionality may be impaired already. The fluorescence assay with Alamar Blue 
measured the metabolic activity of cells, and thereby the results were more 
comprehensive and meaningful. 
The interaction of QDs with biological systems and the toxicity largely depend 
upon their properties, including size, concentration, solubility, and surface chemistry, 
etc.77, 81 It has been found that some hydrophilic surface coatings contribute to the 
cytotoxicity of QDs, such as MPA and polyethylenimine (PEI).205 In addition, 
cytotoxicity was more noticeable with the smaller QDs than with the larger QDs at the 
same concentrations.206 An asymmetrical intracellular uptake of QDs with different sizes 
and a size-dependent autophagy activation were observed.207 Cytotoxicity of QDs was 
also found by many research groups to be dose dependent with higher concentrations 
resulting in significantly higher cell death.31, 208 In our study, all the ZnS and CdS QDs 
had a similar particle size of about 5 nm with spherical shape, as characterized by 
transmission electron microscopy and dynamic light scattering. With the same surface 
condition and concentration, the cytotoxicity results of ZnS and CdS QDs can be 
compared. All test results indicated that ZnS QDs with all four surface conditions were 
nontoxic at both 1 µM and 10 µM, whereas CdS QDs appeared to be nontoxic only at 1 
µM. At 10 µM, CdS QDs started to show significant cytotoxicity after 2 days. It suffices 
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to say that the nontoxicity of the ZnS QDs was due to the fact that they contained no 
toxic elements. The toxicity increased with an increasing CdS QDs concentration and a 
less protective capping layer such as MPA indicated that the toxicity was mainly due to 
the leaking of Cd ions from the CdS QDs.  
Our present cytotoxicity results of various types of water soluble CdS QDs were 
consistent with the results of Lovric74 and Derfus et al.8 on CdTe and CdSe QDs. 
Although a variety of syntheses, storage conditions, and coating strategies have been 
proposed to alleviate the cytotoxicity of Cd-core QDs, inevitably there is always a 
concentration threshold above which cytotoxicity occurs, such as 10 µM found in this 
study and a few µM found in Kirchner’s study.9 In contrast, our results showed that the 
ZnS QDs were nontoxic at 10 µM regardless of the surface capping conditions. This is 
very encouraging for potential in vivo imaging applications of the aqueous ZnS QDs.  
5.6. Summary 
Cytotoxicity tests of water soluble ZnS QDs synthesized with an all-aqueous 
process with various surface conditions were carried out with human endothelial cells by 
cell counting with Trypan blue staining and by the fluorescence assay with Alamar Blue. 
Water soluble CdS QDs synthesized with similar all-aqueous procedures that were of the 
same size and surface conditions were also tested for comparison. The results showed 
that ZnS QDs with all four types of surface conditions were nontoxic at both 1 µM and 
10 µM for at least 6 days. On the other hand, the CdS QDs were nontoxic only at 1 µM. 
At 10 µM, CdS QDs showed significant cytotoxicity after day 2. The results were 
confirmed by the fluorescence microscopy study. The CdS QDs with MPS-replaced 
capping and MPS-replaced with silica capping exhibited less cytotoxicity than the CdS 
113 
 
QDs with MPA-capping. It was indicated that the toxicity of the CdS QDs and the lack of 
it in ZnS QDs were mainly due to presence and absence of a heavy metal element, 
respectively. The nontoxicity of the aqueous ZnS QDs makes them ideal for in vivo 
imaging applications.  
It is worth mentioning that in vitro cytotoxicity studies of QDs using different cell 
lines and colorimetric assays are increasingly being performed.209 A wide range of QD 
concentrations, exposure times, and surface conditions are also applied in the various 
tests. There is a lack of consensus about whether certain QDs are toxic and under what 
conditions. Standardization in experimental set up such as choice of model (cell line, 
animal species) and exposure conditions (cell confluence, exposure duration, QD 
concentration ranges and dosing increments) is necessary in order for comparisons 
between studies conducted by different groups to be more effective. Certainly many 
aspects of QDs cytotoxicity still have to be investigated, since effects strongly depend on 
many parameters such as surface chemistry, type of the cell line, incubation time, serum-
containing/free medium, etc. 
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CHAPTER 6: IMAGING APPLICATIONS OF AQUEOUS QUANTUM DOTS 
 
 In the past decade, using quantum dots (QDs) as the fluorescence marker in 
biological systems is one of the most exciting new nanobiotechnologies.210, 211 Organic 
fluorophores and dyes have been historically used to label cells and tissues for both in 
vitro and in vivo imaging. However, due to their inherent photophysical properties such 
as susceptibility to photobleaching (decay within a few minutes), broad emission spectra, 
and small Stokes shifts, their use is limited and they are not ideal agents for multiplexing, 
long-term, or real-time imaging. On the other hand, QDs are inorganic fluorescent 
semiconductor nanoparticles with superior optical properties compared with organic 
fluorophores. QDs have many desirable properties for biological imaging, such as high 
quantum yields, high molar extinction coefficients, strong resistance to photobleaching 
and chemical degradation, continuous absorption spectra spanning UV to near-infrared 
(NIR), long fluorescence lifetimes, narrow emission spectra, and large effective Stokes 
shifts. QDs and their advantageous photophysical properties have given researchers new 
opportunities to explore advanced imaging techniques at the single-molecule scale with 
superior temporal resolution and spatial precision,8, 212 while also providing new tools to 
revisit traditional fluorescence imaging methodologies and extract previously unobserved 
or inaccessible information.143  
In this chapter, we explore several conjugation strategies for the water soluble 
quantum dots with different capping molecules and demonstrate their imaging 
applications with examples. 
 
 
115 
 
6.1. Imaging of Salmonella t. cells with the aqueous QDs 
 As discussed in chapters 3 and 4, the aqueous MPA-capped CdS and ZnS 
quantum dots have been successfully synthesized with strong visible photoluminescence. 
As a capping molecule, the MPA has the negatively charged carboxyl group in basic 
condition, which helps stabilize the QDs in water, and also can be utilized for conjugation 
with biomolecules. Especially, after conjugated with an antibody, the quantum dots can 
attach to the complementary antigen with high selectivity and strong bonding. This QDs-
antibody complex can be used for cell labeling and disease diagnosis. For example, the 
luminescence of antibody-coated QDs bound to the cancerous tissue in a mouse helped 
locate the tumor.4 In this study, we conjugated the MPA-capped CdS QDs with 
Salmonella t. antibody, which was then used to image the Salmonella t. cells.  The 1-
ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC) and n-
hydroxysulfosuccinimide (sulfo-NHS) were used as the cross-linkers to link the carboxyl 
group of MPA with the amino group of the antibody. 
The schematic in Fig. 6.1 illustrates the reactions between the MPA-capped QDs 
(represented by circle 1) and the amine-containing antibody (represented by circle 2). 
Firstly the EDC reacts with a carboxyl group of MPA on the surface of QDs, and forms 
an amine reactive O-acylisourea intermediate. The intermediate can quickly reacts with 
an amino group to form an amide bond and release an isourea by-product. But it is 
unstable in aqueous solutions. Failure to react with an amine will result in hydrolysis of 
the intermediate, regeneration of the carboxyl and release of an N-substituted urea. 
Therefore, usually the sulfo-NHS is used to form a semi-stable sulfo-NHS ester, which 
may then be reacted with primary amines (-NH2) to form amide cross-links. Although the 
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sulfo-NHS is not required with the EDC to conjugate carboxylates to amines, use of 
sulfo-NHS greatly enhances the coupling efficiency by the two-step reaction. The 
activation with sulfo-NHS preserves or increases water-solubility of the modified 
carboxylate-containing QDs, attributed to the charged sulfonate group.213, 214 
 
 
Fig. 6.1. Scheme of reactions between the MPA-capped QDs (circle 1) and the amine-
containing antibody (circle 2), involving the EDC and sulfo-NHS as cross-linkers.215 
 
In the experiment, an EDC solution (200 mg/ml) and a sulfo-NHS solution (2 
mg/ml) (Evident Technologies Inc., Troy, New York) were prepared in DI water, 
respectively. First, 100 µl of the as-synthesized MPA-capped CdS QDs suspension (12.8 
mM) was mixed with 10 µl of the EDC solution  and 100 µl of the sulfo-NHS solution  in 
190 µl of PBS solution, resulting in the total volume of 400 µl. After incubation at room 
temperature for 1 hr, the carboxyl groups on QDs surface were activated, and the mixture 
was centrifuged with 100 kD filter and rinsed with PBS for 3 times to remove the 
unreacted excess reagents and byproducts. Then the mixture volume was brought to 600 
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µl by adding PBS, and 100 µl of Salmonella t. antibody, CSA-1 (KPL, Gaithersburg, MD) 
(0.1 mg/ml) was added in. After another hour of reaction at room temperature, the 
unbound QDs and unbound antibodies were removed by centrifugation with 300 kD filter 
and rinsing with PBS for 3 times. Only the antibody-conjugated QDs remained, which 
was mixed with 100 µl of Salmonella t. cells suspension (KPL, Gaithersburg, MD) (1 
mg/ml). After incubation for 1 hr at room temperature, the cells were collected by 
centrifugation, and the supernatant was disposed of. The collected cells were centrifuged 
and rinsed with DI water for 3 more times to remove the salt and the excess unbound 
antibody-QDs. Finally, a drop of the Salmonella t. cells suspension was placed on a glass 
slide covered with a cover slip, which was visualized with a Leica DMRX upright 
microscope (Leica Microsystems GmbH, Wetzlar, Germany) equipped with a DAPI 
fluorescence filter. Digital images were acquired using a Leica DC 300FX camera (Leica 
Camera AG, Solms, Germany). 
The micrographs of the Salmonella t. cells were taken both in the bright field and 
in the fluorescence mode, as shown in Fig. 6.2 (a) and (b), respectively. Usually the cells 
have a size of 1-2 µm, and can only be visible under the normal light. After the whole 
process as described above, the cells were lighted up by the fluorescence of QDs. Note 
that the blue tint of the image came from the DAPI fluorescence filter which allows the 
excitation of around 360 nm and the emission of around 460 nm to pass through. The 
fluorescence image of the cells matched that of the cells under the normal light. It was 
indicated that the MPA-capped QDs were successfully activated by the EDC/sulfo-NHS, 
and conjugated with the Salmonella t. antibodies, which were then attached to the surface 
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of the Salmonella t. cells. Using the same strategy, the present aqueous QDs could be 
utilized to image other biological systems with many potential applications.  
 
                                  
(a) (b) 
Fig. 6.2. Micrographs of the Salmonella t. cells attached with the aqueous MPA-capped 
CdS QDs: (a) in the bright field and (b) in the fluorescence mode. 
 
6.2. Streptavidin-QDs conjugate for biotinylated targets 
 The strong and specific binding of streptavidin to biotin has been used as a 
common labeling tool in various bioapplications.216-218 It will be desirable to conjugate 
streptavidin on quantum dots and use them to label any biotinylated target. For example, 
the streptavidin-conjugated CdSe and CdTe QDs were used to label multiple, distinct 
endogenous proteins, i.e., the microtubules and fibroblasts with biotin-conjugated 
antibodies.219 Since biotinylated molecules are readily available, we envisage the wide 
applicability of the streptavidin-QDs conjugate in bio-sensing and bio-imaging 
applications where the unique fluorescence properties of QDs will be useful. 
In this study, the aqueous QDs were prepared with (3-mercaptopropyl) 
trimethoxysilane as the capping molecule. As discussed in chapter 4, the MPS can form a 
network through the cross-linking of silane groups, which protects the surface of QDs 
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well and results in the excellent stability of QDs in various physiological environments. 
Moreover, the sulfhydryl and silane groups of MPS are accessible for conjugation with 
other functional groups. The sulfosuccinimidyl 4-[n-maleimidomethyl]cyclohexane-1-
carboxylate (sulfo-SMCC) can be used as the cross-linker to conjugate the sulfhydryl-
containing QDs with any amine-containing molecules, such as streptavidin.220 Then the 
streptavidin-QDs can attach to any biotinylated targets readily.  
 
 
Fig. 6.3. Reaction scheme for the conjugation of the amine-containing streptavidin (circle 
2) and the sulfhydryl-containing QDs (circle 1) with sulfo-SMCC as the cross-linker.221 
 
The sulfo-SMCC is a soluble heterobifunctional cross-linker that contains N-
hydroxysuccinimide (NHS) ester and maleimide group that allow covalent conjugation of 
amine- and sulfhydryl-containing molecules. NHS esters react with primary amines at pH 
7-9 to form amide bonds, while maleimides react with sulfhydryl groups at pH 6.5-7.5 to 
form stable thioether bonds. In aqueous solutions, hydrolytic degradation of the NHS 
ester is a competing reaction whose rate increases with pH. The maleimide group is more 
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stable than the NHS-ester group but will slowly hydrolyze and lose its reaction specificity 
for sulfhydryls at pH values > 7.5. For these reasons, conjugation experiments involving 
sulfo-SMCC are usually performed at pH 7.2-7.5, with the NHS-ester (amine-targeted) 
reaction being accomplished before or simultaneous with the maleimide (sulfhydryl-
targeted) reaction.222 Specifically, the conjugation between the amine-containing 
streptavidin (represented by circle 2) and the sulfhydryl-containing QDs (represented by 
circle 1) using the sulfo-SMCC can be carried out as a two-step reaction as illustrated in 
Fig. 6.3. 
In the experiment, we prepared the MPS-replaced CdS QDs, which were 
conjugated with streptavidin, and then used to image the biotinylated microbeads. First of 
all, the MPA-capped CdS QDs with the MPA:Cd:S ratio of 2:3:1 and the concentration of 
1.6 mM were synthesized via the aqueous method as described in section 3.1. The 
capping molecule MPA was then replaced by MPS as follows. The MPA-capped CdS 
QDs suspension was centrifuged with 10 kD filter to remove the free MPA and other ions 
from the suspension. Meanwhile, an aqueous MPS solution with appropriate 
concentration was prepared with the pH adjusted to 12 by titration with 
(CH3CH2CH2)4NOH. The MPS solution was then added in the retentate of the CdS QDs 
suspension, resulting in a nominal ratio of MPS:Cd:S = 1/2:3:1 and the estimated CdS 
concentration of about 1.5 mM. Before conjugation, the MPS-replaced CdS QDs were 
centrifuged with 10 kD filter and rinsed with DI water for a few times to remove all the 
excess capping molecules and free ions and to maintain the pH of the suspension to 
around 7.  
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As the first step of conjugation reaction, 200 µl of the streptavidin (Thermo Fisher 
Scientific Inc., Rockford, IL) solution (1 mg/ml) in DI water was mixed with 30 µl of the 
sulfo-SMCC (Thermo Fisher Scientific Inc., Rockford, IL) solution (1 mg/ml) in PBS. 
After stored at room temperature for 1 hr, the mixture was centrifuged with 10 kD filter 
and rinsed with DI water for 3 times to remove the unreacted excess sulfo-SMCC. Then 2 
ml of the desalted MPS-replaced CdS QDs suspension was added to the purified mixture 
and kept at room temperature for 1.5 hr to form the streptavidin-QDs conjugates. 
Meanwhile, 1.9 mg of sulfo-NHS-LC-biotin (Thermo Fisher Scientific Inc., Rockford, IL) 
was added to 250 µl of amino-microbeads (Polysciences Inc., Warrington, PA) 
suspension in PBS (109 bead/ml) to create biotinylated microbeads. After reaction at 
room temperature for 2 hrs, the microbeads suspension was centrifuged and rinsed with 
DI water for 3 times, while the excess biotin was removed with the supernatant. After 
that, the suspension containing the streptavidin-QDs conjugates was mixed with the 
biotinylated microbeads suspension at room temperature for 0.5 hr. Finally, the mixture 
was centrifuged with 300 kD filter and rinsed with DI water for 3 times to remove the 
unbound streptavidin-QDs, and the microbeads were collected for fluorescence 
microscopy. As a control, the mixture of streptavidin-QDs with non-biotinylated 
microbeads was prepared as well, following the same procedure as described above 
except that no biotin was reacted with the microbeads.  
 Both the sample and the control were visualized with a Leica DMRX upright 
microscope (Leica Microsystems GmbH, Wetzlar, Germany) equipped with a DAPI 
fluorescence filter. Digital images were acquired using a Leica DC 300FX camera (Leica 
Camera AG, Solms, Germany).  
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Figure 6.4 shows the micrographs taken both in the bright field and in the 
fluorescence mode, with (a) and (b) for the sample and (c) and (d) for the control. In Fig. 
6.4 (a), every individual dot in the bright field was one microbead which had the size of 
about 1 µm, and the corresponding luminescent dot can be found in Fig. 6.4 (b) in the 
fluorescence mode. As can be seen, the microbeads were dispersed well and very few 
clusters were observed. It was confirmed that the MPS-replaced CdS QDs were 
successfully conjugated with streptavidin, which were then bound to the surface of the 
biotinylated microbeads. As comparison, the control of non-biotinylated microbeads was 
only visible in the bright field in Fig. 6.4 (c), and dark in the fluorescence mode in Fig. 
6.4 (d). Apparently, since these microbeads had no biotin on the surface, the streptavidin-
QDs conjugates could not attach onto them and cannot light them up.  
 
(a) (b) 
                  
(c) (d) 
Fig. 6.4. Micrographs of the biotinylated microbeads (a) in the bright field and (b) in the 
fluorescence mode; micrographs of the non-biotinylated microbeads (c) in the bright field 
and (d) in the fluorescence mode, after reaction with the streptavidin-QDs conjugates. 
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As demonstrated, the sulfo-SMCC can be used as an appropriate cross-linker to 
conjugate the MPS-replaced QDs with streptavidin. Based on the strong and specific 
bonding between streptavidin and biotin, the obtained streptavidin-QDs conjugates are 
ready for labeling of any biotinylated targets, which have great potential value for various 
bioapplications. 
6.3. Summary 
 Quantum dots are an ideal tool to label cells, investigate cellular process, and for 
many other imaging applications, because they provide outstanding features including a 
small and uniform size, modifiable surfaces, and unique optical properties for most 
sensitive detection and imaging. In this context, the delivery of QDs to the target 
represents a crucial step.189 Here we explored several possibilities to attach the aqueous 
QDs to biomolecules, taking advantage of the developed surface chemistry.  
For the MPA-capped QDs, the peptide bond was formed between the carboxyl 
group of MPA and the amino group of antibody, in the presence of coupling reagents 
EDC and sulfo-NHS. The imaging of Salmonella t. cells with the antibody-conjugated 
QDs was successfully demonstrated. For the aqueous QDs with MPS on the surface, 
sulfo-SMCC can be used as a cross-linker to form stable covalent bond between the 
sulfhydryl group of MPS and amine-containing molecules. With this strategy, we 
achieved the streptavidin-QD conjugate, which can be utilized to label any biotinylated 
targets, for example, the microbeads with biotin on the surface. In general, our aqueous 
QDs have great potential value for a wide range of imaging applications, given the 
versatile surface chemistry and modification. 
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CHAPTER 7: COLLABORATIVE RESEARCH ON APPLICATIONS OF THE 
AQUEOUS QUANTUM DOTS 
 
7.1. PEI-QDs complex for intracellular imaging  
 In section 6.1, we have demonstrated that the present water soluble quantum dots 
can be used as extracellular markers for cell targeting and imaging by conjugating 
specific antibody for surface bonding to QDs. Intracellular imaging using QDs would be 
of great interest as well. The delivery of QDs into cells will allow the investigation of 
subcellular events. Generally, live cell studies are limited by the requirement of fairly 
invasive protocols for loading QDs and the relatively large size of QDs compared to the 
cellular machinery, along with the subsequent sequestration of QDs in 
endosomal/lysosomal compartments. For long-period observation the potential 
cytotoxicity of loaded QDs must be evaluated.223 In this study, we explored the 
intracellular use of the present aqueous QDs. 
Although several strategies have been proposed to deliver QDs into cells, each 
method has its shortcomings. For instance, endocytosis of QDs is an easy and 
spontaneous process, but it results in sequestration of most QDs in the endosomal 
compartment where they are unavailable for subsequent intracellular assays. Both 
transfection via cationic liposomes and electroporation allow for parallel delivery of QDs 
in the cells simultaneously with endosomal escape, but the internalized QDs are prone to 
aggregation instead of dispersion. Meanwhile, cytoplasmic microinjection into single 
cells can yield an aggregate-free dispersion of QDs inside the cell with nuclear exclusion. 
However, this technique requires each cell to be individually manipulated.5  
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For cellular uptake, apparently smaller QDs are internalized more efficiently than 
larger ones with similar surface characteristics. Smaller QDs can also bypass degradation 
pathways better than larger particles of the same chemical composition. Due to the 
negative charge of the cellular membrane, positively charged particles are preferentially 
taken up by living cells. Meanwhile, endosome escape has been reported to occur for 
nanoparticles whose surface is positively charged inside the endosome with low pH.224 
Previously it has been shown that polyethylenimine (PEI) is an effective 
transfection medium in gene delivery.225, 226 Since every third atom of PEI is a protonable 
amino nitrogen atom, this makes the polymeric network an effective ‘proton sponge’ at 
virtually any pH. PEI is not only able to move across cell membranes through rapid 
endocytosis but also able to disrupt intracellular organelles through a ‘proton sponge 
effect.’227 This endosomolytic effect is believed to arise from the large number of amines 
in each PEI molecule, leading to proton absorption in acid organelles and an osmotic 
pressure buildup across the organelle membrane. This osmotic pressure causes a 
disruption of the acidic endosomes and a release of the trapped materials into the 
cytoplasm. PEI has been used to coat and deliver silica nanoparticles to mammalian cells, 
enabling the nanoparticles to escape from endosomes and to enter the cytoplasm and 
nucleus.228  
In this study, the intracellular imaging of the aqueous MPS-replaced CdS QDs 
was performed. PEI was used as a carrier to impart positive charges for transfection, and 
the rat PC12 neuronal cells were chosen as an example system.  
First of all, as described in section 6.2, the MPS-replaced CdS QDs were prepared 
with a nominal ratio of MPS:Cd:S = 1/2:3:1 and the estimated concentration of 1.5 mM 
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based on the concentration of S. For transmission electron microscopy, the excess 
capping molecules and ions in the QDs suspension were removed by centrifugation with 
10 kD filter and rinsing with DI water for a few times. The obtained QDs suspension was 
then dropped onto a carbon-coated copper grid, dried in air, and examined with a JEM-
2010F FasTEM high resolution analytical transmission electron microscope (Japan 
Electron Optics Ltd., Tokyo). As shown in Fig. 7.1, the TEM micrograph indicated that 
the MPS-replaced CdS QDs had the size of about 5 nm with clear crystal lattice fringes. 
The ultrafine size of the present QDs was advantageous for the subsequent endocytosis. 
 
 
5 nm 
Fig. 7.1. TEM micrograph of the MPS-replaced CdS QDs with the MPS:Cd:S ratio of 
1/2:3:1 and the concentration of 1.5 mM. 
 
The photoluminescence and absorption of the MPS-replaced CdS QDs were 
measured using a QM-4/2005 spectrofluorometer (Photon Technology International, 
Birmingham, NJ) and a Lambda-40 UV-Vis spectrometer (Perkin-Elmer Life and 
Analytical Sciences Inc., Boston, MA), respectively. As shown in Fig. 7.2, the QDs had 
an emission peak at 570 nm and the absorption edge around 430 nm. Using the same 
method described in section 3.4, we obtained a quantum yield of 7.5% for the present 
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MPS-replaced CdS QDs, which was comparable with that of the CdS QDs synthesized 
directly with MPA as the capping molecule. 
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Fig. 7.2. Photoluminescence (solid line) and absorption (dashed line) spectra of the MPS-
replaced CdS QDs. 
 
To prepare the PEI-QDs complex, the PEI (Mw = 25 kD, branched, Sigma-
Aldrich, St Louis, MO) was first dissolved in PBS with a concentration of 1 µg/µl which 
was equivalent to 4×10-5 M. As the CdS QDs had a size of about 5 nm and the 
conventional lattice constant of about 0.58 nm, a 1.5 mM elemental molar concentration 
(based on the concentration of S) of the CdS QDs suspension was equivalent to about 
4×10-7 M particle molar concentration. For ease and clarity, in what follows a PEI/QD 
number ratio refers to the ratio between the number of PEI molecules and that of the QD 
particles. For extracellular characterization, PEI-QD mixtures with PEI/QD number ratios 
from 0 to 500 were prepared by adding 0 to 1000 µl of the 1 µg/µl PEI solution to 200 µl 
of the CdS QDs suspension, followed by adding an appropriate amount of PBS to bring 
the final volume to 2.2 ml to maintain the same QDs concentration for all PEI-QD 
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mixtures. For example, to achieve a PEI/QD number ratio of 100, 200 µl of the 1 µg/µl 
PEI solution was mixed with 200 µl of the MPS-replaced CdS QDs suspension and 1.8 
ml of PBS. Note that the PEI/QD number ratio was nominal as not all PEIs in the 
suspension were involved in the PEI-QD complex formation. All the PEI-QD complex 
suspensions had a pH about 7. 
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Fig. 7.3. (a) Zeta potential and (b) size (with blow-up to show the size smaller than 50 nm) 
of the PEI-QD complex versus the PEI/QD number ratio. The insert schematics in (b) 
illustrate the PEI-QD complexes with different PEI/QD ratios. The dashed lines are 
guides for eyes to locate the zero zeta potential in (a) and the maximum size in (b). 
 
The MPS-replaced CdS QDs are negatively charged in basic solution, due to the 
dehydrogenation of silanol and thiol groups of the MPS. On the other hand, PEI contains 
plenty of amino groups which attract protons easily and become positively charged when 
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dissolved in water. As a result, when the QDs suspension and PEI solution were mixed, 
the PEI-QD complexes formed spontaneously due to the electrostatic attraction. The zeta 
potential and the size of the PEI-QD complexes were measured using a ZetaSizer Nano 
ZS (Malvern Instruments Ltd., Worcestershire, United Kingdom). 
The zeta potential and size of the PEI-QD complex versus PEI/QD number ratio 
were measured and shown in Fig. 7.3 (a) and (b), respectively. As can be seen, without 
PEI (i.e., the PEI/QD number ratio was 0), the MPS-replaced CdS QDs were negatively 
charged, exhibiting a zeta potential of -25 mV and a size of about 5-7 nm. This was 
consistent with the 5 nm size observed in the TEM micrograph shown in Fig. 7.1, 
indicating that the QDs were well dispersed in PBS. When the PEI/QD number ratio 
increased from 0 to 100, the zeta potential of the complex increased and changed sign at 
around PEI/QD = 20 and reached a positive maximum of 20 mV at around PEI/QD = 50, 
due to the positive charges of the PEI. As illustrated by the schematics in Fig. 7.3 (b), 
three regimes can be considered at different PEI/QD ratios. With the PEI/QD ratio around 
20 (Regime I), the PEI-QD complex contained multiple QDs intertwined by PEI and had 
the maximum size of about 3000 nm, which was coincident with the zero zeta potential of 
the complex at this PEI/QD ratio and indicative of the hetero-coagulation229, 230 nature 
between the positively charged PEI and the negatively charged QDs. Note that the peak 
of the complex size in Fig. 7.3 (b) was fairly narrow. Once the PEI/QD number ratio was 
away from 20, the PEI-QD complex became dispersed again. With the PEI/QD ratio 
around 50 (Regime II), as more PEI molecules were available to cover each QD, the PEI-
QD complex became more stable with the reduced size and the maximum positive zeta 
potential of 20 mV. With the PEI/QD ratios larger than 100 (Regime III), the observed 
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complex size eventually saturated at about 24 nm with the zeta potential of about 15 mV. 
Considering that the size of QDs was around 5 nm and that of PEI was in the range of 2-8 
nm, the PEI-QD complexes of about 24 nm may be thought of as ‘cherries’ with a QD at 
the center as the ‘pit’ and the PEIs surrounding the QD outside with its length (about 8 
nm) aligned along the radial direction as the ‘meat’. In comparison, the present saturated 
PEI-QD complex size of 24 nm was about the same as the size of the CdSe/CdS/ZnS 
QDs encapsulated with PEG-grafted PEI,231 and significantly smaller than the 50 nm size 
of similar CdS-PEI complexes reported by Mao et al.232  
The differentiated rat PC12 neuronal cells were used as targets for QDs 
transfection. For routine culture maintenance, undifferentiated rat PC12 neuronal cells 
(ATCC, Manassas, VA) were placed on plates coated with rat tail collagen (0.1 mg/ml in 
0.02 M acetic acid) and grown in Dulbecco’s modified Eagle’s medium containing 10% 
heat-inactivated horse serum and 5% fetal bovine serum (the so-called complete culture 
medium). Differentiation of PC12 neuronal cells was initiated by growing cells in the 
differentiation medium (DMEM supplemented with 2% horse serum and 1% fetal bovine 
serum) that contained the nerve growth factor (NGF, BD Bioscience, San Jose, CA) of 
100 ng/ml. Typically the NGF-induced neurite outgrowth of PC12 cells can be observed 
in one week post stimulation. All cell cultures were maintained at 37°C in a humidified 
atmosphere with 5% CO2 and 95% air. 
Before the QDs transfection, the cells were placed with the approximate 
concentration of 2×105 per well on a 12-well tissue-culture plate. The PEI-QD complexes 
with different PEI/QD number ratios were prepared by incubating various amounts of 
PEI solution (1 µg/µl in PBS) with 10 µl of the CdS QDs suspension (1.5 mM) in 
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DMEM without serum for 30 minutes. Culture medium was then added to the mixture for 
adjusting the final volume to 1.1 ml. Transfection was carried out by exposing cells to the 
1.1 ml transfection cocktail. Six hours later, 2 ml of complete culture medium was added 
to the culture without removing the PEI-QD complexes. Cells were incubated for 
additional 2 days and then washed thrice with PBS, prior to being immersed in the 
passive lysis buffer (Promega, Madison, WI) for 15 minutes. The fluorescence intensity 
of the cell lysate was measured using a microplate reader (SpectraMax M2e, Molecular 
Devices, Sunnyvale, CA) with the excitation wavelength of 365 nm and the emission 
filter of 505 nm to detect the photoluminescence signal of the CdS QDs. 
Figure 7.4 (a) shows the fluorescence intensity of the QDs in the transfected cells 
versus the PEI/QD number ratio. Note that the measured fluorescence intensity was a 
product of the QDs number inside the transfected cells and the fluorescence intensity of 
the individual QD, both of which could be affected by the PEI/QD ratio. To separate 
these two effects, we measured the fluorescence intensity of the PEI-QD complexes in 
PBS with a constant QD concentration but various PEI/QD ratios. Figure 7.4 (b) shows 
the resultant relative fluorescence intensity per QD versus the PEI/QD ratio, which was 
defined such that it was unity at PEI/QD = 0. As can be seen, the relative fluorescence 
intensity per QD was not constant with respect to the PEI/QD ratio. It peaked at around 
PEI/QD = 20 with higher brightness of the individual QDs, which coincided with the 
maximum of the complex size at this PEI/QD ratio. Although the fluorescence intensity 
per QD decreased with an increasing PEI/QD ratio away from the peak at PEI/QD = 20, 
it is worth noting that at a PEI/QD ratio around 160 and 200, the fluorescence intensity 
per QD still remained about unity, i.e., about the same as that of the uncomplexed QDs.  
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Fig. 7.4. (a) Relative fluorescence intensity of the QDs inside cells, (b) relative 
fluorescence intensity per QD, and (c) relative QD uptake efficiency versus the PEI/QD 
number ratio. * indicates P<0.001. P value was calculated using a two-tailed t test, 
assuming unequal variances. Results are presented as mean ± standard deviation (n = 3). 
 
Even when the PEI/QD ratio was increased to 400, the relative fluorescence intensity per 
QD only decreased slightly below unity. It is encouraging that the present PEI-QD 
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complex did not appear to degrade the fluorescence intensity of the individual QDs. To 
obtain the QD uptake number, we divided the measured fluorescence intensity of QDs in 
the transfected cells shown in Fig. 7.4 (a) by the relative fluorescence intensity per QD 
shown in Fig. 7.4 (b). The obtained relative number of QDs in the transfected cells which 
we dubbed QD uptake efficiency is plotted versus the PEI/QD ratio in Fig. 7.4 (c), where 
the uptake efficiency was defined such that it was unity at PEI/QD = 20 for ease of 
comparison. As can be seen, there was virtually no QD uptake at PEI/QD = 0 and the 
uptake efficiency increased rapidly to more than 17 at PEI/QD = 200. We speculate that 
the higher uptake efficiency at a higher PEI/QD ratio was in part due to the better PEI 
coverage on the QD with a positively charged surface and the reduced size of the PEI-QD 
complex at these PEI/QD ratios. The results indicated that PEI was an effective 
transfection medium for the present aqueous QDs in that it effectively carried the QDs 
into the cells and also that it did not appear to degrade the fluorescence intensity of the 
individual QDs.   
For long period observation, the potential cytotoxicity of the PEI-QD complex 
must be evaluated. In this study, the mitochondrial activity of PEI-QD-treated cells was 
measured using the CellTiter 96 AQueous one solution cell proliferation assay system 
(Promega, Madison, WI) according to the manufacturer’s protocol. In this cell 
viability/proliferation assay, cells were first transfected by the PEI-QD complexes with 
different PEI/QD number ratios. The transfected cells were then exposed to the 
methoxyphenyl-tetrazolium salt (MTS) compound. MTS was reduced by viable cells to 
form a colored formazan product, which was quantified colorimetrically at 490 nm using 
the SpectraMax M2e microplate reader. In Fig. 7.5, we plot the relative mitochondrial 
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activity of the transfected cells versus the PEI/QD number ratio. As can be seen, with the 
sample at PEI/QD = 0 as a control (i.e., no PEI), the relative mitochondrial activity only 
mildly decreased with an increasing PEI/QD ratio, and remained about 70% at a PEI/QD 
ratio of 100-200.  
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Fig. 7.5. Relative mitochondrial activity of PC12 neuronal cells transfected by PEI-QDs 
complexes with different PEI/QD number ratios. Results are presented as mean ± 
standard deviation (n = 3). 
 
In our earlier cytotoxicity test as discussed in chapter 5, it has been shown that the 
aqueous CdS QDs were nontoxic to cells at a concentration of 1 µM for up to six days 
and at a concentration of 10 µM for up to two days.233 In the present transfection studies, 
the CdS QDs concentration was less than 5 µM in the transfection medium. Therefore, 
within the two days of cell uptake period, it was unlikely cytotoxicity would arise from 
the CdS QDs. On the other hand, toxicity is a common characteristic of materials used for 
intracellular delivery because of their ability to alter or disrupt cell membranes. While 
PEI is often used in transfection, its cytotoxicity at high concentrations has been widely 
recognized.234 It was found that moderately branched PEI with low molecular weight (10 
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kD) resulted in efficient delivery with low toxicity in comparison with high molecular 
weight PEI.235 Based on this information and considering that the mild toxicity of the 
present PEI-QD complex only appeared at high PEI/QD ratios, it suffices to say that the 
observed toxicity mainly resulted from the PEI rather than the CdS QDs. For future 
studies, the addition of PEG as co-polymer, which produces sterically stabilized gene 
carriers, or use of low molecular weight of PEI may further reduce the cytotoxicity of the 
PEI-QD complex.236 
After careful characterization of the PEI-QD complex, we employed the confocal 
microscopy to image the transfected cells with various PEI/QD ratios. The PC12 
neuronal cells were transfected on 4-well chamber slides, following the procedure 
described previously. Prior to imaging, the cells were fixed with 4% paraformaldehyde in 
PBS for 15 minutes. Fixed cells were then washed and maintained in PBS. Visualization 
of cells with the internalized QDs was performed using a Zeiss LSM510 laser-scanning 
confocal microscope (Carl Zeiss, Jena GmbH, Germany). A UV laser of 364 nm and a 
long-pass 505 nm filter were used for excitation and fluorescence detection of the CdS 
QDs, respectively. 
In Figs. 7.6 (a)-(c) we show the typically observed confocal micrographs of the 
PC12 cells transfected with PEI/QD = 200, using the fluorescence signal of the CdS QDs 
as the reporter. In Figs. 7.6 (d)-(f), we overlap the fluorescence image with the cell 
morphology. As can be seen, the transfected cells exhibited uniform and diffuse 
fluorescence excluded from the nuclei, indicating an efficient cellular uptake of the PEI-
QD complexes and their uniform dispersion in the cytoplasm. Aggregation of QDs inside 
the transfected cells was visible when the PEI-QD complexes with a lower PEI/QD ratio 
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were used for transfection. With PEI/QD = 200, we were able to successfully deliver the 
complexes inside the cells and the complexes were gradually released to the cytoplasm 
after 3-4 days. This observation suggested that, enough amount of PEI induced the 
‘proton sponge effect’ during endocytosis and led to an escape of the complexes from the 
endocytic vesicles to the cytoplasm. Note that the fluorescence of the QDs was also 
visible within the axons indicating that the QDs were outside of endosomes and travelled 
to the narrow axons. The absence of the overlap of the fluorescence signal with any of the 
nuclei indicated that the present PEI-QD complexes could not enter the nuclei.  
 
 
(a) (b) (c) 
(d) (e) (f) 
Fig. 7.6. Three sets of confocal micrographs of the PEI-QDs-transfected PC12 neuronal 
cells, using the fluorescence of CdS QDs as the reporter (a-c) and overlapping of the 
fluorescence signals with the cell morphology (d-f). The scale bar is 20 µm. 
 
Apparently the aqueous CdS QDs could be effectively delivered and uniformly 
dispersed in the cytoplasm of PC12 cells with a PEI/QD ratio of 200. This result is 
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different from the confined presence of QDs in vesicles which were delivered into PC12 
cells via a QD-NGF-TrkA receptor pathway.237  
So far we have shown that the aqueous QDs can form complexes with PEI by 
electrostatic attraction. In a recent study,  PEG-grafted PEI was used to encapsulate and 
transfect CdSe/CdS/ZnS core-shell QDs synthesized by an organic route.231 The ligand-
exchange reaction between PEG-grafted PEI and capping molecules decreased the 
quantum yield of the QDs, as similar to what is commonly observed in converting QDs 
from an organic solvent to water.238, 239 In addition, the number of the PEG-grafted PEIs 
that could be employed was limited by the QD surface area. As a comparison, our present 
aqueous CdS QDs were synthesized in water, and they can couple to PEI directly through 
the electrostatic attraction, without the QY-reducing ligand-exchange reaction. The 
number of PEI relative to that of the QDs can be readily varied to optimize the complex 
properties and to improve the transfection. We have shown that, with PEI/QD = 200, the 
obtained PEI-QD complexes exhibited a saturated size of about 24 nm and a zeta 
potential of about 15 mV. The presence of PEI generated high cell uptake efficiency 
without sacrificing the photoluminescence of the QDs, and only mildly reduced the 
mitochondrial activity of the transfected cells. Confocal microscopy confirmed that the 
QDs were successfully internalized and uniformly distributed inside the cells. Owing to 
the small hydrodynamic radii and the transfection with no aggregation, the PEI-QD 
complex can be used to visualize the intracellular processes such as cellular trafficking, 
cell polarization, and division, provided that the QDs can be functionalized to bond to 
specific target in the cytoplasm. 
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7.2. QDs in electrospun polymer fibers  
 Usually the as-synthesized quantum dots are dispersed in a solvent. To broaden 
the applications of QDs, we intended to embed QDs in polymer fibers to form a 
composite system, which can provide flexible geometrical conformation while preserving 
the optical properties of QDs. In this study, we examined the feasibility of co-
electrospinning process for the fabrication of quantum dots-polymer composite fibers. 
The results suggested that the electrospun fibers served as a convenient and effective 
medium to carry the QDs and transmit the optical properties of QDs to various structures. 
 
 
Fig. 7.7. Schematic of electrospinning process.240 
 
Electrospinning is a simple process that can produce polymer fibers from melt or 
polymer solution using an electric field. Figure 7.7 illustrates a typical experimental setup 
for electrospinning. As can be seen, the liquid polymer is stored in a syringe with a sharp 
and conductible nozzle, which is placed opposite to a flat grounded target. When an 
electric field is applied between the nozzle and the target, the charged polymer solution 
forms a cone shape droplet at the tip of the nozzle. If the electric field is sufficiently high, 
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the solution droplet can overcome the surface tension and elongate towards the grounded 
target in a form of a jet. This charged jet undergoes a whipping mode, while jets split into 
multiple fine fibers, and travels to the target. The solvent evaporates while the polymer 
jet travels, resulting in dry ultrafine fibers collected by the flat target.241-245  
The diameter and morphology of polymer fibers produced by electrospinning can 
be controlled by varying the solution concentration, molecular weight of polymer, tip-to-
plate distance, applied electric field strength and geometry of the grounded target. 
Usually larger diameters of fibers are produced with higher concentration or higher 
molecular weight of polymer solution. The longer distance from the nozzle tip to the 
target allows more time for the solvent to evaporate thereby creating more favorable 
condition for the production of finer fibers.246-248 It has been observed that oriented fibers 
or yarns can be collected by changing the target geometry and changing the collecting 
mechanism.249-252  
Various synthetic and natural polymers such as conductive polymers, 
biodegradable polymers, silkworm silk and genetically engineered spider silk have been 
spun into fine fibers.253-257 To improve the mechanical, electrical properties of fibers or to 
functionalize the fibers, many different fillers have been incorporated into the polymer 
fibers for various applications.250, 258-260 In our study, we embedded the aqueous CdS 
quantum dots into polyethylene oxide (PEO) fibers to obtain the controllable 
conformation and structure with fluorescent properties. 
The CdS QDs were synthesized with the concentration of 1.6 mM via the 
developed aqueous method, as described in section 3.1. Then the PEO (MW = 600,000, 
Sigma-Aldrich, St Louis, MO) powder was dissolved into the as-prepared aqueous CdS 
140 
 
QDs suspension with 5% weight of the mixture, and followed by continuous stirring for 
24 hours. The prepared mixture was then transferred into a glass syringe with an 18-
gauge metallic needle. A 10×10 cm2 aluminum foil was grounded and placed vertically 
20 cm away from the needle tip. The electric field was applied with a high voltage power 
supply set at 15 kV. After a few hours of electrospinning, the fibers on the aluminum foil 
were collected for characterization. For comparison, some fibers were also prepared 
under the same experimental conditions with pure PEO solution and no CdS QDs.  
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Fig. 7.8. PL Spectra of the CdS QDs suspension (solid line), the CdS-PEO mixture 
(dashed line) and the pure PEO solution (dotted line).  
 
It was noticed that the clear yellowish CdS QDs suspension turned to opaque after 
the addition of PEO. We measured the photoluminescence spectra of the CdS QDs 
suspension, the CdS-PEO mixture and the pure PEO solution, using the QM-4/2005 
spectrofluorometer (Photon Technology International, Birmingham, NJ). As shown in Fig. 
7.8, the addition of PEO decreased the emission intensity of the mixture compared with 
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that of the CdS QDs, but didn’t change the emission wavelength which was around 600 
nm. The pure PEO itself had no emission in the visible range except for some auto-
fluorescence below 450 nm. The emission intensity of the CdS-PEO mixture was 
monitored for more than 3 months, which exhibited to be very stable without any 
discernable change. 
 
(a) (b) 
                                  
(c) (d) 
Fig. 7.9. Micrographs of the fibers made of the CdS-PEO mixture in the bright field (a 
and c) and in the fluorescence mode (b and d). 
 
The electrospun CdS-PEO composite fibers were obtained with continuous 
uniform morphology without beads formation, as shown in Fig. 7.9 (a). The fiber 
diameters ranged between 220 nm to 290 nm, similar to that of fibers made of the pure 
PEO solution. Under the fluorescence microscope, the CdS-PEO fibers glowed, as shown 
in Fig. 7.9 (b). For comparison, we prepared the fibers with the pure PEO as a mesh 
background and put a bundle of the CdS-PEO fibers above that. As can be seen in Fig. 
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7.9 (c) and (d), the fiber bundle with embedded CdS QDs was distinct from the dark 
background of the PEO fibers in the fluorescence mode. 
Apparently we have intimately incorporated the aqueous CdS QDs with PEO and 
formed the composite fibers using the co-electrospinning process. The CdS-PEO fibers 
with diameters of less than 300 nm were accomplished without compromising much of 
the fluorescence properties of the QDs. The fabricated fibers showed excellent 
photostability when stored at room temperature without photobleaching of the 
fluorescence over several months. 
Potentially, the obtained CdS-PEO composite fibers are suitable for many 
applications which require fluorescence properties with flexible structure. It has created a 
new pathway to connect nano-scale effect to macro structure performance and will lead 
to a new family of advanced QDs-polymer composite. The successful demonstration of 
these fluorescent ultrafine fibers opens a door for many promising applications, such as 
optical/biological sensors and labeling, drug delivery, scaffold for tissue engineering, 
anti-counterfeiting, and multi-functional textile, etc. 
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CHAPTER 8: CONCLUSIONS 
 
 The goal of this thesis is to develop an environmentally friendly, aqueous 
synthesis method to produce water soluble quantum dots with strong emission and good 
stability, suitable for biomedical imaging applications. Toward this general goal, I divide 
my effort in achieving the following objectives: 
1. Establish a methodology of aqueous synthesis using a model system: CdS QDs. 
2. Synthesize the water soluble ZnS QDs with surface chemistry to promote PL 
intensity and stability. 
3. Carry out cytotoxicity tests to verify the nontoxicity of the ZnS QDs and compare 
with the results of CdS QDs. 
4. Develop conjugation of the water soluble QDs with biomolecules for imaging 
applications. 
Here I briefly summarize the results of previous chapters as follows. 
1. With CdS QDs as a model system, a simple one-step and environmentally 
friendly synthesis method was developed to produce the QDs in water directly and at 
room temperature. The obtained QDs exhibited an ultra small size of 5 nm with cubic 
zinc blende structure. Despite of the trap-state emissions, the QDs had the size-dependent 
emission and the quantum yield of 6.0%, comparable to that of the commercial CdSe/ZnS 
core/shell QDs, 8.9%. Various processing parameters were studied to improve the 
photoluminescence properties of the CdS QDs. It was shown that, the synthesis of QDs in 
nitrogen atmosphere, with higher pH and with the MPA:Cd ratio of 2:1 can enhance the 
obtained PL intensity significantly. The aqueous CdS QDs displayed excellent stability 
under UV irradiation for 12 hrs, and in DI water, PBS, and the cytosol for more than 26 
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days. As a good capping molecule, MPA helped disperse the QDs well in the aqueous 
suspension, and can be used as a functional linker to conjugate the QDs with 
biomolecules via covalent bonding. The ease of processing and good PL properties of the 
aqueous QDs provided a practical and economical approach for synthesis of aqueous 
QDs, which potentially can be used as fluorescent labels for long-term imaging and 
tracking applications in biological systems. 
2. Via the developed one-step aqueous method, nontoxic ZnS QDs have been 
synthesized with MPA as the capping molecule. The MPA-capped ZnS QDs were 4-5 nm 
in size with a cubic zinc blend structure. Synthesized at pH 12 and with the ratio of 
MPA:Zn:S = 8:4:1, the obtained ZnS QDs exhibited bright blue photoluminescence with 
the quantum yield of 31%, higher than that of the commercial CdSe/ZnS core-shell QDs.  
MPS was also used as the capping molecule to synthesize the ZnS QDs through 
the similar aqueous approach. The MPS-capped ZnS QDs were well dispersed with a 
particle size of around 5 nm and a cubic zinc blende crystalline structure. With the 
MPS:Zn:S ratio of 1/4:2:1 and 1/2:2:1 which provided one or two molecular layers of 
MPS coating on the particle surface, the ZnS QDs exhibited the optimized emission 
intensity with high quantum yields of 25% and 42%, respectively. As the capping 
molecule, MPS can eliminate the dissociation effect of disulfide reaction, and protect the 
QD surface better by the cross linking of hydrolyzed silane groups which formed a 
network surrounding the QDs. Therefore, compared with the MPA-capped ZnS QDs, the 
MPS-capped ZnS QDs exhibited significantly improved colloidal, thermal and photo 
stability under various conditions.  
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To preserve the high PL intensity of the MPA-capped ZnS QDs and the excellent 
stability of the MPS-capped ZnS QDs, a capping molecule replacement process was 
developed. The ZnS QDs were first synthesized with MPA, and then followed by a 
second step to substitute some of MPA with MPS. The resultant MPS-replaced ZnS QDs 
remained the small particle size of around 5 nm and the cubic zinc blende crystal 
structure. Having both MPA and MPS on the surface, the MPS-replaced ZnS QDs with 
the ratio of MPS:Zn:S = 1/2:4:1 were not only brighter than the original MPA-capped 
QDs, but also maintained the colloidal and photo stability of the MPS-capped QDs. The 
extraordinary high quantum yield of 75%, and more than 60 days lifetime in the ambient 
conditions enabled the new MPS-replaced ZnS QDs a very promising imaging tool.  
3. Cytotoxicity tests of the aqueous ZnS QDs were carried out with human 
endothelial cells by cell counting with Trypan blue staining and by the fluorescence assay 
with Alamar Blue. The results showed that the ZnS QDs with all four types of surface 
conditions were nontoxic at both 1 µM and 10 µM for at least 6 days. As comparison, the 
CdS QDs with the same size and surface conditions were nontoxic only at 1 µM and 
showed significant cytotoxicity at 10 µM after day 2. It was indicated that the 
cytotoxicity of the CdS QDs and the lack of it in ZnS QDs were mainly due to presence 
and absence of a toxic element, respectively. The intrinsic nontoxicity of the aqueous 
ZnS QDs presents a step forward in reducing the potential hazards to the environment 
and to human health, making them ideal for in vivo imaging applications.  
4. Taking advantage of the developed surface chemistry, two ways to attach the 
aqueous QDs to imaging targets were investigated. For the MPA-capped QDs, the 
peptide bond can be formed between the carboxyl group of MPA and the amino group of 
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biomolecules, in the presence of coupling reagents EDC and sulfo-NHS. As an example, 
the Salmonella t. cells were successfully imaged with the antibody-conjugated QDs. For 
the QDs with MPS on the surface, sulfo-SMCC can be used as a cross-linker to form 
covalent bond between the sulfhydryl group of MPS and amine-containing molecules. 
Especially, the obtained streptavidin-QD conjugate can be utilized to label any 
biotinylated targets. Moreover, we investigated the delivery of QDs into cells for 
intracellular imaging. Employing electrostatic interaction between the negatively charged 
QDs and the positively charged polyethylenimine (PEI) molecule, the PEI-QDs complex 
was formed and transfected into cells with uniform distribution. Furthermore, the water 
soluble QDs were embedded in polymer fibers through electrospinning, forming the 
composite which possessed both fluorescent properties and flexible conformation.  
In conclusion, a simple, economic, environmental friendly, aqueous synthesis 
method has been developed to produce quantum dots in water directly at room 
temperature. Without any toxic element, the aqueous ZnS QDs were prepared with 
various capping molecules, possessing outstanding features such as small particle size 
(~5 nm), biocompatibility, strong photoluminescence and good stability. The present 
aqueous QDs have great potential for a wide range of imaging applications, due to their 
versatile surface chemistry and modification. 
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CHAPTER 9: FUTURE WORK 
 
 There are two topics that were mentioned in my candidacy proposal, but the 
research was not carried out due to the development of other topics. I would like to 
address how the two topics can be studied by future students. 
9.1. Water soluble QDs with NIR emission 
 In clinical settings to date, optical imaging is restrained in tissues close to the 
surface of the skin, tissues accessible by endoscopy, and intraoperative visualization. 
Near infrared (NIR) imaging of living tissue is an area of growing interest, which can 
provide surgeons with direct visual guidance throughout a sentinel-lymph-node mapping 
procedure, minimizing incision and dissection inaccuracies and permitting real-time 
confirmation of complete resection. NIR optical imaging devices for detecting and 
diagnosing breast cancer have been tested in patients and the initial results are 
encouraging.261, 262  
Photon’s absorption and propagation through living tissue depends on the tissue’s 
scattering, anisotropy, and refractive index. Using visible fluorescent tags, deep organs 
such as the liver and spleen could not be detected in mice because of the limited 
penetration depth of visible light. Deep-tissue imaging requires the use of infrared light 
within a spectral window separated from the major absorption peaks of hemoglobin and 
water. The use of QDs with NIR emission is estimated to improve the tumor-imaging 
sensitivity at least ten fold, allowing sensitive detection of 10-100 cancerous cells. High-
transparency spectra band centered at 840 nm, 1110 nm, 1320 nm, and 1680 nm can 
enable detection depth of 5-10 cm.44  
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In addition to absorption, tissue ‘autofluorescence’ can severely limit the signal-
background-ratio (SBR) of optical imaging. The strong green autofluorescence of the 
skin and viscera, and especially the gallbladder, small intestine and bladder, is 
astoundingly high, which precludes the use of visible light for most in vivo imaging 
applications.263 In contrast, using NIR light can solve this problem and eliminate the 
autofluorescence background effectively with a NIR filter set.  
Therefore, the aqueous quantum dots with NIR emission are greatly desirable as a 
powerful fluorescent label for deep living tissue imaging. Moreover, the applications of 
infrared-emitting QDs also include monolithic integration of fiber optic and free space 
telecommunications, solar and thermal photovoltaic for long wavelength energy 
conversion, and infrared sensing and imaging including thermal signatures.264  
Generally, there are two strategies to tune the band gap and change the emission 
wavelength of QDs, i.e., controlling the particle size and choosing different 
semiconductor materials.  
As discussed in previous chapters, the particle size of QDs can be affected by 
various processing parameters, including sonication time, refrigeration condition, 
synthesis atmosphere, temperature and time of heat treatment, etc. Comprised of the same 
material, QDs with larger particle size may be grown to achieve smaller band gap with 
red-shifted emission. However, this method can only adjust the emission wavelength in a 
limited range, since the band gap of QDs is always larger than the value of the 
corresponding bulk material. 
Doping in QDs can create new energy states within the band gap of the host 
material and thereby help generate emission with longer wavelength. As the electron 
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clouds of localized ions are allowed to overlap and hybridize, the exciton energy in doped 
nanocrystals can be fast transferred into the energy state of the impurity, and then 
followed by an efficient and fast radiative recombination with emission.265 Many rare 
earth ions were doped into nanocrystals and exhibited NIR photoluminescence, such as  
erbium (Er3+), ytterbium (Yb3+), neodymium (Nd3+),266 etc. But the emission of these 
doped ‘color center’ is usually very weak. Meanwhile, doping nanocrystals has proved 
difficult. One explanation for this is the possible existence of intrinsic self-purification 
processes that could hamper the introduction of dopant at the nanoscale. Depending on 
the preparation conditions, II-VI nanocrystals doped with transition metals may suffer 
from irregularities in their lattice structure.267 It was also suggested that the underlying 
mechanism that controls doping is the initial adsorption of impurities on the nanocrystal 
surface during growth, which depends on the strength of its binding with surface atoms 
and is affected by three main factors: surface morphology, nanocrystal shape, and 
surfactants in the growth solution.268 More effort is needed to investigate the doping of 
QDs to engineer the band gap energy of various systems and to obtain different emission 
wavelengths. 
Another approach to alter the band gap of QDs is by forming solid solution of 
multiple compositions with different band gaps. According to Vegard's law,269 both the 
lattice parameter and the band gap can be varied linearly with the compositions of two 
constituents in a solid solution, given a small compositional range. Consider a solid 
solution which is formed between the cubic compounds AC and BC with respective 
lattice parameters aAC and aBC, and band gaps (Eg)AC and (Eg)BC. If the molar ratio 
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AC:BC in the solid solution is (1-x) : x, then the lattice parameter for the solid solution is 
given by  
                                             aA1-xBxC = (1 – x) aAC + x aBC                                             (9.1) 
And the band gap is given by  
                                       (Eg)A1-xBxC ≈ (1 – x) (Eg)AC + x (Eg)BC                                   (9.2) 
The above relation suggests that band gap tailoring can be achieved by adjusting the 
composition of the constituents in a solid solution. For instance, ternary cadmium 
selenium telluride (CdSe1-xTex) QDs have been prepared for potential use as constant-size 
biolabels with tunable fluorescence emission in the far-red and near-infrared (650-850 
nm) spectral range.270  
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Fig. 9.1. NIR photoluminescence of the aqueous Cd0.75Pb0.25S QDs. 
 
 In the future work, many other solid solutions of QDs with different band gaps 
will be explored to yield the desired NIR emission. As an example, since CdS has the 
band gap of 2.4 eV and PbS has the band gap of 0.3 eV, the alloyed Cd(1-x)PbxS QDs may 
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have the adjusted band gap between those of CdS and PbS, therefore can probably emit 
the photoluminescence in NIR range. The preliminary results achieved by Andrew Kopek 
indicated that the Cd0.75Pb0.25S QDs suspension was clear with yellow tint, exhibiting the 
emission around 840 nm as shown in Fig. 9.1. Though the emission intensity was not 
very strong yet, more systematic study will be performed to optimize the synthesis and 
composition of the alloyed QDs to enhance the photoluminescence.  
Another promising solid solution system is the Zn(1-x)PbxS QDs. By replacing Cd 
with Zn, the toxicity of the QDs will be eliminated significantly. Compared with the pure 
ZnS QDs, the Zn(1-x)PbxS QDs will have the excitation with larger wavelength (> 340 
nm), which will not be blocked by the lens in microscopes and hence expand the potential 
imaging applications. An expectable challenge of the synthesis of Zn(1-x)PbxS QDs is the 
big difference between the solubility of ZnS and of PbS. Since PbS has much lower 
solubility than ZnS and can precipitate easily, low percentage of Pb, i.e., less than 25%, 
will be tried to avoid the phase separation of these two compositions. 
In addition, a direct approach to achieve the NIR emission of QDs is to choose the 
semiconductor materials with small enough band gap. So far, most of the QDs with NIR 
or infrared emission are made of the toxic elements, such as Cd,31, 270 Hg, 271-274 Pb,275-279 
and As.280, 281 To reduce the toxicity, ZnSe QDs is a new system worth to try. Although 
ZnSe has a relatively large band gap of 2.7 eV, with trap state emissions and appropriate 
doping, it is possible to obtain red or even NIR emission from ZnSe QDs, which will be 
good for tissue imaging and separate from the green autofluorescence. As reported, ZnSe 
nanocrystals were synthesized by a high temperature organic chemical route,282 and by an 
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aqueous synthesis with reflux at 100oC.283 It will be valuable to synthesize the ZnSe QDs 
via the newly developed simple aqueous method.  
Another good candidate for nontoxic QDs with NIR emission is FeS2. Fe is a 
benign and nutrient element needed by human body. As a semiconductor, FeS2 has the 
band gap of about 0.9 -1.4 eV, which is good for infrared emission. With small enough 
particle size, it is possible to have the emission of FeS2 QDs blue-shifted to NIR range. 
To avoid the formation of Fe(OH)3, acidic environment is preferred for the aqueous 
synthesis of FeS2 QDs and cysteamine can be used as the capping molecule.284 
9.2. Thin film of QDs 
 For applications involving the electroluminescence and/or photovoltaic properties 
of QDs, the QD-containing thin film structure is required.  Usually the thin film of QDs is 
formed via phase segregation between the QDs with capping molecules and organic 
materials. The process is governed by the physical size and chemical character of the two 
solvated constituents. Therefore, the pair of materials with disparate chemical 
functionality must be carefully selected, such as the N,N'-diphenyl-N,N'-bis(3-
methylphenyl)-(1,1'-biphenyl)-4,4'-diamine (TPD) molecule with aromatic character and 
the capping molecule of QDs with aliphatic chains.59  
With our aqueous MPS-capped QDs, the cross linking of the hydrolyzed silane 
groups will form a network automatically, which can be utilized to deposit the QDs on a 
glass surface. The film thickness can be controlled by the number of cross linking layers 
through multiple depositions. The thin film structure of QDs can then be integrated into 
LED, solar cells, etc. for display and energy harvesting applications.  
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